Insecticidal proteins and methods of use thereof

By encoding the nucleic acid sequence and peptide of the shuffled Cry toxin polypeptide, the limitations of existing anti-insect crops to narrow-range insect pest resistance are solved, effective control of a variety of insect pests is achieved, and economical and environmentally friendly organisms are provided. Control method.

CN119060146APending Publication Date: 2024-12-03PIONEER HI BREED INTERNATIONAL INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411050097.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2018-08-29
Filing Date
2019-08-22
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

Existing insect-resistant crop plants provide resistance to economically important insect pests in a narrow range, but new alternative biological control agents are needed to effectively control insect pests when they develop resistance in the face of different insecticidal compounds.

Method used

Provides nucleic acid sequences encoding shuffled Cry toxin polypeptides and corresponding polypeptides by transforming organisms to produce activities that kill Lepidoptera, Coleoptera, Diptera, fungal and nematode pests, including through domain exchange and amino acids Methods such as substitution improve insecticidal activity.

Benefits of technology

It realizes effective control of a variety of insect pests, enhances crop resistance, provides environmentally friendly alternative biological control methods, and reduces production costs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119060146A_ABST
    Figure CN119060146A_ABST
Patent Text Reader

Abstract

The present invention relates to insecticidal proteins and methods of use thereof. The present disclosure relates to the field of molecular biology. Novel genes encoding pesticidal proteins are provided. These pesticidal proteins and nucleic acid sequences encoding them are useful in the preparation of pesticidal biologics and the production of pest resistant transgenic plants. Methods are provided for generating or altering pesticidal proteins in order to alter or enhance pesticidal activity.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application is a divisional application of Chinese patent application No. 201980056580.7 “Insecticide protein and method of use thereof” filed on August 22, 2019.

[0002] References to electronically submitted sequence listings

[0003] An official copy of the sequence listing is submitted electronically via EFS-Web as an ASCII formatted sequence listing with the file name "6806_SeqList," created on August 19, 2019, and having a size of 825 kilobytes, and is submitted concurrently with this specification. The sequence listing contained in the ASCII formatted file is a part of this specification and is incorporated herein by reference in its entirety.

[0004] CROSS-REFERENCE TO RELATED APPLICATIONS

[0005] This application claims the benefit of U.S. Provisional Application No. 62 / 724,276, filed August 29, 2018, which is incorporated herein by reference in its entirety. Technical Field

[0006] The present disclosure relates to the field of molecular biology. Novel genes encoding pesticidal proteins are provided. These pesticidal proteins and the nucleic acid sequences encoding them can be used to prepare pesticidal formulations and produce pest-resistant transgenic plants. Methods are also provided for producing or modifying pesticidal proteins to alter or enhance their pesticidal activity. Background Art

[0007] The use of microbial agents (such as fungi, bacteria, or other insect species) to biologically control insect pests of agricultural significance provides an environmentally friendly and commercially attractive alternative to synthetic chemical pesticides. Generally speaking, the use of biopesticides carries a lower risk of pollution and environmental harm, and biopesticides offer greater target specificity than that characteristic of traditional broad-spectrum chemical insecticides. In addition, biopesticides tend to be less expensive to produce and, therefore, can increase the economic yield of various crops.

[0008] Certain species of Bacillus microorganisms are known to have insecticidal activity against a range of insect pests, including those in the orders Lepidoptera, Diptera, Coleoptera, and Hemiptera. Bacillus thuringiensis (Bt) and Bacillus popilliae are the most successful biological control agents discovered to date. Insect pathogenicity has also been attributed to strains of Bacillus larvae, Bacillus lentimorbus, Bacillus sphaericus, and Bacillus cereus. Microbial insecticides, particularly those obtained from Bacillus strains, play an important role in agriculture as an alternative to chemical pest control.

[0009] By carrying out genetic engineering to produce pest-killing protein from Bacillus, crop plants with insect-resistant enhancement have been developed.For example, corn and cotton plants have been genetically engineered to produce pest-killing protein separated from Bacillus thuringiensis strain.Now, these genetically engineered crops are widely used in agriculture, and provide the environmentally friendly alternative that replaces traditional insect control method for farmers.Although they have been proven to be very successful commercially, these genetically engineered insect-resistant crop plants may only provide resistance for the economically important insect pests of a narrow range.In some cases, insects can produce resistance to different insecticide compounds, which just causes the need to identify the alternative biological control agents for pest control.

[0010] Thus, there remains a need for novel pesticidal proteins having a diverse range of insecticidal activity against insect pests, such as insecticidal proteins active against a variety of insects in the Lepidoptera and Coleoptera orders, including but not limited to insect pests that have developed resistance to existing insecticides. Summary of the Invention

[0011] In one aspect, compositions and methods for conferring pesticidal activity on bacteria, plants, plant cells, tissues, and seeds are provided. The compositions include nucleic acid molecules encoding pesticidal and insecticidal polypeptides, vectors containing those nucleic acid molecules, and host cells containing the vectors. The compositions also include the pesticidal polypeptide sequences and antibodies against those polypeptides. The compositions also include transformed bacteria, plants, plant cells, tissues, and seeds.

[0012] On the other hand, there is provided an isolated or recombinant nucleic acid molecule encoding a shuffled Cry toxin polypeptide, the polypeptide comprising amino acid substitutions, deletions, insertions, and fragments thereof. There is provided an isolated or recombinant nucleic acid molecule capable of encoding SEQ ID NOs: 57-112 and 275-278 and shuffled Cry toxin polypeptides comprising amino acid substitutions, deletions, insertions, fragments thereof, and combinations thereof. In certain embodiments, there is provided a polynucleotide encoding an insecticidal polypeptide, wherein the polynucleotide comprises a nucleic acid sequence as shown in any one of SEQ ID NOs: 57-112, 214-246, and 275-278. Also encompassed are nucleic acid sequences that are complementary to the nucleic acid sequences of the embodiments or hybridize with the sequences of the embodiments. The nucleic acid sequence can be used in a DNA construct or expression cassette for transformation and expression in a variety of organisms (including microorganisms and plants). The nucleotide or amino acid sequence can be a synthetic sequence that has been designed for expression in an organism, including but not limited to a microorganism or a plant.

[0013] In another aspect, shuffled Cry toxin polypeptides are contemplated. Also provided are isolated or recombinant shuffled Cry toxin polypeptides of SEQ ID NOs: 57-112 and 275-278, as well as amino acid substitutions, deletions, insertions, fragments thereof, and combinations thereof.

[0014] On the other hand, methods for producing polypeptides and using those polypeptides to control or kill lepidoptera, coleoptera, nematodes, fungi, and / or dipteran pests are provided. The transgenic plants of the embodiments express one or more of the pest killing sequences disclosed herein. In various embodiments, the transgenic plants further comprise one or more other insect-resistant genes, for example, one or more other genes for controlling coleoptera, lepidoptera, hemiptera, or nematode pests. It will be understood by those skilled in the art that the transgenic plants may comprise any gene that imparts agronomic traits of interest.

[0015] In another aspect, methods for detecting the nucleic acids and polypeptides of the embodiments in a sample are also included. Kits for detecting the presence of shuffled Cry toxin polypeptides or polynucleotides encoding shuffled Cry toxin polypeptides in a sample are provided. The kits can be provided along with all reagents and control samples required to perform the method for detecting the desired agent, as well as instructions for use.

[0016] In another aspect, the compositions and methods of the embodiments can be used to generate organisms with enhanced pest resistance or tolerance. These organisms and compositions comprising them are desirable for agricultural purposes. The compositions of the embodiments can also be used to generate altered or improved proteins with pesticidal activity, or to detect the presence of shuffled Cry toxin polypeptides.

[0017] On the other hand, a method for reorganizing a Cry toxin polypeptide is provided, the method comprising exchanging the alpha ring domain of domain 1 (Dm1) from a first Cry toxin to a second Cry toxin. In some embodiments, the reorganized Cry toxin polypeptide has a changed spectrum of activity. In another embodiment, the reorganized Cry toxin polypeptide has a changed amount of pesticidal activity. In some embodiments, the reorganized cry toxin polypeptide has a changed mode of action or site of action. In some embodiments, the reorganization comprises exchanging alpha ring 2, 3, 4, 5 and / or 6 from a first Cry toxin to a second Cry toxin. In some embodiments, the Cry toxin is a natural Cry toxin. In some embodiments, the Cry toxin is a reorganized or hybrid Cry toxin. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] Figure 1 Shown are different full-type Bt Cry toxin domain fragments (Dm1, Dm2, and Dm3) optimized for E. coli expression and synthesized for some shuffling reactions and templated for fragment PCR. Shown are the border sequences at the junctions of Dm1, Dm2, and Dm3 (SEQ ID NOs: 266 and 267, respectively).

[0019] Figure 2 A schematic diagram of a library of 12 constructs synthesized as described in Example 2, used to exchange the α loop 3-5 of various shuffled Cry toxins. In Library 1, the Dm1α fragments of Cry1Jc, Cry1Ca, and Cry1Ah were mixed with the Dm3 fragments of Cry1Jc, Cry1Ac, and Cry1Ca, along with Cry1Jc Dm2. Six constructs were synthesized. In Library 2, the Dm1α fragments of Cry1Ja, Cry1Ca, and Cry1Ah were mixed with the Dm3 fragments of Cry1Ja, Cry1Ac, and Cry1Ca, along with Cry1Ja Dm2. Six constructs were synthesized.

[0020] Figure 3The library design is shown, whereby several hybrid domains 1 (Dm1) are reorganized with Cry1Ea domain 2 (Dm2) and Cry1Ca domain 3 (Dm3) at three different intersections of Cry1Ca Dm3 with different lengths. The hybrid Dm1s differ in the α3-5 region. Together with nine hybrid Dmls, three Cry1Ea-like Dm1 hybrids were designed. Dm1 and Dm1α fragments of different Cry toxins were mixed with Cry1Ea and Cry1Ca Dm2-Dm3 fusion fragments to produce different novel Cry toxin variants. Cry1Ea Dm2 and Cry1Ca Dm2 were fused at different intersections: WTHRS (ECF2 library, SEQ ID NO: 251), ITQIP (ECF3 library, SEQ ID NO: 252), and GFTGG (ECF4 library, SEQ ID NO: 253).

[0021] Figure 4 Shown are comparisons of several Cry toxins with seven different intersection regions between Dm2 and Dm3 or only within Dm3, which are used as recombination sites for Dm3 fusion on the C16, C18, and C21 Dm1-Dm2 backbones. Dm3 shuffling is performed by fusing Dm3 to the Dm1-Dm2 backbone at different intersection (fusion) points. The intersections are labeled F2 to F8 (SEQ ID NOs: 251-257).

[0022] Figure 5 Shown is the homology model of IPRS-C16 with the domain of different mark.The α spiral (single and combination both) of reorganization is represented with black, and the rest of albumen (the rest of Dm1, Dm2 and Dm3) is colored with grey.α reorganization is completed in IPRS-C16 and IPRS-C21.

[0023] Figure 6 Shown is the homology model of IPRS-C16 (top view image), which shows the reorganized fragments (α-3, α-4 and a portion of the α-5 fragment) of Dm1 colored in black. Different α helices and domains are marked. The position of the helices is determined based on the comparison of multiple Cry toxins and the X-ray structural information of known Cry toxins.

[0024] Figure 7Shown are the tabulations of all IPRS-C variants that use different Cry toxin fragment reorganizations to produce.The domain composition of all variants is shown.Dm2 and Dm3 fusion intersection (F) are also shown.Determine the specific activity (IC50 and LC50) of all these variants for CEW, FAW and ECB, and be listed as having tested.The variant in the table is based on its activity for FAW, CEW or both being divided.

[0025] Figure 8 Shown are fragments of Dm1 shuffled in Examples 1, 2, and 3 (α-loop 3 - a portion of α-loop 5). The shaded area is the anchor sequence where the shuffled fragments are fused to the backbone. Typically, the 5' anchor sequence motif is QIEQL (SEQ ID NO: 247), and the 3' anchor sequence motif is ANLHL (SEQ ID NO: 250). The diversity at each of these anchor sequence positions is also listed below the normal anchor sequence motif.

[0026] Figure 9 Shown are fragments of Dm1 shuffled as described in the Examples (α-loop 3, 4, 5, 3-4, 4-5, and 3-5). The shaded areas are anchor sequences where the shuffled fragments are fused to the backbone. Typically, the 5' anchor sequence motifs are QIEQL (SEQ ID NO: 247, for shuffling α-helices 3, 4 & 5, and 3 & 5), DPXNP (SEQ ID NO: 248, for shuffling α-4, 4 & 5), and SLQPG (SEQ ID NO: 249, for shuffling α-5). The 3' anchor sequence motifs are DPXNP (SEQ ID NO: 248, for shuffling α-3), SLQPG (SEQ ID NO: 249, for shuffling α-3 & 4), and GQRWG (SEQ ID NO: 268, for shuffling α-5, 4 & 5, and 3 & 5). The diversity at each of these anchor sequence positions is also listed below the normal anchor sequence motifs.

[0027] Figure 10 IPRS variants (and associated SEQ ID NOs) generated as described in the Examples are shown.

[0028] Figure 11 Cry toxin alpha loops (and associated SEQ ID NOs) that can be used for alpha loop exchange are shown.

[0029] Figure 12 Proprietary Cry toxins (and associated SEQ ID NOs) that exhibit insecticidal activity and can be used for shuffling as described herein are shown.

[0030] Figure 13Shown are regions of Cry toxin Dm3 (and associated SEQ ID NOs) that exhibit altered activity when exchanged with another Cry toxin. DETAILED DESCRIPTION

[0031] As used herein, the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to "a cell" includes a plurality of such cells, and reference to "a protein" includes reference to one or more proteins and their equivalents, and so forth. All technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs, unless expressly indicated otherwise.

[0032] The present disclosure relates to compositions and methods for controlling pests. The methods involve transforming organisms with nucleic acid sequences encoding reorganized Cry toxin polypeptides. Specifically, the nucleic acid sequences of the embodiments can be used to prepare plants and microorganisms with pesticidal activity. Therefore, transformed bacteria, plants, plant cells, plant tissues, and seeds are provided. The compositions include pesticidal nucleic acids and proteins of bacterial species. The nucleic acid sequences can be used to construct expression vectors that are subsequently transformed into target organisms, as probes for isolating other homologous (or partially homologous) genes, and for producing altered reorganized Cry toxin polypeptides by utilizing various aspects of certain methods known in the art (such as directed mutagenesis, domain exchange, or DNA shuffling). The reorganized Cry toxin polypeptides can be used to control or kill Lepidoptera, Coleoptera, Diptera, fungi, Hemiptera, and nematode pest populations, and can be used to produce compositions with pesticidal activity. Insect pests of interest include, but are not limited to, Lepidoptera species, including, but not limited to, corn earworm (CEW) (Spodoptera zea), European Corn Borer (ECB) (Ostrinia nubialis), diamond-back moths, such as Helicoverpa zea Boddie; soybean loopers, such as Pseudoplusia includens Walker; and velvet bean caterpillars, such as Anticarsia gemmatalis Hübner; and Coleoptera species, including, but not limited to, Western corn rootworm (Diabrotica virgifera) - WCRW, Southern corn rootworm (Diabrotica undecimpunctata howardi))-SCRW, and Northern cornrootworm (Diabrotica barberi)-NCRW.

[0033] "Pesticide toxin" or "pesticide protein" is used herein to refer to a toxin that has toxic activity against one or more pests. For example, the pests may include members of the orders Lepidoptera, Diptera, Hemiptera, and Coleoptera, or the phylum Nematoda, or proteins that have homology to such proteins. Pesticide proteins have been isolated from organisms including, for example, Bacillus species, Bacillus thurengiensi ("Bt"), Pseudomonas species, Photorhabdus species, Xenorhabdus species, Clostridium bifermentans, and Paenibacillus popilliae.

[0034] In some embodiments, the reorganized Cry toxin polypeptide comprises an amino acid sequence deduced from the full-length nucleic acid sequence disclosed herein, as well as an amino acid sequence that is shorter than the full-length sequence due to the use of an alternative downstream start site or due to processing that produces a shorter protein with pesticidal activity. Processing can occur in the organism in which the protein is expressed or in the pest after ingestion of the protein.

[0035] In another aspect, a method for shuffling Cry toxin polypeptides is provided, the method comprising exchanging or shuffling the α-loop domain of Domain 1 (Dm1) from a first Cry toxin into a second Cry toxin, generating a heterologous α-loop region in the second shuffled Cry toxin.

[0036] In some embodiments, the methods and compositions disclosed herein relate to shuffling or exchanging all or part of domain 3 (Dm3) from a first Cry toxin (heterologous portion) into a second Cry toxin, generating a heterologous domain 3 region in the second Cry shuffled or exchanged toxin. In some embodiments, the shuffled or exchanged domain 3 appears at any one of the intersections shown in SEQ ID NOs: 250-257. In some embodiments, the heterologous portion of domain 3 comprises a fragment derived from Cry1If, Cry1Cb, Cry1Fa, Cry 9Eb, Cry1Ae, Cry1Ja, Cry1Da, Cry1Bb or Cry1Ca toxins or any one of SEQ ID NOs: 259-265 or 268-270.

[0037] In some embodiments, the shuffled Cry toxin polypeptides have an altered spectrum of activity. In another embodiment, the shuffled Cry toxin polypeptides have an altered amount of pesticidal activity. In some embodiments, the shuffled Cry toxin polypeptides have an altered mode of action or site of action. In some embodiments, the shuffled Cry toxin polypeptides have an altered solubility.

[0038] In some embodiments, the shuffling comprises exchanging or shuffling all or part of α-ring 2, 3, 4, 5, and / or 6 from a first Cry toxin into a second Cry toxin, thereby generating a heterologous α-ring region. In some embodiments, the Cry toxin is a natural Cry toxin. In some embodiments, the Cry toxin is a shuffled or hybrid Cry toxin derived from a natural Cry toxin. In some embodiments, the α-ring exchange or shuffling occurs at a sequence motif having at least 90% or at least 95% sequence identity to any one of SEQ ID NOs: 247-250.

[0039] In another embodiment, the alpha loop exchange or shuffling occurs at a sequence motif comprising a variant of SEQ ID NO: 247, wherein the variant comprises: 1) a histidine or arginine at position 1 of SEQ ID NO: 247; 2) a valine, methionine, or leucine at position 2 of SEQ ID NO: 247; 3) a leucine at position 3 of SEQ ID NO: 247; 4) an arginine, glutamic acid, leucine, or serine at position 4 of SEQ ID NO: 247; or 5) an isoleucine at position 5 of SEQ ID NO: 247.

[0040] In another embodiment, the alpha loop exchange or shuffling occurs at a sequence motif comprising a variant of SEQ ID NO: 250, wherein the variant comprises: 1) a valine at position 1 of SEQ ID NO: 250; 2) a phenylalanine at position 2 of SEQ ID NO: 250; or 3) a phenylalanine at position 3 of SEQ ID NO: 250.

[0041] In another embodiment, the alpha loop exchange or shuffling occurs at a sequence motif comprising a variant of SEQ ID NO: 248, wherein the variant comprises: 1) an asparagine, serine, threonine, or arginine at position 1 of SEQ ID NO: 248; 2) an arginine at position 2 of SEQ ID NO: 248; 3) an aspartic acid, glycine, or alanine at position 4 of SEQ ID NO: 248; 4) an arginine, glutamic acid, leucine, or serine at position 4 of SEQ ID NO: 248; or 5) an alanine, serine, threonine, glutamic acid, or valine at position 5 of SEQ ID NO: 248.

[0042] In another embodiment, the alpha loop exchange or shuffling occurs at a sequence motif comprising a variant of SEQ ID NO: 249, wherein the variant comprises: 1) an arginine, alanine, threonine, lysine, or glycine at position 1 of SEQ ID NO: 249; 2) a threonine, serine, valine, isoleucine, or glutamic acid at position 2 of SEQ ID NO: 249; 3) a serine, isoleucine, proline, alanine, arginine, threonine, glycine, or asparagine at position 3 of SEQ ID NO: 249; 4) an asparagine, glutamine, glutamic acid, glycine, aspartic acid, serine, or threonine at position 4 of SEQ ID NO: 249; 5) a phenylalanine, glutamic acid, tyrosine, or glutamine at position 5 of SEQ ID NO: 249.

[0043] In another embodiment, the alpha loop exchange or shuffling occurs at a sequence motif comprising a variant of SEQ ID NO: 258, wherein the variant comprises: 1) glutamic acid, alanine, serine, arginine, lysine, or threonine at position 2 of SEQ ID NO: 258; 2) alanine, glycine, or glutamic acid at position 3 of SEQ ID NO: 258; or 3) serine or phenylalanine at position 4 of SEQ ID NO: 258.

[0044] Therefore, the present invention provides isolated or recombinant nucleic acid sequences encoding shuffled Cry toxin polypeptides that confer pesticidal activity. Also provided are amino acid sequences of shuffled Cry toxin polypeptides. The polypeptides produced by translation of these shuffled Cry toxin genes allow cells to control or kill harmful organisms that have ingested the polypeptides.

[0045] Members of the Bacillus thuringiensis insecticidal protein class are known to those skilled in the art (see Crickmore et al., Microbiology and Molecular Biology Reviews (1998) Vol. 62: 807-813; and Crickmore et al., "Bacillus thuringiensis toxin nomenclature" (2016), available at btnomenclature.info / , accessible on the World Wide Web using the "www" prefix). As used herein, "Bt Cry toxins" or "Cry toxins" refer to spore-like inclusion body (crystal) proteins from Bacillus thuringiensis that exhibit some experimentally verifiable toxic effects on target organisms, or any protein with significant sequence similarity to a known Cry protein (Crickmore et al., Microbiology and Molecular Biology Reviews (1998) Vol. 62: 807).

[0046] Shuffled Cry toxin proteins and variants and fragments thereof

[0047] The present disclosure encompasses reorganized Cry toxin polypeptides. As used interchangeably herein, "reorganized Cry toxin polypeptides" and "reorganized Cry toxin proteins" refer to polypeptides having insecticidal activity (including but not limited to insecticidal activity against one or more insect pests of the Lepidoptera and / or Coleoptera) and that have been reorganized from one or more natural Bacillus thuringiensis Cry toxin polypeptides. In some embodiments, the reorganized Cry toxin polypeptides comprise reorganized Cry toxins, wherein the reorganization includes a heterologous α-loop exchange in domain 1 ("Dm1") or a heterologous fragment of domain 3 ("Dm 3"). Various reorganized Cry toxin polypeptides are contemplated. The sources of reorganized Cry toxin polypeptides or related proteins include bacterial species selected from, but not limited to, Bacillus thuringiensis (Bt) species.

[0048] As used herein, "substantially identical" refers to an amino acid sequence having at least about 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or more sequence identity. In one embodiment, the shuffled Cry toxin polypeptide is identical to SEQ ID %, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or more sequence identity compared to any one of NOs:57-112, 214-246, and 275-278. When used herein in connection with percent sequence identity, the term "about" means + / - 1.0%.

[0049] As used herein, a "recombinant protein" refers to a protein that is no longer in its native environment (eg, in vitro or in a recombinant bacterial or plant host cell).

[0050] As used herein, "substantially free of cellular material" refers to polypeptides that include protein preparations having less than about 30%, 20%, 10%, or 5% (by dry weight) of non-pesticidal proteins (also referred to herein as "contaminating proteins").

[0051] "Fragments" or "biologically active portions" include polypeptide fragments comprising an amino acid sequence that is sufficiently identical to a shuffled Cry toxin polypeptide and exhibits insecticidal activity. "Fragments" or "biologically active portions" of shuffled Cry toxin polypeptides include fragments comprising an amino acid sequence that is sufficiently identical to the amino acid sequence set forth in any one of SEQ ID NOs: 57-112, 214-246, and 275-278, wherein the shuffled Cry toxin polypeptide has insecticidal activity. Such biologically active portions can be prepared by recombinant technology and evaluated for insecticidal activity. In some embodiments, the shuffled Cry toxin polypeptide fragment is an N-terminal and / or C-terminal truncation of at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31 or more amino acids from the N-terminus and / or C-terminus relative to any one of SEQ ID NOs: 57-112, 214-246, and 275-278, by, for example, proteolysis, by insertion of a start codon, by deletion of the codon encoding the deleted amino acid and simultaneous insertion of a start codon, and / or insertion of a stop codon. In some embodiments, the shuffled Cry toxin polypeptide fragment is an N-terminal truncation of at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24 amino acids from the N-terminus of any one of SEQ ID NOs: 57-112, 214-246, and 275-278. In some embodiments, the shuffled Cry toxin polypeptide fragment is an N-terminal and / or C-terminal truncation of at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34 or more amino acids from the N-terminus and / or C-terminus relative to any one of SEQ ID NOs: 57-112, 214-246, and 275-278.

[0052] As used herein, "variant" refers to a protein or polypeptide having an amino acid sequence that is at least about 50%, 55%, 60%, 65%, 70%, 75%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or more identical to the parent amino acid sequence.

[0053] In some embodiments, the reorganized Cry toxin polypeptide comprises at least about 40%, 45%, 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, 100%, 101%, 102%, 103%, 104%, 105%, 106%, 107%, 108%, 109%, 110%, 111%, 112%, 113%, 114%, 115%, 116%, 117%, 118%, 119%, 120%, 121%, 122%, 123%, 124%, 125%, 126%, 127%, 128%, 129%, 130%, 131%, 132%, 133%, 134%, 135 , 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or more sequence identity, wherein the reorganized Cry toxin polypeptide has insecticidal activity.

[0054] In some embodiments, the reorganized Cry toxin polypeptide comprises an amino acid sequence of any one or more of SEQ ID NOs: 57-112, 214-246, and 275-278, which has 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85 , 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95 or more amino acid substitutions.

[0055] Methods for such manipulations are generally known in the art. For example, amino acid sequence variants of reorganized Cry toxin polypeptides can be prepared by mutations in DNA. This can also be accomplished by one of several forms of mutagenesis, such as site-specific double-strand break technology, and / or directed evolution. In some aspects, the changes encoded in the amino acid sequence will not substantially affect the function of the protein. Such variants will have the desired pesticidal activity. However, it should be understood that the ability of the reorganized Cry toxin polypeptides to confer pesticidal activity or other polypeptide physical properties can be improved or changed by using these techniques on the compositions of the present disclosure.

[0056] Conservative amino acid substitutions can be made at one or more predicted non-essential amino acid residues. "Non-essential" amino acid residues are residues that can be changed from the wild-type sequence of the reorganized Cry toxin polypeptide and do not change the biological activity. "Conservative amino acid substitutions" are substitutions in which the amino acid residue is replaced with an amino acid residue having a similar side chain. Families of amino acid residues with similar side chains have been defined in the art. These families include: amino acids with basic side chains (e.g., lysine, arginine, histidine); amino acids with acidic side chains (e.g., aspartic acid, glutamic acid); amino acids with polar, negatively charged residues and their amides (e.g., aspartic acid, asparagine, glutamic acid, glutamine); amino acids with uncharged polar side chains (e.g., glycine, asparagine, glutamine, serine, threonine, tyrosine, cysteine); amino acids with small aliphatic, non-polar or slightly polar residues (e.g., alanine, serine, threonine, proline); , glycine); amino acids with non-polar side chains (e.g., alanine, valine, leucine, isoleucine, proline, phenylalanine, methionine, tryptophan); amino acids with large aliphatic, non-polar residues (e.g., methionine, leucine, isoleucine, valine, cystine); amino acids with β-branched side chains (e.g., threonine, valine, isoleucine); amino acids with aromatic side chains (e.g., tyrosine, phenylalanine, tryptophan, histidine); amino acids with large aromatic side chains (e.g., tyrosine, phenylalanine, tryptophan).

[0057] Amino acid replacement can be carried out in the non-conservative region of retention function.Usually, this type of replacement is not carried out for conserved amino acid residues or for the amino acid residue in conserved motif, and wherein this type of residue is necessary for protein activity.Conservative and for the example of residue that may be necessary for protein activity include for example, between whole proteins included in the comparison of toxin similar to the sequence of embodiment or related, be identical residue (for example, in homologous protein comparison, be identical residue).Conservative but can allow conservative amino acid replacement and still retain the example of active residue include for example, between whole proteins included in the comparison of toxin similar to the sequence of embodiment or related, only have conservative substituted residue (for example, between whole proteins included in homologous protein comparison, only have conservative substituted residue).But it will be appreciated by those skilled in the art that functional variant can have a small amount of conservative or non-conservative change in conservative residue.

[0058] Alternatively, the protein sequence of various proteins may be altered at the amino or carboxyl termini without substantially affecting activity. This may include insertions, deletions, or changes introduced by modern molecular methods such as PCR, including PCR amplification, which alters or extends the protein coding sequence by including the amino acid coding sequence in the oligonucleotides used in the PCR amplification. Alternatively, the added protein sequence may include the entire protein coding sequence, such as those commonly used in the art to generate protein fusions. Such fusion proteins are often used to (1) increase expression of the protein of interest; (2) introduce binding domains, enzymatic activities, or epitopes to facilitate protein purification, protein detection, or other experimental uses known in the art; and (3) target protein secretion or translation to subcellular organelles such as the periplasmic space of Gram-negative bacteria, mitochondria or chloroplasts of plants, or the endoplasmic reticulum of eukaryotic cells, the latter of which often results in glycosylation of the protein.

[0059] The variant nucleotide and amino acid sequences disclosed herein also encompass sequences derived from mutagenesis and recombinant programs (such as DNA shuffling). Under such a program, one or more different shuffled Cry toxin polypeptides of the coding region can be used to produce new shuffled Cry toxin polypeptides with desired properties. In this way, a recombinant polynucleotide library is produced from a population of related sequence polynucleotides, which contain sequence regions with basic sequence identity and capable of homologous recombination in vitro or in vivo. For example, using this method, the sequence motifs encoding the target domain can be shuffled between pesticidal genes and other known pesticidal genes to obtain new genes encoding proteins with improved target properties (such as increased insecticidal activity). The strategy of this DNA shuffling is known in the art. See, e.g., Stemmer, (1994) Proc. Natl. Acad. Sci. USA 91: 10747-10751; Stemmer, (1994) Nature 370: 389-391; and U.S. Patent Nos. 5,605,793 and 5,837,458.

[0060] Domain swapping or shuffling is another mechanism for generating altered Cry toxin polypeptides. Domains can be swapped between shuffled Cry toxin polypeptides to generate hybrid or chimeric toxins with altered insecticidal activity or target spectrum. Methods for producing recombinant proteins and testing them for pesticidal activity are known in the art (see, e.g., Naimov et al., (2001) Appl. Environ. Microbiol. 67:5328-5330; de Maagd et al., (1996) Appl. Environ. Microbiol. 62:1537-1543; Ge et al., (1991) J. Biol. Chem. 266:17954-17958; Schnepf et al., (1990) J. Biol. Chem. 265:20923-21010; Rang et al., (1999) Appl. Environ. Microbiol. 65:2918-2925).

[0061] In some embodiments, the reorganized Cry toxin polypeptides have modified physical properties. As used herein, the term "physical property" refers to any parameter suitable for describing the physicochemical characteristics of a protein. As used herein, "target physical property" and "target property" are used interchangeably to refer to the physical properties of the protein being studied and / or modified. Examples of physical properties include, but are not limited to: net surface charge and charge distribution on the protein surface, net hydrophobicity and hydrophobic residue distribution on the protein surface, surface charge density, surface hydrophobic density, total count of surface ionized groups, surface tension, protein size and its distribution in solution, melting temperature, heat capacity, and second virial coefficient. Examples of physical properties also include that the reorganized Cry toxin polypeptides have increased expression, increased solubility, reduced phytotoxicity, and digestibility of protein hydrolysis fragments in the insect gut. Models simulating gastric digestion are known to those skilled in the art (Fuchs, RL and JD Astwood. Food Technology 50:83-88, 1996; Astwood, JD et al., Nature Biotechnology 14:1269-1273, 1996; Fu TJ et al., J. Agric Food Chem. 50:7154-7160, 2002).

[0062] In some embodiments, variants include polypeptides that differ in amino acid sequence due to mutagenesis. Variant proteins encompassed by the present disclosure are biologically active, i.e., they still possess the desired biological activity (i.e., pesticidal activity) of the native protein. In some embodiments, the variants will have at least about 10%, at least about 30%, at least about 50%, at least about 70%, at least about 80%, or more of the insecticidal activity of the native protein. In some embodiments, the variants may have improved activity compared to the native protein.

[0063] Bacterial genes usually have multiple methionine start codons near the start of the open reading frame. Usually, the translation initiation at one or more of these start codons will result in the production of functional proteins. These start codons can include ATG codons. However, bacteria (such as Bacillus species) also recognize the codon GTG as a start codon, and the protein that starts translation at the GTG codon contains methionine at the first amino acid. In a few cases, translation in the bacterial system can start at the TTG codon, although in this event, TTG encodes methionine. In addition, it is usually not determined a priori which of these codons are naturally used in bacteria. Therefore, it should be understood that using one of alternative methionine codons may also result in the production of pesticidal proteins. These pesticidal proteins are encompassed in the present disclosure and can be used in the methods of the present disclosure. It should be understood that when expressed in plants, it is necessary to change the alternative start codon to ATG for correct translation.

[0064] In some embodiments, the shuffled Cry toxin polypeptide comprises the amino acid sequence of any one or more of SEQ ID NOs: 57-112 and 275-278.

[0065] In some embodiments, chimeric polypeptides are provided that comprise regions of at least two different shuffled Cry toxin polypeptides of the present disclosure.

[0066] In some embodiments, chimeric polypeptides are provided that comprise regions of at least two different shuffled Cry toxin polypeptides selected from any one or more of SEQ ID NOs: 57-112, 214-246, and 275-278.

[0067] In some embodiments, one or more chimeric shuffled Cry toxin polypeptides are provided, comprising the N-terminal region of a first shuffled Cry toxin polypeptide of the present disclosure operably fused to the C-terminal region of a second shuffled Cry toxin polypeptide of the present disclosure.

[0068] In other embodiments, the reorganized Cry toxin polypeptide can be expressed as a precursor protein with an intervening sequence that catalyzes multi-step post-translational protein splicing. Protein splicing involves the excision of an intervening sequence from a polypeptide and the concomitant attachment of flanking sequences to produce a new polypeptide (Chong et al., (1996) J. Biol. Chem. [Journal of Biological Chemistry], 271: 22159-22168). This intervening sequence or protein splicing element, known as an intein, catalyzes its own excision by three coordinated reactions at the N- and C-terminal splice junctions: acyl rearrangement of the N-terminal cysteine ​​or serine; transesterification reaction to form a branched ester or thioester intermediate between the two ends, and peptide bond cleavage coupled to the cyclization of the intein C-terminal asparagine to release the intein (Evans et al., (2000) J. Biol. Chem. [Journal of Biological Chemistry], 275: 9091-9094).

[0069] In another embodiment, a fusion protein is provided, wherein the amino acid sequence of the fusion protein contains the amino acid sequence of the reorganized Cry toxin polypeptide disclosed herein. Methods for designing and constructing fusion proteins (and polynucleotides encoding them) are known to those skilled in the art. The polynucleotides encoding the reorganized Cry toxin polypeptide can be fused to signal sequences that will direct the reorganized Cry toxin polypeptide to be localized to a specific compartment of a prokaryotic or eukaryotic cell and / or direct the secretion of the reorganized Cry toxin polypeptide from the embodiments of the prokaryotic or eukaryotic cell.

[0070] For example, in E. coli, one may wish to direct protein expression to the periplasmic space. Examples of signal sequences or proteins (or fragments thereof) that can be fused to the reorganized Cry toxin polypeptide to direct the expression of the polypeptide to the bacterial periplasmic space include, but are not limited to, the pelB signal sequence, the maltose binding protein (MBP) signal sequence, the MBP, the ompA signal sequence, the signal sequence of the periplasmic E. coli heat-labile enterotoxin B subunit, and the signal sequence of alkaline phosphatase. Several vectors for constructing fusion proteins that direct protein localization are commercially available, such as the pMAL series of vectors (particularly the pMAL-p series) available from New England Biolabs. In specific embodiments, the reorganized Cry toxin polypeptide can be fused to the pelB pectate lyase signal sequence to increase the efficiency of expression and purification of such polypeptides in Gram-negative bacteria (see, U.S. Patent Nos. 5,576,195 and 5,846,818).

[0071] Plant plastid transit peptide / polypeptide fusions are known in the art. Apoplast transit peptides such as rice or barley α-amylase secretion signals are also known in the art. The plastid transit peptide is typically fused to the N-terminus of the polypeptide to be targeted (e.g., a fusion partner). In one embodiment, the fusion protein consists essentially of the plastid transit peptide and the shuffled Cry toxin polypeptide to be targeted. In another embodiment, the fusion protein comprises the plastid transit peptide and the polypeptide to be targeted. In such embodiments, the plastid transit peptide is preferably located at the N-terminus of the fusion protein. However, additional amino acid residues may be located at the N-terminus of the plastid transit peptide, provided that the fusion protein is at least partially targeted to the plastid. In a specific embodiment, the plastid transit peptide is located at the N-terminal half, N-terminal third, or N-terminal quarter of the fusion protein. When inserted into the plastid, most or all of the plastid transit peptide is typically cleaved from the fusion protein. Due to specific intercellular conditions or the specific combination of transit peptide / fusion partner used, the cleavage position may vary slightly between plant species at different plant development stages. In one embodiment, the plastid transit peptide is cut uniformly so that the cleavage site is the same in the fusion protein population. In another embodiment, the plastid transit peptide is not uniform so that the cleavage site differs by 1-10 amino acids in the fusion protein population. The plastid transit peptide can be recombinantly fused to a second protein in one of several ways. In some embodiments, the reorganized Cry toxin polypeptide is fused to a heterologous signal peptide or a heterologous transit peptide.

[0072] In some embodiments, a fusion protein comprising a shuffled Cry toxin polypeptide or a chimeric Cry toxin polypeptide of the present disclosure is provided, wherein the fusion protein is represented by a formula selected from the group consisting of:

[0073] R 1 -LR 2 、R 2 -LR 1 、R 1 -R 2 or R 2 -R 1

[0074] where R 1 is a shuffled Cry toxin polypeptide or a chimeric shuffled Cry toxin polypeptide of the present disclosure, and R 2 is the target protein. In some embodiments, R 1 and R 2 It is a shuffled Cry toxin polypeptide or a chimeric shuffled Cry toxin polypeptide disclosed herein. 1 The polypeptide is fused directly or via a linker (L) segment to the R 2 The term "directly" defines a fusion in which the polypeptide is linked without a peptide linker. Thus, "L" represents a polypeptide linked to R 1and R 2 In-frame fusion of chemically bound or polypeptide segments, most commonly, L is R 1 and R 2 R 1 The carboxyl terminus of L is connected to the amino terminus of L and the carboxyl terminus of L is connected to R 2 "In-frame fusion" means that R 1 and R 2 There is no translation termination or interruption between the reading frames of the two proteins. The linker (L) is typically a polypeptide between 1 and 500 amino acids in length. The linker connecting the two molecules is preferably designed to (1) allow the two molecules to fold and function independently of each other, (2) have no tendency to develop ordered secondary structures that may interfere with the functional domains of the two proteins, (3) have minimal hydrophobic or charged characteristics that can interact with the functional protein domains, and (4) provide R 1 and R 2 The spatial separation of R 1 and R 2 Can interact simultaneously with the corresponding receptor on a single cell. Typically, the surface amino acids in the flexible protein region include Gly, Asn and Ser. It is expected that almost any arrangement of the amino acid sequence comprising Gly, Asn and Ser will meet the criteria for the above-mentioned linker sequence. Other neutral amino acids such as Thr and Ala can also be used in the linker sequence. Due to the addition of unique restriction sites in the linker sequence to facilitate the construction of fusions, additional amino acids can also be included in the linker.

[0075] In some embodiments, the linker comprises a sequence selected from the group consisting of: (Gly3Ser) n 、(Gly4Ser) n 、(Gly5Ser) n 、(Gly n Ser) n or (AlaGlySer) n, wherein n is an integer. An example of a highly flexible linker is a spacer region rich in (GlySer) present in the pill protein of a filamentous phage (e.g., phage M13 or fd) (Schaller et al., 1975). This region provides a long, flexible spacer region between two domains of pill surface protein. Also included is a linker comprising an endopeptidase recognition sequence in the linker. This cleavage site may be valuable for separating the various components of the fusion to determine whether they are properly folded and active in vitro. Examples of various endopeptidases include, but are not limited to: plasmin, enterokinase, kallikrein, urokinase, tissue plasminogen activator, clostripain, chymosin, collagenase, Russell's viper venom protease, post-proline cleavage enzyme, V8 protease, thrombin and factor Xa. In certain embodiments, the linker comprises amino acids from a multigene expression vector (MGEV), which is cleaved by vacuolar proteases as disclosed in U.S. Patent Application Publication No. US2007 / 0277263. In other embodiments, the peptide linker segment from the hinge region of heavy chain immunoglobulin IgG, IgA, IgM, IgD or IgE provides the angular relationship between the attached polypeptides. Particularly useful are hinge regions in which cysteine ​​is replaced by serine. Linkers of the present disclosure include sequences derived from the hinge region of mouse IgGγ2b in which cysteine ​​has been changed to serine. The fusion protein is not limited by the form, size or number of the linker sequence used, and the only requirement of the linker is that it functionally does not adversely interfere with the folding and function of the individual molecules being fused.

[0076] Nucleic acid molecules and variants and fragments thereof

[0077] Provided are isolated or recombinant nucleic acid molecules comprising nucleic acid sequences encoding Cry toxin polypeptides or biologically active portions thereof, as well as nucleic acid molecules sufficient to be used as hybridization probes to identify nucleic acid molecules encoding proteins having regions of sequence homology. As used herein, the term "nucleic acid molecule" refers to DNA molecules (e.g., recombinant DNA, cDNA, genomic DNA, plasmid DNA, mitochondrial DNA) and RNA molecules (e.g., mRNA) and analogs of DNA or RNA produced using nucleotide analogs. Nucleic acid molecules can be single-stranded or double-stranded, but are preferably double-stranded DNA.

[0078] As used herein, "isolated" nucleic acid molecules (or DNA) refer to nucleic acid sequences (or DNA) that are no longer in their natural environment (e.g., in vitro). "Recombinant" nucleic acid molecules (or DNA) used herein refer to nucleic acid sequences (or DNA) in recombinant bacteria or plant host cells. In some embodiments, "isolated" or "recombinant" nucleic acids do not contain sequences that are naturally located on the flanks of the nucleic acid in the genomic DNA of the organism from which the nucleic acid is derived (i.e., sequences at the 5' and 3' ends of the nucleic acid) (preferably sequences encoding proteins). For the purposes of this disclosure, "isolated" or "recombinant" excludes isolated chromosomes when used to refer to nucleic acid molecules. For example, in different embodiments, the recombinant nucleic acid molecules encoding Cry toxin polypeptides can include less than about 5kb, 4kb, 3kb, 2kb, 1kb, 0.5kb, or 0.1kb of nucleic acid sequences that are naturally located on the flanks of the nucleic acid molecules in the genomic DNA of the cell from which the nucleic acid is derived.

[0079] In some embodiments, the isolated nucleic acid molecule encoding the Cry toxin polypeptide has one or more changes in the nucleic acid sequence compared to the native or genomic nucleic acid sequence. In some embodiments, changes in the native or genomic nucleic acid sequence include, but are not limited to: changes in the nucleic acid sequence due to the degeneracy of the genetic code; changes in the nucleic acid sequence due to amino acid substitutions, insertions, deletions, and / or additions compared to the native or genomic sequence; removal of one or more introns; deletion of one or more upstream or downstream regulatory regions; and deletion of the 5' and / or 3' untranslated regions associated with the genomic nucleic acid sequence. In some embodiments, the nucleic acid molecule encoding the Cry toxin polypeptide is a non-genomic sequence.

[0080] A variety of polynucleotides encoding Cry toxin polypeptides or related proteins are contemplated. When operably linked to appropriate promoters, transcription termination and / or polyadenylation sequences, such polynucleotides can be used to produce Cry toxin polypeptides in host cells. Such polynucleotides can also be used as probes for isolating homologous or substantially homologous polynucleotides encoding Cry toxin polypeptides or related proteins.

[0081] Polynucleotide encoding a polypeptide

[0082] One source of polynucleotides encoding Cry toxin polypeptides or related proteins is a Bacillus bacterium, which may contain Cry toxin polynucleotides of any one of SEQ ID NOs: 1-56, 181-213, and 271-274 encoding Cry toxin polypeptides of SEQ ID NOs: 57-112, 214-246, and 271-274, respectively. Polynucleotides of any one or more of SEQ ID NOs: 1-56, 181-213, and 271-274 can be used to express Cry toxin polypeptides in recombinant bacterial hosts, including but not limited to Agrobacterium, Bacillus, Escherichia, Salmonella, Lysinibacillus, Acetobacter, Pseudomonas, and Rhizobium bacterial host cells. The polynucleotides can also be used as probes for isolating homologous or substantially homologous polynucleotides encoding Cry toxin polypeptides or related proteins. Such probes can be used to identify homologous or substantially homologous polynucleotides, or portions thereof, derived from Bacillus thuringiensis.

[0083] The polynucleotide encoding the Cry toxin polypeptide can also be synthesized de novo from the Cry toxin polypeptide sequence. The sequence of the polynucleotide gene can be deduced from the Cry toxin polypeptide sequence using the genetic code. Computer programs such as "BackTranslate" (GCG TM The Cry toxin polypeptide sequences of the present invention can be converted into corresponding nucleotide sequences encoding the peptides. Examples of Cry toxin polypeptide sequences that can be used to obtain corresponding nucleotide coding sequences include, but are not limited to, Cry toxin polypeptides of SEQ ID NOs: 57-112, 214-246, and 275-278. In addition, the synthetic Cry toxin polynucleotide sequences of the present invention can be designed so that they are expressed in plants.

[0084] In some embodiments, the nucleic acid molecule encoding the Cry toxin polypeptide is a polynucleotide having a sequence as shown in any one of SEQ ID NOs: 1-56, 181-213 and 271-274, and variants, fragments and complementary sequences thereof. As used herein, "complementary sequence" refers to a nucleic acid sequence that is sufficiently complementary to a given nucleic acid sequence so that it can hybridize with the given nucleic acid sequence to form a stable duplex. As used herein, "polynucleotide sequence variant" refers to a nucleic acid sequence that encodes the same polypeptide except for the degeneracy of the genetic code.

[0085] In some embodiments, the nucleic acid molecule encoding the Cry toxin polypeptide is a non-genomic nucleic acid sequence. As used herein, "non-genomic nucleic acid sequence" or "non-genomic nucleic acid molecule" or "non-genomic polynucleotide" refers to a nucleic acid molecule having one or more changes in the nucleic acid sequence compared to a natural or genomic nucleic acid sequence. In some embodiments, changes in natural or genomic nucleic acid molecules include, but are not limited to: changes in nucleic acid sequence due to the degeneracy of the genetic code; optimization of nucleic acid sequences for expression in plants; changes in nucleic acid sequences that introduce at least one amino acid substitution, insertion, deletion and / or addition compared to a natural or genomic sequence; removal of one or more introns associated with the genomic nucleic acid sequence; insertion of one or more heterologous introns; deletion of one or more upstream or downstream regulatory regions associated with the genomic nucleic acid sequence; insertion of one or more heterologous upstream or downstream regulatory regions; deletion of 5' and / or 3' untranslated regions associated with the genomic nucleic acid sequence; insertion of heterologous 5' and / or 3' untranslated regions; and modification of polyadenylation sites. In some embodiments, the non-genomic nucleic acid molecule is a synthetic nucleic acid sequence.

[0086] In some embodiments, the nucleic acid molecule encoding the Cry toxin polypeptide disclosed herein is a non-genomic polynucleotide having a nucleotide sequence similar to SEQ ID The nucleic acid sequence of any one of NOs: 1-56, 181-213 and 271-274 has at least 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or more sequence identity, wherein the Cry toxin polypeptide has insecticidal activity.

[0087] In some embodiments, the nucleic acid molecule encodes a Cry toxin polypeptide variant comprising one or more amino acid substitutions to the amino acid sequence of any one of SEQ ID NOs: 57-112, 214-246, and 275-278.

[0088] Also provided are nucleic acid molecules encoding transcription and / or translation products, which are subsequently spliced ​​to ultimately produce functional Cry toxin polypeptides. Splicing can be completed in vitro or in vivo and can involve cis or trans splicing. The substrate for splicing can be a polynucleotide (e.g., RNA transcript) or a polypeptide. An example of cis splicing of a polynucleotide is to remove the introns inserted into the coding sequence and splice two flanking exon regions to produce a Cry toxin polypeptide coding sequence. An example of trans splicing is to encrypt a polynucleotide by separating the coding sequence into two or more fragments, which can be transcribed separately and then spliced ​​to form a full-length pest-killing coding sequence. Using a splicing enhancer sequence that can be introduced into a construct can promote cis or trans splicing of a polypeptide (U.S. Patent numbers 6,365,377 and 6,531,316). Therefore, in some embodiments, these polynucleotides do not directly encode full-length Cry toxin polypeptides, but rather one or more fragments of encoding Cry toxin polypeptides. These polynucleotides can be used to express functional Cry toxin polypeptides by a mechanism involving splicing, wherein splicing can occur at the level of polynucleotides (e.g., introns / exons) and / or polypeptides (e.g., inteins / extenes). This can be used, for example, to control the expression of pesticidal activity, because only functional pesticidal polypeptides are expressed if all necessary fragments are expressed in an environment that allows the splicing process to produce a functional product. In another example, the introduction of one or more insertion sequences into a polynucleotide can promote recombination with polynucleotides of low homology; the use of introns or inteins directed against the insertion sequence facilitates the removal of the intervening sequence, thereby restoring the function of the encoded variant.

[0089] Nucleic acid molecules that are fragments of these nucleic acid sequences encoding Cry toxin polypeptides are also encompassed in the embodiments. As used herein, "nucleotide fragment" refers to a portion of a nucleic acid sequence encoding a Cry toxin polypeptide. The nucleotide fragment of a nucleic acid sequence can encode a biologically active portion of a Cry toxin polypeptide, or it can be a fragment that can be used as a hybridization probe or PCR primer using the methods disclosed below. Nucleic acid molecules that are fragments of a nucleic acid sequence encoding a Cry toxin polypeptide contain at least about 150, 180, 210, 240, 270, 300, 330, 360, 400, 450 or 500 consecutive nucleotides or up to the number of nucleotides present in the full-length nucleic acid sequence encoding the Cry toxin polypeptide disclosed herein, depending on the intended use. "Contiguous nucleotides" used herein refers to nucleotide residues that are immediately adjacent to each other. The fragments of the nucleic acid sequences of the embodiments will encode protein fragments that retain the biological activity of the Cry toxin polypeptide and therefore retain insecticidal activity. "Retaining insecticidal activity" is used herein to refer to a polypeptide having at least about 10%, at least about 30%, at least about 50%, at least about 70%, 80%, 90%, 95% or more of the insecticidal activity of any of the full-length Cry toxin polypeptides set forth in SEQ ID NOs: 57-112, 214-246, and 275-278. In some embodiments, the insecticidal activity is against a Lepidoptera species. In one embodiment, the insecticidal activity is against a Coleoptera species. In some embodiments, the insecticidal activity is against one or more insect pests of the corn rootworm complex: western corn rootworm, Diabrotica virgifera; northern corn rootworm, D. barberi; southern corn rootworm or spotted cucumber beetle; Diabrotica undecimpunctata howardi, Diabrotica speciosa, and Mexican corn rootworm, D. virgifera zeae. In one embodiment, the insecticidal activity is against Diabrotica species.

[0090] In some embodiments, the Cry toxin polypeptide is encoded by a nucleic acid sequence that is sufficiently homologous to any one of the nucleic acid sequences of SEQ ID NOs: 1-56, 181-213, and 271-274.

[0091] " Percentage (%) of sequence identity " is determined to be the percentage of amino acid residues or nucleotides in a candidate sequence (query sequence) that are identical to the corresponding amino acid residues or nucleotides in the reference sequence, after aligning the sequences and introducing gaps (if necessary) to achieve maximum percentage sequence identity, and without considering any conservative substitutions of amino acids as part of sequence identity. The comparison for determining the percentage of sequence identity can be achieved in various ways within the technical scope of the art, for example, using publicly available computer software, such as BLAST, BLAST-2. Those skilled in the art can determine the appropriate parameters for aligning sequences, including any algorithm required for achieving maximum alignment over the full length of the sequences being compared. The percentage of identity between two sequences is a function of the number of identical positions shared by the sequences (e.g., the number of identical positions between the query sequence and the subject sequence / the total number of positions of the query sequence × 100).

[0092] In some embodiments, the Cry toxin polynucleotide encodes a Cry toxin polypeptide comprising an amino acid sequence having at least about 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or more sequence identity to the entire length of the amino acid sequence of any one of SEQ ID NOs: 57-112, 214-246, and 275-278.

[0093] In some embodiments, polynucleotides encoding chimeric polypeptides are provided, wherein the chimeric polypeptides comprise regions of at least two different Cry toxin polypeptides of the present disclosure.

[0094] In some embodiments, polynucleotides encoding chimeric polypeptides are provided, comprising the N-terminal region of a first Cry toxin polypeptide of the present disclosure operably fused to the C-terminal region of a second Cry toxin polypeptide of the present disclosure.

[0095] The embodiments also encompass nucleic acid molecules encoding Cry toxin polypeptide variants. "Variants" of nucleic acid sequences encoding Cry toxin polypeptides include those sequences encoding the Cry toxin polypeptides disclosed herein but having conservative differences due to the degeneracy of the genetic code, as well as those sequences that are sufficiently identical as described above. Naturally occurring allelic variants can be identified using well-known molecular biology techniques, such as polymerase chain reaction (PCR) and hybridization techniques as outlined below. Variant nucleic acid sequences also include nucleic acid sequences of synthetic origin, which are generated, for example, by using directed mutagenesis, but still encode the disclosed Cry toxin polypeptides discussed below.

[0096] The present disclosure provides isolated or recombinant polynucleotides encoding any of the Cry toxin polypeptides disclosed herein. One of ordinary skill in the art will readily appreciate that, due to the degeneracy of the genetic code, there are many nucleotide sequences encoding the Cry toxin polypeptides of the present disclosure.

[0097] The skilled artisan will further appreciate that changes can be introduced by mutation of the nucleic acid sequence, thereby resulting in changes in the amino acid sequence of the encoded Cry toxin polypeptide without changing the biological activity of the protein. Thus, variant nucleic acid molecules can be generated by introducing one or more nucleotide substitutions, additions and / or deletions into the corresponding nucleic acid sequence disclosed herein, such that one or more amino acid substitutions, additions or deletions are introduced into the encoded protein. Mutations can be introduced by standard techniques, such as directed mutagenesis and PCR-mediated mutagenesis. Such variant nucleic acid sequences are also encompassed by the present disclosure.

[0098] Alternatively, variant nucleic acid sequences can be prepared by randomly introducing mutations along all or part of the coding sequence (e.g., by saturation mutagenesis), and the resulting mutants can be screened for their ability to confer pesticidal activity to identify mutants that retain activity. Following mutagenesis, the encoded protein can be recombinantly expressed, and the activity of the protein can be determined using standard assay techniques.

[0099] The polynucleotides of the present disclosure and their fragments are optionally used as substrates for various recombination and recursive recombination reactions, in addition to the standard cloning methods described by, for example, Ausubel, Berger, and Sambrook, i.e., to produce additional pesticidal polypeptide homologs and fragments thereof with desired properties. Various such reactions are known. Methods for producing variants of any nucleic acid listed herein (these methods include recursively recombining such polynucleotides with a second (or more) polynucleotides to form a variant polynucleotide library) are also embodiments of the present disclosure, as are the libraries produced, the cells comprising such libraries, and any recombinant polynucleotides produced by such methods. Additionally, such methods optionally include selecting variant polynucleotides from such libraries based on pesticidal activity, as where such recursive recombination is performed in vitro or in vivo.

[0100] Various diversity generation schemes (including nucleic acid recursive recombination schemes) are available and are fully described in the art. The programs can be used alone and / or in combination to generate one or more variants of a nucleic acid or nucleic acid set, as well as variants of an encoded protein. Individually or collectively, these programs provide robust and widely applicable methods for generating diverse nucleic acids and nucleic acid sets (including, for example, nucleic acid libraries) that can be used, for example, to engineer or rapidly evolve nucleic acids, proteins, pathways, cells, and / or organisms with new and / or improved characteristics.

[0101] Although for the sake of clarity, distinctions and classifications are made in the subsequent discussion, it should be understood that the techniques are generally not mutually exclusive. In fact, various methods can be used alone or in combination, in parallel or in series, to obtain different sequence variants.

[0102] The result of any diversity generation program described herein can be the generation of one or more nucleic acids, which can select or screen for nucleic acids having or conferring desired properties or nucleic acids encoding proteins having or conferring desired properties. After diversification by one or more methods described herein or otherwise available to the skilled person, any nucleic acid produced can be selected for a desired activity or property (e.g., pesticidal activity) or such activity at a desired pH. This can include identifying any activity that can be detected, for example, in an automated or automatable form, by any assay in the art, referring to, for example, the following discussion of insecticidal activity screening. Various related (or even unrelated) properties can be evaluated in series or in parallel, as appropriate, by the practitioner.

[0103] Descriptions of various diversity generation procedures for generating modified nucleic acid sequences (e.g., those encoding polypeptides or fragments thereof having pesticidal activity) can be found in the following publications and references cited therein: Soong et al., (2000) Nat Genet 25(4):436-439; Stemmer et al., (1999) Tumor Targeting 4:1-4; Ness et al., (1999) Nat Biotechnol 17:893-896; Chang et al., (1999) Nat Biotechnol 17:793-797; Minshull and Stemmer, (1999) Curr Opin Chem Biol 3:284-290; Christians et al. (1999) Nat Biotechnol 17:259-264; Crameri et al. (1998) Nature 391:288-291; Crameri et al. (1997) Nat Biotechnol 15:436-438; Zhang et al. (1997) PNAS USA 94:4504-4509; Patten et al. (1997) Curr Opin Biotechnol 8:724-733; Crameri et al. (1996) Nat Med 2:100-103; Crameri et al. (1996) Nat Biotechnol [Nature Biotechnology] 14:315-319; Gates et al., (1996) J Mol Biol [Journal of Molecular Biology] 255:373-386; Stemmer, (1996) “Sexual PCR and Assembly PCR” In: The Encyclopedia of Molecular Biology.Encyclopedia of Molecular Biology, VCH Publishers, New York, pp. 447-457; Crameri and Stemmer, (1995) BioTechniques 18:194-195; Stemmer et al., (1995) Gene 164:49-53; Stemmer, (1995) Science 270:1510; Stemmer, (1995) Bio / Technology 13:549-553; Stemmer, (1994) Nature 370:389-391 and Stemmer, (1994) PNAS USA 91:10747-10751.

[0104] Mutational methods for generating diversity include, for example, directed mutagenesis (Ling et al., (1997) Anal Biochem 254(2):157-178; Dale et al., (1996) Methods Mol Biol 57:369-374; Smith, (1985) Ann Rev Genet 19:423-462; Botstein and Shortle, (1985) Science 229:1193-1201; Carter, (1986) Biochem J 237:1-7 and Kunkel, (1987) "The efficiency of oligonucleotide directed mutagenesis," In: Nucleic Acids & Molecular Biology (Eckstein and Lilley, eds., Springer Verlag, Berlin); mutagenesis using uracil-containing templates (Kunkel, (1985) PNAS USA 82:488-492; Kunkel et al., (1987) Methods Enzymol 154:367-382 and Bass et al., (1988) Science 242:240-245); oligonucleotide-directed mutagenesis (Zoller and Smith, (1983) Methods Enzymol 100:468-500; Zoller and Smith, (1987) Methods Enzymol 154:329-350 (1987); Zoller and Smith, (1982) Nucleic Acids Res 10:6487-6500); mutagenesis of DNA by phosphorothioate modification (Taylor et al., (1985) Nucl Acids Res 13:8749-8764; Taylor et al., (1985) Nucl Acids Res 13:8765-8787 (1985); Nakamaye and Eckstein, (1986) Nucl Acids Res 14:9679-9698);Sayers et al., (1988) Nucl Acids Res 16:791-802 and Sayers et al., (1988) Nucl Acids Res 16:803-814); mutagenesis using gapped duplex DNA (Kramer et al., (1984) Nucl Acids Res 12:9441-9456; Kramer and Fritz, (1987) Methods Enzymol 154:350-367; Kramer et al., (1988) Nucl Acids Res 16:7207 and Fritz et al., (1988) Nucl Acids Res 16:6987-6999);

[0105] Other suitable methods include point mismatch repair (Kramer et al., (1984) Cell 38:879-887), mutagenesis using a repair-deficient host strain (Carter et al., (1985) Nucl Acids Res 13:4431-4443 and Carter, (1987) Methods in Enzymol 154:382-403), deletion mutagenesis (Eghtedarzadeh and Henikoff, (1986) Nucl Acids Res 14:5115), restriction-selection and restriction-purification (Wells et al., (1986) Phil Trans R Soc Lond Philosophical Transactions of the Royal Society of London Series A 317:415-423), mutagenesis by total gene synthesis (Nambiar et al., (1984) Science 223:1299-1301; Sakamar and Khorana, (1988) Nucl Acids Res 14:6361-6372; Wells et al., (1985) Gene 34:315-323, and et al., (1985) Nucl Acids Res 13:3305-3316), double-strand break repair (Mandecki, (1986) PNAS USA 83:7177-7181 and Arnold, (1993) Curr Opin Biotech 4:450-455). Additional details of many of the above methods can be found in Methods Enzymol, Vol. 154, which also describes useful controls for troubleshooting using various mutagenesis methods.

[0106] The nucleotide sequence of embodiment can also be used for separating corresponding sequence from bacterial origin, and these bacterial origins include but are not limited to Pseudomonas species.In this way, such sequence (based on the sequence homology of itself and sequence shown in this paper) can be identified using methods such as PCR, hybridization. The sequence selected based on the sequence identity of full sequence shown in this paper or its fragment is contained in embodiment. Such sequence includes the sequence of the straight homologue as disclosed sequence.Term " straight homologue " refers to the gene that is derived from common ancestor gene and is found in different species due to species formation.When its nucleotide sequence and / or its encoded protein sequence have basic identity as defined elsewhere herein, the gene found in different species is considered to straight homologue.The function of straight homologue is usually highly conservative between species.

[0107] In the PCR method, oligonucleotide primers can be designed for use in a PCR reaction to amplify a corresponding DNA sequence from cDNA or genomic DNA extracted from any organism of interest. Methods for designing PCR primers and PCR cloning are generally known in the art and are disclosed in Sambrook et al., (1989) Molecular Cloning: A Laboratory Manual (2nd ed., Cold Spring Harbor Laboratory Press, Plainview, New York), hereinafter "Sambrook". See also, Innis et al., eds., (1990) PCR Protocols: A Guide to Methods and Applications (Academic Press, New York); Innis and Gelfand, eds., (1995) PCR Strategies (Academic Press, New York); and Innis and Gelfand, eds., (1999) PCR Methods Manual (Academic Press, New York). Known PCR methods include, but are not limited to, methods using paired primers, nested primers, single-specific primers, degenerate primers, gene-specific primers, vector-specific primers, partially mismatched primers, and the like.

[0108] In order to identify potential Cry toxin polypeptides from bacterial collections, bacterial cell lysates can be screened using Western blot and / or ELISA methods with antibodies raised against Cry toxin polypeptides. This type of assay can be performed in a high-throughput manner. Positive samples can be further analyzed by various techniques (such as antibody-based protein purification and identification). Methods for generating antibodies are well known in the art, as described below.

[0109] Alternatively, mass spectrometry-based protein identification methods can be used to identify homologs of Cry toxin polypeptides using protocols in the literature (Scott Patterson, (1998), 10.22, 1-24, Current Protocol in Molecular Biology published by John Wiley & Son Inc). Specifically, the MS data of a given cell lysate or a desired molecular weight enriched sample (excised from an SDS-PAGE gel of the relevant molecular weight band of the Cry toxin polypeptide) is combined with the sequence information of the Cry toxin polypeptide disclosed herein using an LC-MS / MS-based protein identification method. Any match in the peptide sequence indicates the possibility of having a homologous protein in the sample. Additional techniques (protein purification and molecular biology) can be used to separate proteins and identify the sequences of homologs.

[0110] In hybridization methods, all or part of the pesticidal nucleic acid sequence can be used to screen cDNA or genomic libraries. Methods for constructing such cDNA and genomic libraries are generally known in the art and are disclosed in Sambrook and Russell, (2001), supra. So-called hybridization probes can be genomic DNA fragments, cDNA fragments, RNA fragments or other oligonucleotides, and can be labeled with a detectable group (such as 32P or any other detectable label, such as other radioisotopes, fluorescent compounds, enzymes or enzyme cofactors). Probes for hybridization can be prepared by labeling synthetic oligonucleotides based on the nucleic acid sequence encoding known Cry toxin polypeptides disclosed herein. Degenerate primers can be used in addition, and the degenerate primers are designed based on the conserved nucleotides or amino acid residues in the nucleic acid sequence or the encoded amino acid sequence. Such probes typically comprise a region of nucleic acid sequence that hybridizes under stringent conditions to at least about 12, at least about 25, at least about 50, 75, 100, 125, 150, 175, or 200 consecutive nucleic acids encoding a Cry toxin polypeptide of the present disclosure, or a fragment or variant thereof. Methods and stringent conditions for preparing probes for hybridization are generally known in the art and are disclosed in Sambrook and Russell, (2001), supra, which is incorporated herein by reference.

[0111] Antibody

[0112] Also encompassed are antibodies to the Cry toxin polypeptides of the embodiments or antibodies to variants or fragments of the Cry toxin polypeptides. The antibodies disclosed herein include polyclonal and monoclonal antibodies and fragments thereof that retain their ability to bind to Cry toxin polypeptides. It is believed that antibodies, monoclonal antibodies or fragments thereof are capable of binding to molecules, provided that the antibodies, monoclonal antibodies or fragments thereof are capable of specifically reacting with the molecules, thereby binding the molecules to the antibodies, monoclonal antibodies or fragments thereof. The terms "antibody" (Ab) or "monoclonal antibody" (Mab) are intended to include complete molecules and fragments thereof or binding regions or domains (e.g., like Fab and F(ab).sub.2 fragments) that are capable of binding to haptens. Such fragments are typically produced by proteolytic cleavage (such as papain or pepsin). Alternatively, hapten binding fragments can be produced by applying recombinant DNA technology or by synthetic chemistry. Methods for preparing antibodies disclosed herein are generally known in the art. See, eg, Antibodies, A Laboratory Manual, Ed Harlow and David Lane (eds.), Cold Spring Harbor Laboratory, NY (1988), and references cited therein. Standard reference texts that set forth the general principles of immunology include: Klein, J. Immunology: The Science of Cell-Noncell Discrimination, John Wiley & Sons, New York (1982); Dennett et al., Monoclonal Antibodies, Hybridoma: A New Dimension in Biological Analyses, Plenum Press, New York (1980); and Campbell, "Monoclonal Antibody Technology," in Laboratory Techniques in Biochemistry and Molecular Biology, Vol. 13, Burdon et al. (eds.), Elsevier, Amsterdam (1984). See also, U.S. Patent Nos. 4,196,265; 4,609,893; 4,713,325; 4,714,681; 4,716,111; 4,716,117 and 4,720,459.Antibodies to Cry toxin polypeptides or antigen-binding portions thereof can be produced by a variety of techniques, including conventional monoclonal antibody methods, such as the standard somatic cell hybridization technique described in Kohler and Milstein, (1975) Nature 256: 495. Other techniques for producing monoclonal antibodies, such as viral or oncogenic transformation of B lymphocytes, can also be used. The animal system used to prepare hybridomas is the mouse system. Immunization protocols and techniques for isolating immune spleen cells for fusion are known in the art. Fusion partners (e.g., mouse myeloma cells) and fusion methods are also known. The antibodies and monoclonal antibodies disclosed herein can be prepared by utilizing Cry toxin polypeptides as antigens.

[0113] Kits for detecting the presence of Cry toxin polypeptides or nucleotide sequences encoding Cry toxin polypeptides in a sample are provided. In one embodiment, the kit provides antibody-based reagents for detecting the presence of Cry toxin polypeptides in a tissue sample. In another embodiment, the kit provides labeled nucleic acid probes for detecting the presence of one or more polynucleotides encoding Cry toxin polypeptides. The kits are provided along with appropriate reagents and controls for performing the detection method, as well as instructions for use of the kit.

[0114] Receptor identification and isolation

[0115] Also encompassed are receptors for the Cry toxin polypeptides of the embodiments or their variants or fragments. Methods for identifying receptors are known in the art (see, Hofmann et al., (1988) Eur. J. Biochem. [European Journal of Biochemistry] 173: 85-91; Gill et al., (1995) J. Biol. Chem. [Journal of Biological Chemistry] 27277-27282), and the methods can be used to identify and separate receptors that recognize Cry toxin polypeptides using brush border membrane vesicles from susceptible insects. In addition to the radiolabeling methods listed in the cited literature, Cry toxin polypeptides can be labeled with fluorescent dyes and other common markers such as streptavidin. Brush border membrane vesicles (BBMVs) of susceptible insects (such as soybean budworms and stink bugs) can be prepared according to the scheme listed in the references of Hofmann and Gill above, and separated on SDS-PAGE gels, and blotted on suitable membranes. The labeled Cry toxin polypeptide can be incubated with the blotting membrane of BBMV, and the labeled Cry toxin polypeptide can be identified with a labeled reporter gene. The identification of one or more protein bands interacting with the Cry toxin polypeptide can be detected by N-terminal amino acid gas phase sequencing or mass spectrometry-based protein identification methods (Patterson, (1998) 10.22, 1-24, published by John Wiley & Son Inc. Current Protocol in Molecular Biology [current molecular biology program]). Once the protein is identified, the corresponding gene can be cloned from the genomic DNA or cDNA library of susceptible insects, and the binding affinity can be measured directly with Cry toxin polypeptides. The receptor function of the insecticidal activity of the Cry toxin polypeptide can be verified by RNAi-type gene knockout method (Rajagopal et al., (2002) J.Biol.Chem. [Journal of Biological Chemistry], 277: 46849-46851).

[0116] Nucleotide constructs, expression cassettes and vectors

[0117] The use of the term "nucleotide construct" herein is not intended to limit the embodiments to nucleotide constructs comprising DNA. Those of ordinary skill in the art will recognize that nucleotide constructs, particularly polynucleotides and oligonucleotides consisting of ribonucleotides and combinations of ribonucleotides and deoxyribonucleotides, can also be used in the methods disclosed herein. The nucleotide constructs, nucleic acids, and nucleotide sequences of the embodiments additionally encompass all complementary forms of such constructs, molecules, and sequences. In addition, the nucleotide constructs, nucleic acid molecules, and nucleotide sequences of the embodiments encompass all nucleotide constructs, molecules, and sequences that can be used for the plant transformation methods of the embodiments, including but not limited to those consisting of deoxyribonucleotides, ribonucleotides, and combinations thereof. Such deoxyribonucleotides and ribonucleotides include both naturally occurring molecules and synthetic analogs. The nucleotide constructs, nucleic acids, and nucleotide sequences of the embodiments also encompass all forms of nucleotide constructs, including but not limited to single-stranded forms, double-stranded forms, hairpins, stem-loop structures, etc.

[0118] Additional embodiments relate to transformed organisms, such as organisms selected from the group consisting of plant and insect cells, bacteria, yeast, baculovirus, protozoa, nematodes, and algae, wherein the transformed organism comprises a DNA molecule of the embodiments, an expression cassette comprising the DNA molecule, or a vector comprising the expression cassette, which is stably incorporated into the genome of the transformed organism.

[0119] The sequence of the embodiment is provided in a DNA construct for expression in a target organism. The construct will include 5' and 3' regulatory sequences operably connected to the sequence of the embodiment. As used herein, the term "operably connected" refers to a functional connection between a promoter and a second sequence, wherein the promoter sequence initiates and mediates transcription of the DNA sequence corresponding to the second sequence. Typically, being operably connected means that the connected nucleotide sequence is continuous and, if necessary, connects two protein coding regions in the same reading frame. The construct can additionally contain at least one other gene to be co-transformed into an organism. Alternatively, one or more other genes can be provided on a plurality of DNA constructs.

[0120] The DNA construct provided has multiple restriction sites for inserting the Cry toxin polypeptide gene sequence of the present disclosure, which will be under the transcriptional regulation of the regulatory region. The DNA construct may further comprise a selectable marker gene.

[0121] In the transcription direction from 5' to 3', the DNA construct will generally include: a transcription and translation initiation region (i.e., a promoter), the DNA sequence of the embodiment, and a transcription and translation termination region (i.e., a termination region) that functions in the organism used as the host. For the host organism and / or sequence of the embodiment, the transcription initiation region (i.e., a promoter) can be natural, similar, exogenous, or heterologous. In addition, the promoter can be a native sequence, or alternatively, a synthetic sequence. As used herein, the term "exogenous" represents that a promoter is not found in the natural organism into which the promoter is introduced. In the case where a promoter or any other nucleotide or amino acid sequence is "exogenous" or "heterologous" for the sequence of the embodiment, it refers to a promoter or nucleotide sequence that is not natural or naturally occurring for the sequence that is operably connected to the embodiment. As used herein, a chimeric gene comprises a coding sequence that is operably connected to a transcription initiation region that is heterologous to the coding sequence. When the promoter is a native or natural sequence, expression of the operably linked sequence is altered from wild-type expression, which results in a change in phenotype.

[0122] In some embodiments, the DNA construct comprises a polynucleotide encoding a Cry toxin polypeptide of the embodiments. In some embodiments, the DNA construct comprises a polynucleotide encoding a fusion protein comprising a Cry toxin polypeptide of the embodiments.

[0123] In some embodiments, the DNA construct may further include a transcription enhancer sequence. As used herein, the term "enhancer" refers to a DNA sequence that can stimulate promoter activity and may be an innate element or heterologous element inserted to enhance the level or tissue specificity of a promoter. Various enhancers are known in the art, including, for example, introns with gene expression enhancing properties in plants (U.S. Patent Application Publication No. 2009 / 0144863), the ubiquitin intron (i.e., maize ubiquitin intron 1 (see, e.g., NCBI sequence S94464)), the ω enhancer or ω major enhancer (Gallie et al., (1989) Molecular Biology of RNA, Cech, ed. (Liss, New York) 237-256 and Gallie et al., (1987) Gene 60:217-25), the CaMV 35S enhancer (see, e.g., Benfey et al., (1990) EMBO J. 9:1685-96), and the enhancer of U.S. Patent No. 7,803,992 may also be used. The above list of transcriptional enhancers is not meant to be limiting. Any suitable transcriptional enhancer can be used in the embodiments.

[0124] The termination region may be native to the transcriptional initiation region, may be native to the operably linked DNA sequence of interest, may be native to the plant host, or may be derived from another source (i.e., foreign or heterologous to the promoter, sequence of interest, plant host, or any combination thereof).

[0125] Convenient termination regions are available from the Ti-plasmid of A. tumefaciens, such as the octopine synthase and nopaline synthase termination regions. See also Guerineau et al., (1991) Mol. Gen. Genet. 262:141-144; Proudfoot, (1991) Cell 64:671-674; Sanfacon et al., (1991) Genes Dev. 5:141-149; Mogen et al., (1990) Plant Cell 2:1261-1272; Munroe et al., (1990) Gene 91:151-158; Ballas et al., (1989) Nucleic Acids Res. 17:7891-7903 and Joshi et al., (1987) Nucleic Acids Res. 15:9627-9639.

[0126] When appropriate, nucleic acid can be optimized to increase expression in the host organism. Therefore, when the host organism is a plant, synthetic nucleic acids can be synthesized using plant preference codons to improve expression. For discussion of the use of relevant host preference, see, for example, Campbell and Gowri, (1990) Plant Physiol. [plant physiology] 92: 1-11. For example, although the nucleotide sequence of the embodiment can be expressed in monocotyledonous and dicotyledonous plant species, the sequence can be modified to consider the specific preference and GC content preference of monocotyledonous or dicotyledonous plants, because these preferences have shown differences (Murray et al. (1989) Nucleic Acids Res. [nucleic acid research] 17: 477-498). Thus, the corn preference of specific amino acids can be derived from the known gene sequence of corn. From the maize of 28 kinds of genes of maize plant, use is listed in Table 4 of Murray et al. (the same). The method for synthesizing plant preference genes can be obtained in this area. See, for example, Murray et al. (1989) Nucleic Acids Res. 17:477-498, and Liu H et al. Mol Bio Rep. 37:677-684, 2010, which are incorporated herein by reference. A corn (Zea maize) usage table can also be found at kazusa.or.jp / / cgi-bin / show.cgi? species=4577, which can be accessed using the www prefix. A soybean (Glycine max) usage table can be found at kazusa.or.jp / / cgi-bin / show.cgi? species=3847&aa=1&style=N, which can be accessed using the www prefix.

[0127] In some embodiments, the recombinant nucleic acid molecule encoding the Cry toxin polypeptide has maize-optimized codons.

[0128] It is known that there are other sequence modifications that can enhance gene expression in cellular hosts. These include eliminating sequences encoding false polyadenylation signals, sequences encoding exon-intron splice site signals, sequences encoding transposon-like repeats, and other sequences that are well characterized and may be detrimental to gene expression. The GC content of the sequence can be adjusted to the average level of a given cellular host, as calculated by reference to known genes expressed in the host cell. As used herein, the term "host cell" refers to a cell that contains a vector and supports replication and / or expression of an expression vector. The host cell can be a prokaryotic cell such as Escherichia coli, or a eukaryotic cell such as a yeast, insect, amphibian or mammalian cell, or a monocotyledonous or dicotyledonous plant cell. An example of a monocotyledonous host cell is a maize host cell. When possible, the sequence is modified to avoid the occurrence of predictable hairpin secondary mRNA structures.

[0129] The expression cassette may additionally comprise a 5' leader sequence. Such leader sequences can serve to enhance translation. Translation leader sequences are known in the art and include: picornavirus leader sequences, such as the EMCV leader sequence (encephalomyocarditis 5' non-coding region) (Elroy-Stein et al., (1989) Proc. Natl. Acad. Sci. USA [Proceedings of the National Academy of Sciences of the United States], 86: 6126-6130); Potyvirus leader sequences, such as the TEV leader sequence (tobacco etch virus) (Gallie et al., (1995) Gene [gene] 165 (2): 233-238), the MDMV leader sequence (maize dwarf mosaic virus), the human immunoglobulin heavy chain binding protein (BiP) (Macejak et al., (1991) Nature [nature] 353: 90-94); the untranslated leader sequence from the coat protein mRNA of alfalfa mosaic virus (AMV RNA 4) (Jobling et al., (1987) Nature 325:622-625); tobacco mosaic virus leader (TMV) (Gallie et al., (1989) Molecular Biology of RNA, Cech, ed. (Leeds, New York), pp. 237-256); and maize chlorotic mottle virus leader (MCMV) (Lommel et al., (1991) Virology 81:382-385). See also, Della-Cioppa et al., (1987) Plant Physiol. 84:965-968. Such constructs may also contain a "signal sequence" or "leader sequence" to facilitate co-translational or post-translational trafficking of the peptide to certain intracellular structures, such as chloroplasts (or other plastids), the endoplasmic reticulum, or the Golgi apparatus.

[0130] As used herein, "signal sequence" refers to a sequence known or suspected to cause co-translational or post-translational peptide transport across the cell membrane. In eukaryotes, this typically involves secretion into the Golgi apparatus, with the glycosylation of some production. Bacterial insecticide toxins are usually synthesized as protoxins, which are activated by proteolysis in the intestine of the target pest (Chang, (1987) Methods Enzymol. [Enzymology Methods] 153: 507-516). In some embodiments, the signal sequence is located in the natural sequence, or can be derived from the sequence of the embodiment. As used herein, the term "leader sequence" refers to any sequence that, when translated, produces an amino acid sequence sufficient to initiate the co-translational transport of a peptide chain with a subcellular organelle. Therefore, this includes leader sequences that target transport and / or glycosylation by entering the endoplasmic reticulum, entering the vacuole, plastids (including chloroplasts, mitochondria), etc. Nuclear-encoded proteins targeting the chloroplast thylakoid lumen have a characteristic bipartite transit peptide consisting of a matrix-targeting signal peptide and a lumen-targeting signal peptide. The matrix targeting information is located in the amino-proximal portion of the transit peptide. The lumen targeting signal peptide is located in the carboxyl-proximal portion of the transit peptide and contains all the information for targeting the lumen. Recent studies in the chloroplast proteomics of higher plants have made progress in identifying many nuclear-encoded lumen proteins (Kieselbach et al. FEBSLETT [FEBSLETT Newsletter] 480:271-276, 2000; Peltier et al. Plant Cell 12:319-341, 2000; Bricker et al. Biochim. Biophys Acta 1503:350-356, 2001), and lumen targeting signal peptides of such nuclear-encoded lumen proteins may be used according to the present disclosure. Kieselbach et al., Photosynthesis Research 78:249-264, 2003 reported about 80 proteins from Arabidopsis and homologous proteins from spinach and pea. In particular, Table 2 of this publication, which is incorporated herein by reference, discloses 85 proteins from the chloroplast lumen identified by their accession numbers (see also US Patent Application Publication No. 2009 / 09044298).

[0131] Suitable chloroplast transit peptides (CTPs) well known to those skilled in the art also include chimeric CT's, including but not limited to: the N-terminal domain, central domain or C-terminal domain of the following CTPs: rice (Oryza sativa) 1-deoxy-D-xylulose-5-phosphate synthase, rice-superoxide dismutase, rice-soluble starch synthase, rice-NADP-dependent malic enzyme, rice-2-dehydro-3-deoxyheptanoate phosphate aldolase 2, rice-L-ascorbate peroxidase 5, rice-phosphoglucan water dikinase, maize ssRUBISCO, maize-β-glucosidase, maize-malate dehydrogenase, maize thioredoxin M-type (see U.S. Patent Application Publication No. 2012 / 0304336).

[0132] Cry toxin polypeptide genes to be targeted to the chloroplast can be optimized for expression in the chloroplast to account for differences in usage between the plant nucleus and this organelle. In this way, nucleic acids of interest can be synthesized using chloroplast-preferred sequences.

[0133] In preparing the expression cassette, the various DNA fragments may be manipulated to provide the DNA sequence in the proper orientation and, where appropriate, in the proper reading frame. To this end, adapters or linkers may be employed to connect the DNA fragments, or other manipulations may be involved to provide convenient restriction sites, remove excess DNA, remove restriction sites, etc. For this purpose, in vitro mutagenesis, primer repair, restriction enzyme digestion, annealing, and resubstitution (e.g., conversion and transversion) may be involved.

[0134] Many promoters can be used to implement the embodiments. The promoter can be selected based on the desired results. The nucleic acid can be combined with a constitutive, tissue-preferred, inducible, or other promoter for expression in the host organism. Suitable constitutive promoters for use in plant host cells include, for example, the core promoter of the Rsyn7 promoter and other constitutive promoters disclosed in WO 1999 / 43838 and U.S. Patent No. 6,072,050; the core CaMV 35S promoter (Odell et al., (1985) Nature 313:810-812); rice actin (McElroy et al., (1990) Plant Cell 2:163-171); ubiquitin (Christensen et al., (1989) Plant Mol. Biol. 12:619-632 and Christensen et al., (1992) Plant Mol. Biol. Mol. Biol. [Plant Molecular Biology] 18: 675-689); pEMU (Last et al., (1991) Theor. Appl. Genet. [Theoretical and Applied Genetics] 81: 581-588); MAS (Velten et al., (1984) EMBO J. [Journal of the European Molecular Biology Association] 3: 2723-2730); ALS promoter (U.S. Patent No. 5,659,026), etc. Other constitutive promoters include those discussed in, for example, the following U.S. Patent Nos.: 5,608,149; 5,608,144; 5,604,121; 5,569,597; 5,466,785; 5,399,680; 5,268,463; 5,608,142; and 6,177,611.

[0135] Depending on the desired outcome, it may be beneficial to express the gene from an inducible promoter. Of particular interest for use in regulating expression of the nucleotide sequences of the embodiments in plants are wound-inducible promoters. Such wound-inducible promoters may respond to damage caused by insect feeding and include potato proteinase inhibitors (PIs). II) genes (Ryan (1990) Ann. Rev. Phytopath. 28:425-449; Duan et al. (1996) Nature Biotechnology 14:494-498); wun1 and wun2 (U.S. Pat. No. 5,428,148); win1 and win2 (Stanford et al. (1989) Mol. Gen. Genet. 215:200-208); systemin (McGurl et al. (1992) Science 225:1570-1573); WIP1 (Rohmeier et al. (1993) Plant Mol. Biol. 22:783-792; Eckelkamp et al. (1993) FEBS Letters [FEBS News] 323: 73-76); MPI gene (Corderok et al. (1994) Plant J. [Plant Journal] 6(2): 141-150), etc.

[0136] In addition, pathogen-inducible promoters can be used in the methods and nucleotide constructs of the embodiments. Such pathogen-inducible promoters include those from pathogenesis-related proteins (PR proteins), which are induced after pathogen infection; for example, PR proteins, SAR proteins, β-1,3-glucanases, chitinases, etc. See, for example, Redolfi et al., (1983) Neth. J. Plant Pathol. [Netherlands Journal of Plant Pathology] 89: 245-254; Uknes et al., (1992) Plant Cell [Plant Cell] 4: 645-656; and Van Loon, (1985) Plant Mol. Virol. [Plant Molecular Virology] 4: 111-116. See also WO 1999 / 43819.

[0137] Of interest are promoters that are expressed locally at or near the site of pathogen infection. See, for example, Marineau et al., (1987) Plant Mol. Biol. 9:335-342; Matton et al., (1989) Molecular Plant-Microbe Interactions 2:325-331; Somsisch et al., (1986) Proc. Natl. Acad. Sci. USA 83:2427-2430; Somsisch et al., (1988) Mol. Gen. Genet. 2:93-98 and Yang, (1996) Proc. Natl. Acad. Sci. USA 93:14972-14977. See also Chen et al., (1996) Plant J. 10:955-966; Zhang et al., (1994) Proc. Natl. Acad. Sci. USA 91:2507-2511; Warner et al., (1993) Plant J. 3:191-201; Siebertz et al., (1989) Plant Cell 1:961-968; U.S. Pat. No. 5,750,386 (nematode-inducible) and references cited therein. Of particular interest is the inducible promoter of the maize PRms gene, expression of which is induced by the pathogen Fusarium moniliforme (see, eg, Cordero et al., (1992) Physiol. Mol. Plant Path. 41: 189-200).

[0138] Chemically regulated promoters can be used to regulate gene expression in plants by applying exogenous chemical regulators. Depending on the target, the promoter can be a chemically inducible promoter, in which chemicals are applied to induce gene expression, or a chemically repressible promoter, in which chemicals are applied to repress gene expression. Chemically inducible promoters are known in the art and include, but are not limited to, the maize In2-2 promoter activated by benzenesulfonamide herbicide safeners, the maize GST promoter activated by hydrophobic electrophilic compounds used as pre-emergence herbicides, and the tobacco PR-1a promoter activated by salicylic acid. Other chemically-regulated promoters of interest include steroid-responsive promoters (see, e.g., Schena et al., (1991) Proc. Natl. Acad. Sci. USA 88: 10421-10425 and McNellis et al., (1998) Plant J. 14(2): 247-257 for glucocorticoid-inducible promoters) and tetracycline-inducible and tetracycline-repressible promoters (see, e.g., Gatz et al., (1991) Mol. Gen. Genet. 227: 229-237, and U.S. Pat. Nos. 5,814,618 and 5,789,156).

[0139] Tissue-preferred promoters can be used to target enhanced Cry toxin polypeptide expression in specific plant tissues. Tissue-preferred promoters include those described in the following literature: Yamamoto et al., (1997) Plant J. 12(2):255-265; Kawamata et al., (1997) Plant Cell Physiol. 38(7):792-803; Hansen et al., (1997) Mol. Gen Genet. 254(3):337-343; Russell et al., (1997) Transgenic Res. 6(2):157-168; Rinehart et al., (1996) Plant Physiol. 112(3):1331-1341; Van Camp et al. (1996) Plant Physiol. 112(2):525-535; Canevascini et al. (1996) Plant Physiol. 112(2):513-524; Yamamoto et al. (1994) Plant Cell Physiol. 35(5):773-778; Lam (1994) Results Probl. Cell Differ. 20:181-196; Orozco et al. (1993) Plant Mol Biol. 23(6):1129-1138; Matsuoka et al. (1993) Proc. Natl. Acad. Sci. USA 23(6):1129-1138. Natl. Acad. Sci. USA [Proceedings of the National Academy of Sciences of the United States of America] 90(20):9586-9590 and Guevara-Garcia et al., (1993) Plant J. [Plant Journal] 4(3):495-505. If necessary, such promoters can be modified for weak expression.

[0140] Leaf-preferred promoters are known in the art. See, for example, Yamamoto et al., (1997) Plant J. 12(2):255-265; Kwon et al., (1994) Plant Physiol. 105:357-67; Yamamoto et al., (1994) Plant Cell Physiol. 35(5):773-778; Gotor et al., (1993) Plant J. 3:509-18; Orozco et al., (1993) Plant Mol. Biol. 23(6):1129-1138 and Matsuoka et al., (1993) Proc. Natl. Acad. Sci. USA 90(20):9586-9590.

[0141] Root-preferred or root-specific promoters are known and can be selected from the many available promoters from the literature or re-isolated from different compatible species. See, e.g., Hire et al., (1992) Plant Mol. Biol. 20(2):207-218 (soybean root-specific glutamine synthetase gene); Keller and Baumgartner, (1991) Plant Cell 3(10):1051-1061 (root-specific control elements in the GRP 1.8 gene of French bean); Sanger et al., (1990) Plant Mol. Biol. 14(3):433-443 (root-specific promoter of the mannan synthase (MAS) gene of Agrobacterium tumefaciens); and Miao et al., (1991) Plant Cell 3(1):11-22 (full-length cDNA clone encoding cytosolic glutamine synthetase (GS) expressed in roots and nodules of soybean). See also, Bogusz et al. (1990) Plant Cell 2(7):633-641, which describes two root-specific promoters isolated from the hemoglobin gene of the nitrogen-fixing non-legume Parasponia andersonii and the related non-nitrogen-fixing non-legume Trematomentosa. The promoters of these genes were linked to a β-glucuronidase reporter gene and introduced into both the non-legume Nicotiana tabacum and the legume Lotus corniculatus, and in both cases retained root-specific promoter activity. Leach and Aoyagi (1991) describe their analysis of the promoters of the highly expressed rolC and rolD root-inducing genes of Agrobacterium rhizogenes (see, Plant Science (Limerick) 79(1):69-76). They concluded that the enhancer and tissue-preferential DNA determinants are dissociated in the promoter. Teeri et al. (1989) used gene fusions with lacZ to show that the Agrobacterium T-DNA gene encoding octopine synthase is active particularly in the epidermis of the root tip and that the TR2' gene is root-specific in intact plants and is stimulated by wounding in leaf tissue, a particularly desirable combination of features for use with insecticidal or larvicidal genes (see, EMBO J. [Journal of the European Molecular Biology Association] 8(2):343-350).TR1' gene fused to nptII (neomycin phosphotransferase II) shows similar characteristics. Additional root-preferential promoters include the VfENOD-GRP3 gene promoter (Kuster et al., (1995) Plant Mol. Biol. [Plant Molecular Biology] 29 (4): 759-772); and the rolB promoter (Capana et al., (1994) Plant Mol. Biol. [Plant Molecular Biology] 25 (4): 681-691). See also, U.S. Patent Nos. 5,837,876; 5,750,386; 5,633,363; 5,459,252; 5,401,836; 5,110,732 and 5,023,179. Arabidopsis thaliana root-preferential regulatory sequences are disclosed in US20130117883.

[0142] "Seed-preferred" promoters include "seed-specific" promoters (those active during seed development, such as promoters of seed storage proteins) and "seed-germinating" promoters (those active during seed germination). See Thompson et al., (1989) BioEssays 10:108. Such seed-preferred promoters include, but are not limited to, Cim1 (cytokinin-induced message); cZ19B1 (maize 19 kDa zein); and milps (inositol-1-phosphate synthase) (see, U.S. Patent No. 6,225,529). γ-zein and Glb-1 are endosperm-specific promoters. For dicots, seed-specific promoters include, but are not limited to, Kunitz trypsin inhibitor 3 (KTi3) (Jofuku and Goldberg, (1989) Plant Cell 1: 1079-1101), bean-β-phaseolin, napin, β-conglycinin, glycinin 1, soybean lectin, cruciferin, etc. For monocots, seed-specific promoters include, but are not limited to, maize 15 kDa zein, 22 kDa zein, 27 kDa zein, g-zein, wax, contractin 1, contractin 2, globulin 1, etc. See also WO 2000 / 12733, which discloses seed-preferred promoters from the end1 and end2 genes. In dicots, seed-specific promoters include, but are not limited to, the seed coat promoter from Arabidopsis, pBAN; and the early seed promoters from Arabidopsis, p26, p63, and p63tr (U.S. Patent Nos. 7,294,760 and 7,847,153). Promoters that have "preferential" expression in a particular tissue are expressed to a greater extent in that tissue than in at least one other plant tissue. Some tissue-preferential promoters are expressed almost exclusively in a particular tissue.

[0143] When low-level expression is needed, a weak promoter can be used. Generally, as used herein, the term "weak promoter" refers to a promoter that drives the expression of a coding sequence at a low level. Low-level expression is intended to be a level between about 1 / 1000 transcripts to about 1 / 100,000 transcripts to about 1 / 500,000 transcripts. Alternatively, it should be appreciated that the term "weak promoter" also encompasses promoters that drive expression only in a few cells but not in other cells, thereby having a low-level total expression. When a promoter drives expression at an unacceptably high level, portions of the promoter sequence can be deleted or modified to reduce the level of expression.

[0144] Such weak constitutive promoters include, for example, the core promoter of the Rsyn7 promoter (WO 1999 / 43838 and U.S. Patent No. 6,072,050), the core 35S CaMV promoter, etc. Other constitutive promoters include, for example, those disclosed in the following patent documents: U.S. Patent Nos. 5,608,149; 5,608,144; 5,604,121; 5,569,597; 5,466,785; 5,399,680; 5,268,463; 5,608,142 and 6,177,611.

[0145] The above list of promoters is not meant to be limiting. Any suitable promoter can be used in the embodiments.

[0146] Typically, the expression cassette will contain a selective marker gene for selecting transformed cells. Selectable marker genes are used to select transformed cells or tissues. Marker genes include genes encoding antibiotic resistance, such as those encoding neomycin phosphotransferase II (NEO) and hygromycin phosphotransferase (HPT), and genes that confer resistance to herbicidal compounds such as glufosinate, bromoxynil, imidazolinone, and 2,4-dichlorophenoxyacetic acid (2,4-D). Other examples of suitable selectable marker genes include, but are not limited to, genes encoding resistance to chloramphenicol (Herrera Estrella et al., (1983) EMBO J. 2:987-992); methotrexate (Herrera Estrella et al., (1983) Nature 303:209-213 and Meijer et al., (1991) Plant Mol. Biol. 16:807-820); streptomycin (Jones et al., (1987) Mol. Gen. Genet. 210:86-91); spectinomycin (Bretagne-Sagnard et al., (1996) Transgenic Res. 5:131-137); bleomycin (Hille et al., (1990) Plant Mol. Biol. 16:807-820); Mol. Biol. 7:171-176); sulfonamides (Guerineau et al. (1990) Plant Mol. Biol. 15:127-136); bromoxynil (Stalker et al. (1988) Science 242:419-423); glyphosate (Shaw et al. (1986) Science 233:478-481 and U.S. patent application Ser. Nos. 10 / 004,357 and 10 / 427,692); glufosinate (DeBlock et al. (1987) EMBO J. 6:2513-2518). See primarily Yarranton, (1992) Curr. Opin. Biotech. 3:506-511; Christopherson et al., (1992) Proc. Natl. Acad. Sci. USA 89:6314-6318; Yao et al., (1992) Cell 71:63-72; Reznikoff, (1992) Mol. Microbiol.[Molecular Microbiology] 6: 2419-2422; Barkley et al. (1980) in The Operon, pp. 177-220; Hu et al. (1987) Cell 48:555-566; Brown et al. (1987) Cell 49:603-612; Figge et al. (1988) Cell 52:713-722; Deuschle et al. (1989) Proc. Natl. Acad. Sci. USA 86:5400-5404; Fuerst et al. (1989) Proc. Natl. Acad. Sci. USA 86:2549-2553; Deuschle et al. (1990) Science 248:480-483; Gossen, (1993) Ph.D. Thesis, University of Heidelberg [University of Heidelberg, Germany]; Reines et al. (1993) Proc. Natl. Acad. Sci. USA 90:1917-1921; Labow et al. (1990) Mol. Cell. Biol. 10:3343-3356; Zambretti et al. (1992) Proc. Natl. Acad. Sci. USA 89:3952-3956; Baim et al. (1991) Proc. Natl. Acad. Sci. USA 88:5072-5076; Wyborski et al. (1991) Nucleic Acids Res. Nucleic Acids Res. 19:4647–4653; Hillenand-Wissman (1989) Topics Mol. Struc. Biol. 10:143–162; Degenkolb et al. (1991) Antimicrob. Agents Chemother. 35:1591–1595; Kleinschnidt et al. (1988) Biochemistry 27:1094–1104; Bonin (1993) Ph.D. Thesis, University of Heidelberg; Gossen et al. (1992) Proc. Natl. Acad. Sci. USA 89:5547–5551; Oliva et al. (1992) Antimicrob.Agents Chemother. 36:913-919; Hlavka et al. (1985) Handbook of Experimental Pharmacology, vol. 78 (Springer-Verlag, Berlin) and Gill et al. (1988) Nature 334:721-724.

[0147] The above list of selectable marker genes is not intended to be limiting. Any selectable marker gene can be used in the embodiments.

[0148] Plant transformation

[0149] The methods of the embodiments involve introducing a polypeptide or polynucleotide into a plant. As used herein, "introducing" means presenting the polynucleotide or polypeptide to the plant in such a manner that the sequence enters the interior of the plant cell. The methods of the embodiments do not depend on the specific method used to introduce one or more polynucleotides or one or more polypeptides into a plant, as long as the polynucleotide or polypeptide enters the interior of at least one cell of the plant. Methods for introducing one or more polynucleotides or one or more polypeptides into a plant are known in the art and include, but are not limited to, stable transformation methods, transient transformation methods, and viral-mediated methods.

[0150] As used herein, "stable transformation" means that the nucleotide construct introduced into a plant is integrated into the genome of the plant and can be inherited by its progeny. As used herein, "transient transformation" means that a polynucleotide is introduced into the plant and is not integrated into the genome of the plant, or that a polypeptide is introduced into the plant. As used herein, "plant" refers to whole plants, plant organs (e.g., leaves, stems, roots, etc.), seeds, plant cells, propagules, and embryos and progeny thereof. Plant cells can be differentiated or undifferentiated (e.g., callus, suspension culture cells, protoplasts, leaf cells, root cells, phloem cells, and pollen).

[0151] Transformation protocols and protocols for introducing nucleotide sequences into plants can vary depending on the type of plant or plant cell (ie, monocot or dicot) being targeted for transformation. Suitable methods for introducing nucleotide sequences into plant cells and subsequent insertion into the plant genome include microinjection (Crossway et al., (1986) Biotechniques 4:320-334), electroporation (Riggs et al., (1986) Proc. Natl. Acad. Sci. USA 83:5602-5606), Agrobacterium-mediated transformation (U.S. Pat. Nos. 5,563,055 and 5,981,840), direct gene transfer (Paszkowski et al., (1984) EMBO J 3:2717-2722), and ballistic particle acceleration (see, e.g., U.S. Pat. Nos. 4,945,050; 5,879,918; 5,886,244 and 5,932,782; Tomes et al., (1995) Plant Cell, Tissue, and Organ Culture: Fundamental Biology). Methods [Plant Cell, Tissue and Organ Culture: Basic Methods], Gamborg and Phillips, eds. (Springer-Verlag, Berlin; and McCabe et al., (1988) Biotechnology 6:923-926); and Lec1 transformation method (WO 00 / 28058). For potato transformation methods, see Tu et al., (1998) Plant Molecular Biology 37:829-838 and Chong et al., (2000) Transgenic Research 9:71-78. Additional transformation methods can be found in Weissinger et al., (1988) Ann. Rev. Genet. 22:421-477; Sanford et al., (1987) Particulate Science and Technology 5:27-37 (onion); Christou et al., (1988) Plant Physiol. 87:671-674 (soybean); McCabe et al., (1988) Bio / Technology 6:923-926 (soybean); Finer and McMullen, (1991) In Vitro Cell Dev. Biol.In Vitro Cell Biology and Developmental Biology 27P:175-182 (soybean); Singh et al. (1998) Theor. Appl. Genet. 96:319-324 (soybean); Datta et al. (1990) Biotechnology 8:736-740 (rice); Klein et al. (1988) Proc. Natl. Acad. Sci. USA 85:4305-4309 (maize); Klein et al. (1988) Biotechnology 6:559-563 (maize); U.S. Patent Nos. 5,240,855, 5,322,783, and 5,324,646; Klein et al. (1988) Plant Genetics 10:116-123 (soybean); Physiol. 91:440-444 (maize); Fromm et al. (1990) Biotechnology 8:833-839 (maize); Hooykaas-Van Slogteren et al. (1984) Nature (London) 311:763-764; U.S. Patent No. 5,736,369 (cereals); Bytebier et al. (1987) Proc. Natl. Acad. Sci. USA 84:5345-5349 (Liliaceae); De Wet et al. (1985) The Experimental Manipulation of Ovule Tissues [Experimental Manipulations of Ovule Tissue], Chapman et al., eds. (Longman, New York), pp. 197-209 (pollen); Kaeppler et al., (1990) Plant Cell Reports 9:415-418 and Kaeppler et al., (1992) Theor. Appl. Genet. 84:560-566 (whisker-mediated transformation); D'Halluin et al., (1992) Plant Cell 4:1495-1505 (electroporation); Li et al., (1993) Plant Cell Reports 12:250-255 and Christou and Ford, (1995) Annals of Botany 75:407-413 (rice); Osjoda et al., (1996) Nature Biotechnology [Nature Biotechnology] 14:745-750 (maize via Agrobacterium tumefaciens).

[0152] In specific embodiments, various transient transformation methods can be used to provide the sequences of the embodiments to plants. Such transient transformation methods include, but are not limited to, directly introducing Cry toxin polynucleotides or variants and fragments thereof into plants or introducing Cry toxin polypeptide transcripts into plants. Such methods include, for example, microinjection or particle bombardment. See, for example, Crossway et al., (1986) Mol Gen. Genet. [Molecular Genetics and General Genetics] 202: 179-185; Nomura et al., (1986) Plant Sci. [Plant Science] 44: 53-58; Hepler et al., (1994) Proc. Natl. Acad. Sci. [Proceedings of the National Academy of Sciences of the United States of America] 91: 2176-2180 and Hush et al., (1994) The Journal of Cell Science [Cell Science Journal] 107: 775-784. Alternatively, Cry toxin polynucleotides can be transiently transformed into plants using techniques known in the art. Such techniques include viral vector systems and precipitating polynucleotides in a manner that prevents subsequent release of the DNA. Thus, transcription can occur from particle-bound DNA, but the frequency of its release for integration into the genome is greatly reduced. Such methods include the use of particles coated with polyethyleneimine (PEI; Sigma #P3143).

[0153] The method for inserting polynucleotide at the specific position targeting of plant genome is known in the art.In one embodiment, the site-specific recombination system is utilized to realize the insertion of polynucleotide at required genome location.See, for example WO 1999 / 25821, WO 1999 / 25854, WO 1999 / 25840, WO 1999 / 25855 and WO 1999 / 25853.In short, the polynucleotide of embodiment can be included in the transfer box that flanks are two different recombination sites.Transfer box is introduced in plant, and described plant has stably incorporated target site in its genome, and described target site flanks are two different recombination sites corresponding with the site of transfer box.Suitable recombinase is provided, and described transfer box is integrated into target site.Thus, purpose polynucleotide is integrated into the concrete chromosome position in plant genome.

[0154] Plant transformation vectors can be composed of one or more DNA vectors required to achieve plant transformation. For example, it is common practice in the art to utilize plant transformation vectors composed of more than one continuous DNA segment. These vectors are commonly referred to as "binary vectors" in the art. Binary vectors and vectors with helper plasmids are most commonly used for Agrobacterium-mediated transformation, where the size and complexity of the DNA segments required for effective transformation are quite large, and it is advantageous to separate the functions into separate DNA molecules. Binary vectors typically contain a plasmid vector containing the cis-acting sequences required for T-DNA transfer (such as left and right borders), a selective marker engineered to be expressed in plant cells, and a "gene of interest" (a gene engineered to be expressed in plant cells in which transgenic plants are to be produced). Sequences required for bacterial replication are also present on this plasmid vector. The cis-acting sequences are arranged in a manner that allows for efficient transfer into and expression in plant cells. For example, the selective marker gene and the pesticidal gene are located between the left and right borders. Typically, a second plasmid vector contains trans-acting factors that mediate T-DNA transformation from Agrobacterium to plant cells. As is understood in the art, the plasmid typically contains virulence functions (Vir genes) that allow infection of plant cells by Agrobacterium, as well as transfer of DNA by cleavage at border sequences and vir-mediated DNA transfer (Hellens and Mullineaux, (2000) Trends in Plant Science 5:446-451). Several types of Agrobacterium strains (e.g., LBA4404, GV3101, EHA101, EHA105, etc.) can be used for plant transformation. Transformation of plants by other methods such as microprojection, microinjection, electroporation, polyethylene glycol, etc. does not require a second plasmid vector.

[0155] Typically, plant transformation methods involve transferring heterologous DNA into target plant cells (e.g., immature or mature embryos, suspension cultures, undifferentiated callus, protoplasts, etc.), followed by applying a maximum threshold level of appropriate selection (depending on the selective marker gene) to reclaim transformed plant cells from a group of untransformed cell populations. After the heterologous exogenous DNA is integrated into the plant cells, the maximum threshold level of appropriate selection is then applied in culture medium to kill the untransformed cells, and the cells are separated and propagated from the selected cells by regular transfer to fresh culture medium. Attacked by continuous passage and using appropriate selection, the cells transformed with the plasmid vector are identified and propagated. Molecular and biochemical methods can then be used to confirm the presence of the heterologous gene of interest that is integrated into the genome of the transgenic plant.

[0156] Typically, the explant is transferred to a fresh supply of the same medium and cultured conventionally. Subsequently, after being placed on a regeneration medium supplemented with a selection agent of a maximum threshold level, the transformed cells differentiate into buds. The buds are then transferred to a selective rooting medium for reclaiming the rooted buds or plantlets. The transgenic plantlets then grow into mature plants and produce fertile seeds (e.g., Hiei et al., (1994) The Plant Journal 6: 271-282; Ishida et al., (1996) Nature Biotechnology [Natural Biotechnology] 14: 745-750). Typically, the explant is transferred to a fresh supply of the same medium and cultured conventionally. A general description of the techniques and methods for producing transgenic plants is found in the following literature: Ayres and Park, (1994) Critical Reviews in Plant Science [Plant Science Review] 13: 219-239 and Bommineni and Jauhar, (1997) Maydica [Medica Magazine] 42: 107-120. Because the transformed material contains many cells; therefore, in any part of the target callus or tissue or cell group being tested, transformed cells and non-transformed cells are present simultaneously. The ability to kill non-transformed cells and allow transformed cells to proliferate produces transformed plant cultures. Generally, the ability to remove non-transformed cells limits the rapid recovery of transformed plant cells and the successful generation of transgenic plants.

[0157] Transformed cells can be grown into plants in conventional manner. See, for example, McCormick et al. (1986) Plant Cell Reports 5:81-84. These plants can then be grown and pollinated with the same transformed strain or a different strain, and the resulting hybrids identified for constitutive or inducible expression of the desired phenotypic characteristic. Two or more generations can be grown to ensure that expression of the desired phenotypic characteristic is stably maintained and inherited, and seeds can then be harvested to ensure that expression of the desired phenotypic characteristic has been achieved.

[0158] The nucleotide constructs of the embodiments can be provided to plants by contacting the plants with viruses or viral nucleic acids. Typically, such methods involve incorporating the target nucleotide construct into viral DNA or RNA molecules. It should be recognized that the recombinant proteins of these embodiments can be initially synthesized as part of a viral polyprotein, and the synthesized protein can then be processed in vivo or in vitro by proteolysis to produce the desired Cry toxin polypeptide. It is also recognized that such viral polyproteins comprising at least a portion of the amino acid sequence of the Cry toxin polypeptides of these embodiments can have the desired pesticidal activity. Such viral polyproteins and the nucleotide sequences encoding them are encompassed in the embodiments. Methods for providing plants with nucleotide constructs and producing the encoded proteins in plants are known in the art and involve viral DNA or RNA molecules. See, for example, U.S. Patent Nos. 5,889,191, 5,889,190, 5,866,785, 5,589,367 and 5,316,931.

[0159] Methods for transforming chloroplasts are known in the art. See, for example, Svab et al., (1990) Proc. Natl. Acad. Sci. USA 87:8526-8530; Svab and Maliga, (1993) Proc. Natl. Acad. Sci. USA 90:913-917; Svab and Maliga, (1993) EMBO J. 12:601-606. Such methods rely on particle gun delivery of DNA containing a selectable marker and targeting of the DNA to the plastid genome by homologous recombination. Alternatively, plastid transformation can be achieved by transactivating a silent plastid-borne transgene through the use of tissue-preferred expression of a nuclear-encoded and plastid-directed RNA synthase. Such a system has been reported in the following literature: McBride et al., (1994) Proc. Natl. Acad. Sci. USA 91: 7301-7305.

[0160] The embodiments further relate to plant propagation material of the transformed plants of the embodiments, including but not limited to seeds, tubers, corms, bulbs, leaves, and root and shoot cuttings.

[0161] The embodiments described can be used to transform any plant species, including but not limited to monocots and dicots. Examples of plants of interest include, but are not limited to, corn (Zea mays), Brassica species (e.g., B. napus, B. rapa, B. juncea), particularly those Brassica species that can be used as a source of seed oil, alfalfa (Medicago sativa), rice (Oryza sativa), rye (Secale cereale), sorghum (Sorghum bicolor, Sorghum vulgare), millet (e.g., pearl millet (Pennisetum glaucum), proso millet (Panicum miliaceum), foxtail millet (Setaria italica), finger millet (Eleusine coracana), sunflower (Helianthus annuus), safflower (Carthamus tinctorius), wheat (Triticum aestivum), and safflower (Carthamus tinctorius). aestivum, soybean (Glycine max), tobacco (Nicotiana tabacum), potato (Solanum tuberosum), peanut (Arachis hypogaea), cotton (Gossypium barbadense, Gossypium hirsutum), sweet potato (Ipomoea batatas), cassava (Manihot esculenta), coffee (Coffea species), coconut (Cocos nucifera), pineapple (Ananas comosus), citrus (Citrus species), cocoa (Theobroma cacao), tea (Camellia sinensis), banana (Musa species), avocado (Persea americana), fig (Ficus casica), guava (Psidium guajava), mango (Mangifera indica), olive (Oleaeuropaea), papaya (Carica papaya), cashew (Anacardium occidentale), macadamia (Macadamia integrifolia), almond (Prunus amygdalus), sugar beets (Beta vulgaris), sugarcane (Saccharum species), oats, barley, vegetables, ornamentals, and conifers.

[0162] Vegetables include tomatoes (Lycopersicon esculentum), lettuce (e.g., Lactuca sativa), green beans (Phaseolus vulgaris), lima beans (Phaseolus limensis), peas (Lathyrus species), and members of the genus Cucumber such as cucumber (C. sativus), cantaloupe (C. cantalupensis), and musk melon (C. melo). Ornamental plants include azaleas (Rhododendron species), hydrangeas (Macrophylla hydrangea), hibiscus (Hibiscus rosasanensis), roses (Rosa species), tulips (Tulipa species), daffodils (Narcissus species), petunias (Petunia hybrida), carnations (Dianthus caryophyllus), poinsettias (Euphorbia pulcherrima), and chrysanthemums. Conifers that can be used to practice the embodiments include, for example, pines such as loblolly pine (Pinus taeda), slash pine (Pinus elliotii), ponderosa pine (Pinus ponderosa), lodgepole pine (Pinus contorta), and Monterey pine (Pinus radiata); Douglas-fir (Pseudotsuga menziesii); Western hemlock (Tsugacanadensis); Sitka spruce (Picea glauca); redwood (Sequoia sempervirens); true firs such as silver fir (Abies amabilis) and balsam fir (Abies balsamea); and cedars such as western red cedar (Thuja sempervirens). plicata) and Alaskan yellow cedar (Chamaecyparis nootkatensis).Plants of the embodiments include crop plants (eg, corn, alfalfa, sunflower, Brassica, soybean, cotton, safflower, peanut, sorghum, wheat, millet, tobacco, etc.), such as corn and soybean plants.

[0163] Turfgrasses include, but are not limited to, annual bluegrass (Poa annua); annual ryegrass (Lolium multiflorum); Canada bluegrass (Poa compressa); red fescue (Festuca rubra); colonialbentgrass (Agrostis tenuis); creeping bentgrass (Agrostis palustris); crested wheatgrass (Agropyron desertorum); fairway wheatgrass (Agropyron cristatum); hard fescue (Festuca longifolia); Kentucky bluegrass (Poa pratensis); orchardgrass (Dactylis glomerata; perennial ryegrass (Lolium perenne); red foxgrass (Festuca rubra); redtop (Agrostis alba); rough bluegrass (Poa trivialis); sheep fescue (Festuca ovina); smooth bromegrass (Bromus inermis); tall fescue (Festuca arundinacea); timothy (Phleum pratense); velvet bentgrass (Agrostis canina); weeping alkaligrass (Puccinellia distans); western wheatgrass (Agropyron smithii); Bermuda grass (Cynodon species); St. Augustine grass (St.Augustine grass (Stenotaphrum secundatum); Zoysia grass (Zoysia species); Bahia grass (Paspalum notatum); Carpetgrass (Axonopus affinis); Centipede grass (Eremochloa ophiuroides); Kikuyu grass (Pennisetum clandesinum); Seashore paspalum (Paspalumvaginatum); Blue gramma (Bouteloua gracilis); Buffalo grass (Buchloe dactyloids); Sideoats gramma (Bouteloua curtipendula).

[0164] Target plants include cereals, oilseed plants, and legumes that provide target seeds. Target seeds include cereals such as corn, wheat, barley, rice, sorghum, rye, and millet. Oilseed plants include cotton, soybeans, safflower, sunflower, Brassica, corn, alfalfa, palm, coconut, flax, castor, and olive. Legumes include beans and peas. Legumes include guar beans, locust beans, fenugreek, soybeans, green beans, cowpeas, mung beans, lima beans, broad beans, lentils, and chickpeas.

[0165] After the heterologous exogenous DNA is introduced into plant cells, the transformation or integration of the heterologous gene into the plant genome is confirmed by various methods, such as analysis of nucleic acids, proteins, and metabolites associated with the integrated gene.

[0166] PCR analysis is a rapid method for screening transformed cells, tissues, or shoots for the presence of the incorporated gene at an early stage, prior to transplantation into soil (Sambrook and Russell, (2001) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY). PCR is performed using oligonucleotide primers specific for the gene of interest or the Agrobacterium vector background, for example.

[0167] Plant transformation can be confirmed by Southern blot analysis (Sambrook and Russell, (2001), supra). In Northern blot analysis, RNA is isolated from specific tissues of the transformants, fractionated in formaldehyde agar gel, and blotted onto nylon filters according to standard procedures commonly used in the art (Sambrook and Russell, (2001), supra). The expression of RNA encoded by the pesticidal gene is then tested by hybridization of the filter with a radioactive probe from the pesticidal gene by methods known in the art (Sambrook and Russell, (2001) supra). Western blots, biochemical assays, etc. can be performed on these transgenic plants to confirm the presence of a protein encoded by the pesticidal gene by standard methods using antibodies that bind to one or more epitopes present on the Cry toxin polypeptide (Sambrook and Russell, (2001), supra).

[0168] Methods for introducing genome editing technology into plants

[0169] In some embodiments, the disclosed Cry toxin polynucleotide compositions can be introduced into the genome of a plant using genome editing technology, or the Cry toxin polynucleotides previously introduced into the plant genome can be edited using genome editing technology. For example, the disclosed polynucleotides can be introduced into the desired position in the plant genome by using double-strand break technology (such as TALEN, large-range nucleases, zinc finger nucleases, CRISPR-Cas, etc.). For example, for the purpose of site-specific insertion, the disclosed polynucleotides can be introduced into the desired position in the genome using the CRISPR-Cas system. The desired position in the plant genome can be any target site required for insertion, such as a genomic region suitable for breeding, or it can be a target site located in a genomic window with an existing target trait. The existing target trait may be an endogenous trait or a previously introduced trait.

[0170] In some embodiments, when the disclosed Cry toxin polynucleotides have been previously introduced into the genome, genome editing techniques can be used to change or modify the introduced polynucleotide sequence. Site-specific modifications can be introduced into the disclosed Cry toxin polynucleotide compositions, and the site-specific modifications include modifications produced using any method for introducing site-specific modifications, including but not limited to using gene repair oligonucleotides (e.g., U.S. Publication 2013 / 0019349), or by using double-strand break technology, such as TALEN, large-range nucleases, zinc finger nucleases, CRISPR-Cas, etc. Such technology can be used to modify the previously introduced polynucleotides by insertion, deletion or substitution of nucleotides in the introduced polynucleotides. Alternatively, double-strand break technology can be used to add additional nucleotide sequences to the introduced polynucleotides. Additional sequences that can be added include additional expression elements (such as enhancer sequences and promoter sequences). In another embodiment, genome editing techniques can be used to locate additional insecticidal active proteins adjacent to the Cry toxin polynucleotide compositions disclosed herein within the plant genome to produce molecular stacks of insecticidal active proteins.

[0171] "Altered target site," "altered target sequence," "modified target site," and "modified target sequence" are used interchangeably herein and refer to a target sequence as disclosed herein that comprises at least one alteration when compared to an unaltered target sequence. Such "alterations" include, for example: (i) substitution of at least one nucleotide, (ii) deletion of at least one nucleotide, (iii) insertion of at least one nucleotide, or (iv) any combination of (i)-(iii).

[0172] Trait stacking in transgenic plants

[0173] Transgenic plants can comprise stacking of one or more insecticide polynucleotides disclosed herein and one or more other polynucleotides, resulting in the generation or suppression of multiple polypeptide sequences. Transgenic plants comprising stacked polynucleotide sequences can be obtained by traditional breeding methods or by one or both of genetic engineering methods. The method includes, but is not limited to, breeding a single line each comprising a target polynucleotide, transforming a transgenic plant comprising a gene disclosed herein with subsequent gene transformation, and co-transforming the gene into a single plant cell. As used herein, the term "stacked" includes making multiple traits exist in the same plant (i.e., two traits are incorporated into the nuclear genome, one trait is incorporated into the nuclear genome, and one trait is incorporated into the genome of the plastid, or both traits are incorporated into the genome of the plastid). In a non-limiting example, "stacked traits" include molecular stacks in which sequences are physically adjacent to each other. Traits as used herein refer to phenotypes derived from specific sequences or sequence groups. Co-transformation of genes can be carried out using a single transformation vector comprising multiple genes or genes carried respectively on multiple vectors. If sequences are stacked by genetic transformation plants, the target polynucleotide sequences can be combined at any time and in any order. The purpose polynucleotide that any combination of the proterties and transformation cassettes is provided can be introduced together with the co-transformation scheme.For example, if two sequences are introduced, the two sequences can be contained in the transformation cassette (trans) separated or contained in the same transformation cassette (cis). The expression of the sequence can be driven by the same promoter or by different promoters. In some cases, it may be necessary to introduce a transformation cassette that will suppress the expression of the purpose polynucleotides. This can be combined with any combination of other suppression cassettes or overexpression cassettes to produce the desired proterties combination in the plant. It should be further appreciated that site-specific recombination systems can be used to stack polynucleotide sequences in the desired genomic position. See, for example, WO 1999 / 25821, WO 1999 / 25854, WO 1999 / 25840, WO 1999 / 25855 and WO 1999 / 25853, which are all incorporated herein by reference.

[0174] In some embodiments, one or more of the polynucleotides encoding one or more Cry toxin polypeptides disclosed herein, alone or stacked with one or more additional insect resistance traits, can be stacked with one or more additional input traits (e.g., herbicide resistance, fungal resistance, virus resistance, stress tolerance, disease resistance, male sterility, stem strength, etc.) or output traits (e.g., increased yield, modified starch, improved oil characteristics, balanced amino acids, high lysine or methionine, increased digestibility, improved fiber quality, drought resistance, etc.). Thus, the polynucleotide embodiments can be used to provide a complete agronomic solution for improved crop quality with the ability to flexibly and cost-effectively control any number of agronomic pests.

[0175] Transgenes that can be used for stacking include, but are not limited to: transgenes that confer herbicide resistance; transgenes that confer or contribute to altered grain characteristics; genes that control male sterility; genes that create sites for site-specific DNA integration; genes that affect abiotic stress resistance; genes that confer increased yield; genes that confer plant digestibility; and transgenes that confer insect resistance or disease resistance.

[0176] Examples of transgenics that confer insect resistance include genes encoding Bacillus thuringiensis proteins, derivatives thereof, or synthetic polypeptides modeled thereon. See, for example, Geiser et al. (1986) Gene 48:109, which discloses the cloning and nucleotide sequence of a Bt delta-endotoxin gene. In addition, DNA molecules encoding delta-endotoxin genes can be purchased from the American Type Culture Collection (Rockville, Md., USA), for example Accession Nos. 40098, 67136, 31995 and 31998. Other non-limiting examples of genetically engineered Bacillus thuringiensis transgenes are given in the following patents and patent applications: U.S. Patent Nos. 5,188,960; 5,689,052; 5,880,275; 5,986,177; 6,023,013; 6,060,594; 6,063,597; 6,077,824; 6,620,988; 6,642,030; 6,713,259; 6,893,826; 7,105,332; 7,1 79,965, 7,208,474; 7,227,056, 7,288,643, 7,323,556, 7,329,736, 7,449,552, 7,468,278, 7,510,878, 7, 521,235, 7,544,862, 7,605,304, 7,696,412, 7,629,504, 7,705,216, 7,772,465, 7,790,846, 7,858,849 and WO 1991 / 14778; WO 1999 / 31248; WO2001 / 12731; WO 1999 / 24581 and WO 1997 / 40162.

[0177] Genes encoding pesticidal proteins can also be stacked, including but not limited to: insecticidal proteins from Pseudomonas species, such as PSEEN3174 (Monalysin, (2011) PLoS Pathogens, 7: 1-13), from Pseudomonas protegens strains CHA0 and Pf-5 (formerly Pseudomonas fluorescens) (Pechy-Tarr, (2008) Environmental Microbiology 10: 2368-2386: GenBank Accession No. EU400157); from Pseudomonas formosanus (Liu et al., (2010) J. Agric. Food Chem., 58: 12343-12349) and from Pseudomonas pseudoalcaligenes (Zhang et al., (2009) Annals of and / or AfIP-1B polypeptides of U.S. Pat. No. 9,688,730. 20160186204; IPD045 polypeptide, IPD064 polypeptide, IPD074 polypeptide, IPD075 polypeptide, and IPD077 polypeptide of PCT Publication No. WO 2016 / 114973; IPD080 polypeptide of PCT Serial No. PCT / US17 / 56517; IPD078 polypeptide, IPD084 polypeptide, IPD085 polypeptide, IPD086 polypeptide, IPD087 polypeptide, IPD088 polypeptide, and IPD089 polypeptide of Serial No. PCT / US17 / 54160; PIP-72 polypeptide of U.S. Patent Publication No. US20160366891; PtIP-50 polypeptide and PtIP-65 polypeptide of U.S. Publication No. US20170166921;IPD098 polypeptide, IPD059 polypeptide, IPD108 polypeptide, IPD109 polypeptide of U.S. Serial No. 62 / 521084; PtIP-83 polypeptide of U.S. Publication No. US20160347799; PtIP-96 polypeptide of U.S. Publication No. US20170233440; IPD079 polypeptide of PCT Publication No. WO 2017 / 23486; IPD082 polypeptide of PCT Publication No. WO 2017 / 105987, IPD090 polypeptide of Serial No. PCT / US17 / 30602, IPD093 polypeptide of U.S. Serial No. 62 / 434020; IPD103 polypeptide of Serial No. PCT / US17 / 39376; IPD101 polypeptide of U.S. Serial No. US 62 / 508,514 of the IPD121 polypeptide; and delta-endotoxins, including but not limited to Cry1, Cry2, Cry3, Cry4, Cry5, Cry6, Cry7, Cry8, Cry9, Cry10, Cry11, Cry12, Cry13, Cry14, Cry15, Cry16, Cry17, Cry18, Cry19, Cry20, Cry21, Cry22, Cry23, Cry24, Cry25, Cry26, Cry27, Cry 28, Cry 29, Cry 30, Cry31, Cry32, Cry33, Cry34, Cry35, Cry36, Cry37, Cry38, Cry39, Cry40, Cry41, Cry42, Cry43, Cry44, Cry45, Cry46, Cry47, Cry49, Cry50, Cry51, Cry52, Cry53, Cry54, Cry55, Cry56, Cry57, Cry58, Cry59, Cry60, Cry61, Cry62, Cry63, Cry64, Cry65, Cry66, Cry67, Cry68, Cry69, Cry70, Cry71, and Cry72-type delta-endotoxin genes, and the Bacillus thuringiensis cytolytic Cyt1 and Cyt2 genes.

[0178] Examples of delta-endotoxins also include, but are not limited to, the Cry1A proteins of U.S. Pat. Nos. 5,880,275 and 7,858,849; the DIG-3 or DIG-11 toxins (N-terminal deletions of α-helix 1 and / or α-helix 2 variants of Cry proteins (e.g., Cry1A)) of U.S. Pat. Nos. 8,304,604 and 8.304,605, Cry1B of U.S. Patent Application Serial No. 10 / 525,318; Cry1C of U.S. Pat. No. 6,033,874; Cry1F of U.S. Pat. Nos. 5,188,960 and 6,218,188; Cry1A / F chimeras of U.S. Pat. Nos. 7,070,982; 6,962,705 and 6,713,063; and Cry2 proteins, such as Cry2Ab, of U.S. Pat. No. 7,064,249. Cry3A proteins, including but not limited to engineered hybrid insecticidal proteins (eHIPs) produced by fusing unique combinations of variable and conserved regions of at least two different Cry proteins (U.S. Patent Application Publication No. 2010 / 0017914); Cry4 proteins; Cry5 proteins; Cry6 proteins; Cry8 proteins of U.S. Patent Nos. 7,329,736, 7,449,552, 7,803,943, 7,476,781, 7,105,332, 7,378,499, and 7,462,760; Cry9 proteins, such as members of the Cry9A, Cry9B, Cry9C, Cry9D, Cry9E, and Cry9F families; Cry15 proteins, described in Naimov et al., (2008) Applied and Environmental Microbiology 74:7145–7151; U.S. Patent Nos. 6,127,180, 6,624,145, and 6,340,593 for Cry22 and Cry34Ab1 proteins; U.S. Patent Nos. 6,248,535, 6,326,351, 6,399,330, 6,949,626, 7,385,107, and 7,504,229 for CryET33 and CryET34 proteins; U.S. Patent Publication Nos. 2006 / 0191034, 2012 / 0278954, and PCT Publication No. WO CryET33 and CryET34 homologs of US Pat. Nos. 2012 / 139004; Cry35Ab1 protein of U.S. Pat. Nos. 6,083,499, 6,548,291, and 6,340,593; Cry46 protein, Cry 51 protein, Cry binary toxin; TIC901 or related toxins; TIC807 of US2008 / 0295207; ET29, ET37, TIC809, TIC810, TIC812, TIC127, TIC128 of PCT US2006 / 033867; U.S. Pat. Nos. 8,236,AXMI-027, AXMI-036, and AXMI-038 of US 757; AXMI-031, AXMI-039, AXMI-040, AXMI-049 of US 7,923,602; AXMI-018, AXMI-020, and AXMI-021 of WO 2006 / 083891; AXMI-010 of WO 2005 / 038032; AXMI-003 of WO 2005 / 021585; AXMI-008 of US 2004 / 0250311; AXMI-006 of US 2004 / 0216186; AXMI-007 of US 2004 / 0210965; AXMI-009 of US 2004 / 0210964; AXMI-014 of US 2004 / 0197917; AXMI-004 of US 2004 / 0197916; AXMI-028 and AXMI-029 of WO 2006 / 119457; WO AXMI-007, AXMI-008, AXMI-0080rf2, AXMI-009, AXMI-014, and AXMI-004 of 2004 / 074462; AXMI-150 of U.S. Patent No. 8,084,416; AXMI-205 of US20110023184; AXMI-011, AXMI-012, AXMI-013, AXMI-015, AXMI-019, AXMI-044, AXMI-037, AXMI-043, AXMI-033, AXMI-034, AXMI-022, AXMI-023, AXMI-041, AXMI-063, and AXMI-064 of US2011 / 0263488; AXMI-R1 and related proteins of US2010 / 0197592; AXMI221Z, AXMI222z, AXMI223z, AXMI224z, and AXMI225z of 2011 / 103248; WO 11 / 103247; AXMI-115, AXMI-113, AXMI-005, AXMI-163, and AXMI-184 of U.S. Pat. No. 8,334,431; AXMI-001, AXMI-002, AXMI-030, AXMI-035, and AXMI-045 of US2010 / 0298211; AXMI-066 and AXMI-076 of US2009 / 0144852; U.S. Pat. No. 8,318,900's AXMI128、AXMI130、AXMI131、AXMI133、AXMI140、AXMI141、AXMI142、AXMI143、AXMI144、AXMI146、AXMI148、AXMI149、AXMI152、AXMI153、AXMI154、AXMI155、AXMI156、AXMI157、AXMI158、AXMI162、AXMI165、AXMI166、AXMI167、AXMI168、AXMI169、 AXMI170, AXMI171, AXMI172, AXMI173, AXMI174, AXMI175, AXMI176, AXMI177, AXMI178, AXMI179, AXMI180, AXMI181, AXMI182, AXMI185, AXMI186, AXMI187, AXMI188, AXMI189; AXMI079, AXMI080, AXMI081, AXMI082, AXMI091, AXMI092 of US2010 / 0005543. 92. AXMI096, AXMI097, AXMI098, AXMI099, AXMI100, AXMI101, AXMI102, AXMI103, AXMI104, AXMI107, AXMI108, AXMI109, AXM A XMI1257, AXMI1268, AXMI127, AXMI129, AXMI164, AXMI151, AXMI161, AXMI183, AXMI132, AXMI138, AXMI137; and Cry proteins such as Cry1A and Cry3A with modified proteolytic sites of U.S. Patent No. 8,319,019; and Cry1Ac, Cry2Aa and Cry1Ca toxin proteins from Bacillus thuringiensis strain VBTS2528 of U.S. Patent Application Publication No. 2011 / 0064710. Other Cry proteins are well known to those skilled in the art (see, Crickmore et al.,(See "Bacillus thuringiensis toxin nomenclature" (2011), available at lifesci.sussex.ac.uk / home / Neil_Crickmore / Bt / , accessible on the World Wide Web using the "www" prefix.) The insecticidal activity of Cry proteins is well known to those skilled in the art (for review, see van Frannkenhuyzen, (2009) J. Invert. Path. 101: 1-16). The use of Cry proteins as transgenic plant traits is well known to those skilled in the art, and Cry transgenic plants (including but not limited to Cry1Ac, Cry1Ac+Cry2Ab, Cry1Ab, Cry1A.105, Cry1F, Cry1Fa2, Cry1F+Cry1Ac, Cry2Ab, Cry3A, mCry3A, Cry3Bb1, Cry34Ab1, Cry35Ab1, Vip3A, mCry3A, Cry9c and CBI-Bt) have been approved by regulatory authorities (see, Sanahuja, (2011) Plant Biotech Journal 9:283-300 and CERA (2010) GM Crop Database Center for Environmental Risk Assessment (CERA)). Assessment, ILSI Research Foundation, Washington, D.C., cera-gmc.org / index.php?action=gm_crop_database, accessible on the World Wide Web using the "www" prefix). More than one pesticidal protein well known to those skilled in the art can also be expressed in plants, such as Vip3Ab and Cry1Fa (US2012 / 0317682), Cry1BE and Cry1F (US2012 / 0311746), Cry1CA and Cry1AB (US2012 / 0311745), Cry1F and CryCa (US2012 / 0317681), Cry1DA and Cry1BE (US2012 / 0331590), Cry1DA and Cry1Fa (US 2012 / 0331589), Cry1AB and Cry1BE (US2012 / 0324606), and Cry1Fa and Cry2Aa, Cry1I or Cry1E (US2012 / 0324605). Pesticide proteins also include insecticide lipases, including those described in U.S. Patent Nos. 7,491,869, and cholesterol oxidase, such as from Streptomyces (Purcell et al. (1993) Biochem Biophys Res Commun 15: 1406-1413). Pesticide proteins also include VIP (vegetative insecticide protein) toxins of U.S. Pat. Nos. 5,877,012, 6,107,279, 6,137,033, 7,244,820, 7,615,686, and 8,237,020. Other VIP proteins are well known to those skilled in the art (see, lifesci.sussex.ac.uk / home / Neil_Crickmore / Bt / vip.html, which can be accessed on the World Wide Web using the "www" prefix). Pesticide proteins also include toxin complex (TC) proteins obtainable from organisms such as Xenorhabdus, Photorhabdus, and Paenibacillus (see U.S. Patent Nos. 7,491,698 and 8,084,418). Some TC proteins have "standalone" insecticidal activity, while others enhance the activity of standalone toxins produced by the same given organism. The toxicity of "standalone" TC proteins (e.g., from Photorhabdus, Xenorhabdus, or Paenibacillus) can be enhanced by one or more TC protein "potentiators" derived from source organisms of different genera. There are three main types of TC proteins. As referred to herein, Class A proteins ("Protein A") are standalone toxins. Class B proteins ("Protein B") and Class C proteins ("Protein C") enhance the toxicity of Class A proteins. Examples of Class A proteins are TcbA, TcdA, XptA1, and XptA2. Examples of Class B proteins are TcaC, TcdB, XptB1Xb, and XptC1Wi. Examples of Class C proteins are TccC, XptC1Xb, and XptB1Wi. Pesticide proteins also include spider, snake, and scorpion venom proteins. Examples of spider peptides include, but are not limited to, lycotoxin-1 peptide and its mutants (U.S. Patent No. 8,334,366).

[0179] Other transgenes that confer insect resistance can downregulate the expression of target genes in insect pest species by interfering with ribonucleic acid (RNA) molecules (via RNA interference). RNA interference refers to the process of sequence-specific post-transcriptional gene silencing in animals mediated by short interfering RNA (siRNA) (Fire et al., (1998) Nature 391:806). RNAi transgenes can include, but are not limited to, the expression of dsRNA, siRNA, miRNA, iRNA, antisense RNA, or sense RNA molecules that downregulate the expression of target genes in insect pests. PCT Publication WO 2007 / 074405 describes methods for inhibiting target gene expression in invertebrate pests, including the Colorado potato beetle. PCT Publication WO 2005 / 110068 describes methods for inhibiting target gene expression in invertebrate pests, particularly including the western corn rootworm, as a means of controlling insect infestations. Additionally, PCT Publication WO 2009 / 091864 describes compositions and methods for inhibiting target genes from insect pest species, including pests from the genus Lygus.

[0180] Provided RNAi transgenes are for RNAi targeting the H subunit of the vacuolar ATPase, which can be used to control coleopteran pest populations and infestations, as described in U.S. Patent Application Publication No. 2012 / 0198586. PCT Publication No. WO 2012 / 055982 describes RNAi (RNA or double-stranded RNA) that inhibit or downregulate the expression of target genes encoding insect ribosomal proteins, such as ribosomal protein L19, ribosomal protein L40, or ribosomal protein S27A; insect proteasome subunits, such as Rpn6 protein, Pros25, Rpn2 protein, proteasome β1 subunit protein, or Prosβ2 protein; insect β-coat body of COPI vesicle, γ-coat body of COPI vesicle, β'-coat body protein of COPI vesicle, or ζ-coat body protein. The present invention also includes insect proteins such as actin 5C, insect ubiquitin-5E, insect Sec23, a GTPase activator involved in intracellular protein transport, insect wrinkle proteins that act as unconventional myosins involved in motility, insect flexure proteins involved in regulation of nuclear alternative mRNA splicing, insect vesicular H+-ATPase G subunit proteins, and insect Tbp-1, such as Tat-binding protein. PCT Publication WO 2007 / 035650 describes ribonucleic acids (RNA or double-stranded RNA) that inhibit or downregulate expression of target genes encoding Snf7. US Patent Application Publication 2011 / 0054007 describes polynucleotide silencing elements that target RPS10. PCT Publication WO 2016 / 205445 describes polynucleotide silencing elements and target polynucleotides that reduce fertility, including NCLB, MAEL, BOULE, and VgR. U.S. Patent Application Publications 2014 / 0275208 and US2015 / 0257389 describe polynucleotide silencing elements targeting RyanR and PAT3. PCT Publications WO / 2016 / 138106, WO 2016 / 060911, WO 2016 / 060912, WO 2016 / 060913, and WO 2016 / 060914 describe polynucleotide silencing elements targeting COPI coat subunit nucleic acid molecules that confer resistance to coleopteran and hemipteran pests. U.S. Patent Application Publications 2012 / 029750, US20120297501, and 2012 / 0322660 describe interfering ribonucleic acids (RNA or double-stranded RNA) that, when ingested by an insect pest species, act to downregulate expression of a target gene in the insect pest, wherein the RNA comprises at least one silencing element, wherein the silencing element is a double-stranded RNA region comprising an annealed complementary strand, one strand of the double-stranded RNA region comprising or consisting of a nucleotide sequence that is at least partially complementary to a target nucleotide sequence in the target gene.U.S. Patent Application Publication No. 2012 / 0164205 describes potential targets for interfering with double-stranded RNA to inhibit invertebrate pests, including: Chd3 homology sequence, β-tubulin homology sequence, 40 kDa V-ATPase homology sequence, EF1α homology sequence, 26S proteomic subunit p28 homology sequence, juvenile hormone epoxidase hydrolase homology sequence, swelling-dependent chloride channel protein homology sequence, glucose-6-phosphate 1-dehydrogenase protein homology sequence, Act42A protein homology sequence, ADP-ribosyl factor 1 homology sequence, transcription factor IIB protein homology sequence, chitinase homology sequence, ubiquitin conjugating enzyme homology sequence, glyceraldehyde-3-phosphate dehydrogenase homology sequence, ubiquitin B homology sequence, juvenile hormone esterase homolog, and α-tubulin homology sequence.

[0181] Uses in pest control

[0182] General methods for using strains comprising the nucleic acid sequences of the embodiments or variants thereof as pesticides in pest control or engineering other organisms are known in the art.

[0183] Microbial hosts known to occupy the "phyllosphere" (foliage, phyllosphere, rhizosphere and / or rhizosphere) of one or more target crops can be selected. These microorganisms are selected so as to be able to successfully compete with wild-type microorganisms in a specific environment, provide stable maintenance and expression of genes expressing one or more Cry toxin polypeptides, and ideally, increase protection of the pesticide from environmental degradation and inactivation.

[0184] Alternatively, Cry toxin polypeptides are produced by introducing heterologous genes into cell hosts. The expression of heterologous genes directly or indirectly causes the production and maintenance of pesticides in the cells. Then, when the cells are applied to the environment of one or more target pests, these cells are processed under conditions that prolong the activity of the toxins produced in the cells. The resulting product retains the toxicity of the toxins. These naturally encapsulated Cry toxin polypeptides can then be prepared according to conventional techniques to be applied to the environment (e.g., soil, water, and leaves of plants) where the target pests reside. See, for example, EPA 0192319 and the references cited therein.

[0185] Pesticide composition

[0186] In certain embodiments, activeconstituents can be used in the form of composition and can be applied to crop area or the plant that needs to be processed simultaneously or in succession with other compounds.These compounds can be fertilizer, weedicide, cryoprotectant, surfactant, washing composition, pesticidal soap, dormant oil, polymer and / or time-release or biodegradable carrier formulations that allow target area to be given for a long time after single application of the described preparation.They can also be several mixtures in selective herbicides, chemical insecticides, virucides, microbicides, amoebacides, pesticidal agents, fungicides, bactericides, nematocides, molluscicides or these goods, if desired, with the auxiliary agent of normally used other agriculturally acceptable carrier, surfactant or promotion to use in formulation field.Suitable carrier and auxiliary agent can be solid or liquid, and corresponding to the material usually adopted in formulation technology, for example natural or regenerated mineral matter, solvent, dispersant, wetting agent, tackifier, adhesive or fertilizer. Similarly, the formulation can be prepared as edible "baits" or shaped into pest "traps" to allow target pests to feed or ingest the pesticidal formulation.

[0187] Methods for applying active ingredients or agricultural chemical compositions containing at least one of one or more Cry toxin polypeptides produced by bacterial strains include foliar application, seed coating, and soil application. The number of applications and the rate of application depend on the intensity of the corresponding pest infestation.

[0188] The composition can be formulated as a powder, dust, pellet, granule, spray, emulsion, colloid, solution, etc., and can be prepared by conventional methods such as drying, lyophilization, homogenization, extraction, filtration, centrifugation, sedimentation or concentration of cell cultures containing the polypeptide. In all such compositions containing at least one such pesticidal polypeptide, the polypeptide can be present in a concentration of from about 1% to about 99% by weight.

[0189] Can kill lepidoptera, diptera, heteroptera, nematode, hemiptera or coleoptera pests or reduce their number in a given area by the method of the present disclosure, or can preventively apply it to an environmental area to prevent the invasion and attack of susceptible pests.Preferably, the pest ingests the polypeptide of the pest-killing effective dose or contacts it.As used herein, " pest-killing effective dose " refers to the amount of the pesticide that can cause death to at least one pest or significantly reduce pest growth, feeding or normal physiological development.Described amount will be according to factors such as the method, rate, concentration, stability and quantity of the specific target pest to be controlled, the specific environment to be treated, location, plant, crop or agricultural site, environmental conditions and the effective peptide composition of the pest-killing application and change.Preparation also can change according to the severity of climatic conditions, environmental factors and / or application frequency and / or pest infestation.

[0190] The desired pesticide composition can be prepared by formulating a suspension of bacterial cells, crystals, and / or spores or an isolated protein fraction with a desired agriculturally acceptable carrier. The composition can be formulated prior to application in an appropriate manner (e.g., freeze-dried, lyophilized, or dried) or in an aqueous carrier, culture medium, or a suitable diluent (e.g., saline or other buffer). The formulated composition can be in the form of a dust or granular material, or a suspension in oil (plant or mineral), water, or an oil / water emulsion, or as a wettable powder, or in combination with any other carrier material suitable for agricultural application. Suitable agricultural carriers can be solid or liquid and are well known in the art. The term "agriculturally acceptable carrier" encompasses all adjuvants, inert components, dispersants, surfactants, tackifiers, adhesives, etc., commonly used in pesticide formulation technology; these are well known to those skilled in the art of pesticide formulation. The formulation can be mixed with one or more solid or liquid adjuvants and prepared by various methods (e.g., by uniformly mixing, blending, and / or grinding the pesticidal composition with a suitable adjuvant using conventional formulation techniques). Suitable formulations and methods of application are described in U.S. Patent No. 6,468,523. Plants may also be treated with one or more chemical compositions comprising one or more herbicides, insecticides, or fungicides. Exemplary chemical compositions include: Fruit / vegetable herbicide :Atrazine, Herbicide, Diuron, Glyphosate, Linuron, Metribuzin, Simazine, Trifluralin, Fluazifop-P-ethyl, Glufosinate, Halosulfuron-ethyl Gowan, Paraquat, Penthiazolin, Sethoxydim, Fluazifop-butyl, Halosulfuron-ethyl, Indaziflam; Fruit / vegetable insecticide: Aldicarb, Bacillus thuringiensis, Carbaryl, Carbofuran, Chlorpyrifos, Cypermethrin, Deltamethrin, Diazinon, Malathion, Abamectin, Cyfluthrin / β-Cyfluthrin, Cypermethrin, λ-Cyfluthrin, Acequinoxaline, Bifenazate, Methoxyfenozide, Noflufenuron, Cypermethrin, Thiacloprid, Dinotefuran, Pyrimidifen, Tolfenpyrad, Clothianidin, Spirodiclofen, γ-Cyfluthrin, Spiromesibiram, Spinosad, Chlorantraniliprole, Cyantraniliprole, Spinoteram, Diflubenzuron , spirotetramat, imidacloprid, chlorantraniliprole, thiodicarb, metaflumizone, sulfoxaflor, butyroximate, Cyanopyrafen, imidacloprid, clothianidin, thiamethoxam, Spinotoram, thiodicarb, flonicamid, methiocarb, emathin-benzoate, indoxacarb, fosthiazate, fenamiphos, cadusafos, pyriproxyfen, fenbutatin, hexathiazox, methomyl, 4-[[(6-chloropyridin-3-yl)methyl](2,2-difluoroethyl)amino]furan-2(5H)-one; Fruit / vegetable fungicide : Carbendazim, chlorothalonil, EBDC, sulfur, thiophanate-methyl, azoxystrobin, cymoxanil, fluazinam, fosetyl, iprodione, kresoxim-methyl, metalaxyl / metalaxyl-M, trifloxystrobin, ethaboxam, propineb, trifloxystrobin, fenhexamid, oxadiazol, cyazolin, fenamid, zoxamide, picoxystrobin, pyraclostrobin, cyfluanid, boscalid; Cereal herbicides :Isoproturon, bromoxynil, iobenzonil, phenoxy, chlorsulfuron, clodinafop-butyl, diclofop-butyl, fluazifop-butyl, oxadiazol-butyl, fluroxypyr, metsulfuron-methyl, bensulfuron-methyl, flucarbamyl, iodosulfuron, propensulfuron-methyl, flupyralid, mesosulfuron-methyl, flubutamide, pinoxaden, amidosulfuron, thifensulfuron-methyl, bensulfuron-methyl, flupyralid, sulfasulfuron-methyl, sulfasulfuron-methyl, sulfasulfuron-methyl, pyrasulfuron, methoxysulfuron, flufenacet, oxazolidinone, pyroxensulfuron; Cereal fungicides : Carbendazim, thiophanate-methyl, azoxystrobin, cyproconazole, cyprodinil, fenpropimorph, epoxiconazole, kresoxim-methyl, quinoxyfen, tebuconazole, trifloxystrobin, silystrobin, picoxystrobin, pyraclostrobin, kresoxim-methyl, prothioconazole, fluoxastrobin; Cereal insecticides : Dimethoate, λ-cyhalothrin, deltamethrin, α-cypermethrin, β-cyhalothrin, bifenthrin, imidacloprid, clothianidin, thiamethoxam, thiacloprid, acetamiprid, dinotefuran, Clorphyriphos, methamidophos, acephate, pirimicarb, methiocarb; Corn herbicide : Atrazine, Alachlor, Bromoxynil, Acetochlor, Mediben, Clopyralid, (S-) Dimethoate, Glufosinate, Glyphosate, Isoxathiapiprolin, (S-) Isopropyl Metolachlor, Mesotrione, Nicosulfuron, Primosulfuron, Sulfonsulfuron, Sulcotrione, Foramsulfuron, Benpyraclostrobin, Tembotrione, Fenpyramidoxime, Carbofuran, Flufenacet, Pyrosulfuron; Corn insecticide: Carbofuran, chlorpyrifos, bifenthrin, fipronil, imidacloprid, λ-cyhalothrin, tefluthrin, terbufos, thiamethoxam, clothianidin, spiromesifen, chlorantraniliprole, chlorfenapyr, chlorantraniliprole, deltamethrin, thiodicarb, β-cyfluthrin, cypermethrin, bifenthrin, lufenuron, triflumuron, tefluthrin, pyrimidinephos, ethiprole, cyanamide, thiacloprid, acetamiprid, dinotefuran, abamectin, methiocarb, spirodiclofen, spirotetramat; Corn fungicide : chlorpyrifos, thiram, prothioconazole, tebuconazole, trifloxystrobin; Rice herbicide :Butachlor, Dipyridamole, Tetrasodium, Bensulfuron-methyl, Cyhalofop-butyl, Cypermethrin, Tetrasodium, Azosulfuron-methyl, Mefenacet, Debaran, Pyrazosulfuron-methyl, Barbaryan, Dichloroquine, Cyclopentanil, Indole, Flufenacet, Tetrasodium, Halosulfuron-methyl, Debaran, Benzobicyclon, Cyclohexanil, Penoxsulam, Bispyribac-butyl, Oxadiazole, Ethoxysulfuron-methyl, Pretilachlor, Mesotrione, Tefudan, Oxadiazole, Oxadiazole, Pyriproxyfen-butyl, Pyriproxyfen-butyl; Rice insecticide :diazinon, fenitrothion, fostobacyl, monocrotophos, benfuracarb, buprofezin, dinotefuran, fipronil, imidacloprid, isoprocarb, thiacloprid, cyclamen, thiacloprid, dinotefuran, clothianidin, ethiprole, chlorantraniliprole, chlorantraniliprole, deltamethrin, acetamiprid, thiamethoxam, cyantraniliprole, spinosad, Spinotoram, fenthion-benzoate, cypermethrin, chlorpyrifos, cartap, methamidophos, ethomethrin, triazophos, 4-[[(6-chloropyridin-3-yl)methyl](2,2-difluoroethyl)amino]furan-2(5H)-one, carbofuran, benfuracarb; rice fungicides :Methyl thiophanate, azoxystrobin, cyproconazole, dichlorvos, pyrimidine, isothiocarb, blastifogluconol, pencycuron, thiabendazole, pyroquilon, tricyclazole, trifloxystrobin, dichlorocyanamide, cyanamide, silyfloxacin, thiabendazole; Cotton herbicide : Diuron, fluazifop-butyl, MSMA, oxyfluorfen, prometryn, trifluralin, mesotrione, clethodim, fluazifop-butyl-butyl, glyphosate, norfloxacin, pendimethalin, pyrithione sodium, trifloxysulfuron, oxadiazon, glufosinate, fluazifop-butyl, thiabendazim; cotton Insecticides: Acephate, Aldicarb, Chlorpyrifos, Cypermethrin, Deltamethrin, Malathion, Monocrotophos, Avermectin, Acetamiprid, Indometin-Benzoate, Imidacloprid, Indoxacarb, λ-Cyfluthrin, Spinosad, Thiodicarb, γ-Cyfluthrin, Spiromesibir, Pyridalyl, Flonicamid, Chlorantraniliprole, Diflubenzuron, Chlorantraniliprole, β-Cyfluthrin, Spirotetramat, Clothianidin , thiamethoxam, thiacloprid, dinotefuran, chlorantraniliprole, cyantraniliprole, spinosad, Spinotoram, gamma-cyhalothrin, 4-[[(6-chloropyridin-3-yl)methyl](2,2-difluoroethyl)amino]furan-2(5H)-one, thiodicarb, abamectin, flonicamid, pyridalyl, spiromesifen, sulfoxaflor, profenofos, triazophos, endosulfan; Cotton fungicide Dosage: Azolesin, metalaxyl, quinaloxaline; soybean herbicides: alachlor, bentazone, trifluralin, chlorimuron-ethyl, clorac-4-sulfuron, oxadiazon, fomesafen, fluazifop-butyl, glyphosate, imazamox, imazaquin, imazamox, (S-)isopropylamine, metribuzin, pendimethalin, chlorpyrifos, and glufosinate; soybean insecticide : lambda-cyhalothrin, methomyl, parathion, thiocarb, imidacloprid, clothianidin, thiamethoxam, thiacloprid, acetamiprid, dinotefuran, chlorantraniliprole, chlorantraniliprole, cyantraniliprole, spinosad, Spinotoram, fenvalerate-benzoate, fipronil, ethiprole, deltamethrin, beta-cyhalothrin, gamma and lambda cyhalothrin, 4-[[(6-chloropyridin-3-yl)methyl](2,2-difluoroethyl)amino]furan-2(5H)-one, spirotetramat, spirodiclofen, triflumuron, flonicamid, thiodicarb, beta-cyhalothrin; soybean fungicide : Azoxystrobin, Cyproconazole, Fluoxetine, Flutriafol, Pyraclostrobin, Tebuconazole, Trifloxystrobin, Prothioconazole, Tetraconazole; Beet weeding agent : Cypermethrin, betadine, oxyfluanid, betadine, wild wheat chlorpyrifos, clopyralid, fluazifop-butyl, lenacil, metamitron, quinclorac, cycloxydim, flumethalin, chloranil, quizalofop-ethyl; Beet insecticide :Imidacloprid, clothianidin, thiamethoxam, thiamethoxam, acetamiprid, dinotefuran, deltamethrin, β-cyfluthrin, γ / λ cyfluthrin, 4-[[(6-chloropyridin-3-yl)methyl](2,2-difluoroethyl)amino]furan-2(5H)-one, tefluthrin, chlorantraniliprole, cyanamide, fipronil, carbofuran; Canola herbicide : Clopyralid, diclofenac, fluazifop-butyl, glufosinate, glyphosate, metachlorpyrifos, trifluralin, ethametsulfuron, quinclorac, quizalofop-ethyl, clethodim, and weed killer; Canola Fungicide : Azoxystrobin, carbendazim, fludioxonil, iprodione, prochloraz, vinclozolin; Canola Insecticide: Carbofuran, organophosphates, pyrethroids, thiacloprid, deltamethrin, imidacloprid, clothianidin, thiamethoxam, acetamiprid, dinotefuran, β-cyfluthrin, γ and λ cyfluthrin, τ-flucythrin, ethiprole, spinosad, Spinotoram, chlorantraniliprole, chlorantraniliprole, cyanamide, 4-[[(6-chloropyridin-3-yl)methyl](2,2-difluoroethyl)amino]furan-2(5H)-one.

[0191] In some embodiments, the herbicide is atrazine, bromocriptine, diuron, chlorsulfuron, metsulfuron-methyl, thifensulfuron-methyl, bensulfuron-methyl, acetochlor, dicamba, isoxaflutole, nicosulfuron, sulfamethoxam, pyrasulfuron-sodium, fluazifop-propyl, chlorsulfuron-ethyl, metribuzin, quizalofop-ethyl, S-metolachlor, Hexazinne, or a combination thereof.

[0192] In some embodiments, the insecticide is esfenvalerate, chlorantraniliprole, methomyl, indoxacarb, oxamyl, or a combination thereof.

[0193] Pesticide and insecticide activity

[0194] "Pests" include, but are not limited to, insects, fungi, bacteria, nematodes, mites, ticks, etc. Insect pests include insects selected from the following orders: Coleoptera, Diptera, Hymenoptera, Lepidoptera, Mallophaga, Homoptera, Hemiptera, Orthroptera, Thysanoptera, Dermaptera, Isoptera, Anoplura, Siphonaptera, Trichoptera, etc., in particular Lepidoptera and Coleoptera.

[0195] Those skilled in the art will appreciate that not all compounds are equally effective against all pests. The compounds of the examples show activity against insect pests, which can include economically important agronomy, forest, greenhouse, nursery ornamental, food and fiber, public and animal health, domestic and commercial structures, household and stored product pests.

[0196] Lepidoptera larvae include, but are not limited to, noctuidae, cutworms, geometrids, and heliothis subfamily, Spodoptera frugiperda JE Smith (fall armyworm); S. exigua Hübner (beet armyworm); S. litura Fabricius (tobacco cutworm, cluster caterpillar); Mamestraconfigurata Walker (bertha armyworm); M. brassicae Linnaeus (cabbage moth); Agrotis ipsilon Hufnagel (black cutworm); A. orthogonia Morrison (western cutworm); A.subterranea Fabricius (granulate cutworm); Alabama argillacea Hübner (cotton leaf worm); Trichoplusiani Hübner (cabbage looper); Pseudoplusia includensWalker (soybean looper); Anticarsia gemmatalis Hübner (velvetbean caterpillar); Hypena scabra Fabricius (green cloverworm); Heliothis virescens Fabricius (tobacco budworm); Pseudaletia unipuncta Haworth (snodus); Athetismindara Barnes and Mcdunnough (rough skinned cutworm); Euxoa messoria Harris (darksided cutworm); Eariasinsulana Boisduval (spiny bollworm); E.vittella Fabricius (spotted bollworm); Helicoverpa armigera Hübner (American bollworm); corn earworm (corn earworm or cotton bollworm); Melanchra picta Harris (zebra caterpillar); Egira (Xylomyges) curialis Grote (citrus cutworm); borers, sheath moths, webworms, coneworms, and skeletonizers from the family Pyralidae, Ostrinia nubilalis Hübner (European corn borer); Amyelois transitella Walker (naval orange borer); orangeworm); Anagasta kuehniella Zeller (Mediterranean flour moth); Cadra cautella Walker (almond moth); Chilo suppressalis Walker (rice stem borer); C. partellus (sorghum borer); Corcyracephalonica Stainton (rice moth); Crambus caliginosellus Clemens (corn root webworm); C. teterrellus Zincken (bluegrass webworm); Cnaphalocrocis medinalis (rice leaf roller) Guenée (rice leaf roller); Desmia funeralis Hübner (grape leaffolder); Diaphania hyalinata Linnaeus (melon melonworm); Cucumber borer (D.nitidalis Stoll) (pickleworm); Diatraea grandiosella Dyar (southwestern corn borer); sugarcane borer (D.saccharalis Fabricius (sugarcane borer); Eoreumaloftini Dyar (Mexican rice borer); Ephestia elutella Hübner (tobacco (cacao) moth); Galleria mellonella Linnaeus (greater wax moth); Herpetogramma licarsisalis Walker (sod webworm); Homoeosoma electellum Hulst (sunflower moth); Elasmopalpus lignosellus Zeller (lesser cornstalk borer); Achroia grisella Fabricius (lesser waxmoth); Loxostege sticticalis Linnaeus (beet webworm); Orthaga thyrisalis Walker (tea tree web moth); Marucatestulalis Geyer (bean pod borer); Plodia interpunctella Hübner (Indian meal moth); Scirpophaga incertulas Walker (yellow stem borer); Udea rubigalis Guenée (celery leaffolder); and leaffolders, aphids, seed and fruit insects in the family Tortricidae, including Acleris gloverana Walsingham) (Western blackheaded budworm); Eastern blackheaded budworm (A.variana Fernald (Eastern blackheaded budworm); Archips argyrospila Walker (fruittree leaf roller); A. rosana Linnaeus (European leafroller); and other A. rosana species, Adoxophyes orana Fischer von. ) (summer fruit tortrix moth); Cochylishospes Walsingham (banded sunflower moth); Cydialatiferreana Walsingham (filbertworm); C. pomonella Linnaeus (apple codling moth); Platynota flavedana Clemens (variegated leafroller); P. stultana Walsingham (omnivorous leafroller); Lobesia botrana Denis & Schiffermüller (European grape vine moth); Spilonota ocellana Denis & Schiffermüller (eyespotted apple leafroller). bud moth); Endopizaviteana Clemens (grape berry moth); Eupoecilia ambiguella Hübner (vine moth); Bonagota salubricola Meyrick (Brazilian apple leafroller); Grapholitamolesta Busck (oriental fruit moth); Suleimahelianthana Riley (sunflower bud moth); Argyrotaenia spp.; Choristoneura spp.

[0197] Other selected agronomic pests from the order Lepidoptera include, but are not limited to, Alsophilapometaria Harris (fall cankerworm); Anarsia lineatella Zeller (peach twig borer); Anisota senatoria JESmith (orange striped oakworm); Antheraea pernyi Guérin-Méneville (Chinese Oak Tussah Moth); Bombyx mori Linnaeus (Silkworm); Bucculatrix thurberiella Busck (cotton leafperforator); Colias eurytheme Boisduval (alfalfa caterpillar); Datana integerrima Grote & Robinson (walnut caterpillar); Dendrolimus sibiricus Tschetwerikov (Siberian silk moth), Ennomos subsignaria Hübner (elmspanworm); Erannis tiliaria Harris (linden looper); Euproctis chrysorrhoea Linnaeus (browntail moth); Harrisina americana Guérin-Méneville (grapeleaf skeletonizer); Hemileuca oliviae Cockrell (range caterpillar); Hyphantria cunea Drury (fall webworm); Keiferialycopersicella Walsingham (tomato pinworm); Lambdina fiscellaria fiscellaria Hulst (Eastern hemlock looper); hemlocklooper)); western hemlocklooper (L.fiscellaria lugubrosa Hulst (Western hemlock looper); Leucoma salicis Linnaeus (satin moth); Lymantria dispar Linnaeus (gypsy moth); Manducaquinquemaculata Haworth (five-spotted hawk moth, tomato hornworm); M. sexta Haworth (tomato hornworm, tobacco hornworm); Operophtera brumata Linnaeus (wintermoth); Paleacrita vernata Peck (spring cankerworm); Papilio cresphontes Cramer (giant swallowtail, orangedog); Phryganidia californica Packard (Californian stork moth); Phyllocnistis citrella Stainton (citrus leafminer); Phyllonorycter blancardella Fabricius (spotted tentiform leafminer); Pieris brassicae Linnaeus (large white butterfly); P. rapae Linnaeus (small white butterfly); P.napi Linnaeus (green-veined white butterfly); Platyptilia carduidactyla Riley (artichoke plume moth); Plutella xylostella Linnaeus (diamondback moth); Pectinophora gossypiella Saunders (pink bollworm); Pontia protodice (Boisduval and Leconte) (Southern cabbageworm); Sabulodes aegrotata Guenée (omnivorous looper); Schizura concinna JESmith (red humped caterpillar); Sitotroga cerealella Olivier (Angoumois grain moth); Thaumetopoea pityocampa Schiffermuller (pine processionary caterpillar); Tineola bisselliella Hummel (webbing clothes moth); Tuta absoluta Meyrick (tomato leaf miner); Yponomeuta padella Linnaeus (ermine moth); Heliothis subflexa Guenée; Malacosoma species and Orgyia species.

[0198] The purpose is to obtain larvae and adults of the order Coleoptera, which includes weevils from the families Anthribidae, Bruchidae, and Curculionidae (including, but not limited to: Anthonomus grandis Boheman (boll weevil); Lissorhoptrus oryzophilus Kuschel (rice water weevil); Sitophilus granarius Linnaeus (granary weevil); S. oryzae Linnaeus (rice weevil); Hypera punctata Fabricius (clover leaf weevil); Cylindrocopturus adspersus LeConte (sunflower stem weevil); Smicronyx truncatus (sunflower stem weevil); fulvus LeConte (red sunflower seedweevil); S. sordidus LeConte (gray sunflower seedweevil); Sphenophorus maidis Chittenden (maize billbug); flea beetles, cucumber beetles, rootworms, leaf beetles, potato beetles, and leaf miners of the family Chrysomelidae (including but not limited to Leptinotarsa ​​decemlineata Say (Colorado potato beetle); Diabrotica virgifera virgifera LeConte (western corn rootworm); D. barberi (Smith and Lawrence) (northern corn rootworm); D.undecimpunctata howardi Barber (southern corn rootworm); Chaetocnema pulicaria Melsheimer (corn flea beetle); Phyllotreta cruciferae Goeze (Crucifer flea beetle); Phyllotretastriolata (stripped flea beetle); Colaspis brunnea Fabricius (grape colaspis); Oulema melanopus Linnaeus (cereal leaf beetle); Zygogramma exclamationis Fabricius (sunflower leaf beetle). beetle); beetles from the family Coccinellidae (including but not limited to: Epilachna varivestis Mulsant (Mexican beetle); beetles and other beetles from the family Scarabaeidae (including but not limited to: Popillia japonica Newman (Japanese beetle); Cyclocephala borealis Arrow (northern masked chafer, white grub); southern rhinoceros beetle (C.immaculata Olivier (southern masked chafer, white grub); Rhizotrogus majalis Razoumowsky (European chafer); Phyllophaga crinita Burmeister (white grub); Ligyrus gibbosus De Geer (carrot beetle); carpet beetle from the family Dermestidae; wireworms from the family Elateridae, Eleodes spp., Melanotus spp.; Conoderus spp.; Limonius spp. spp.); Agriotes spp.; Ctenicera spp.; Aeolus spp.; bark beetles from the Scolytidae family and beetles from the Tenebrionidae family.

[0199] Of interest are adults and immature insects of the order Diptera, including the leafminer Agromyza parvicornis Loew (corn blotch leafminer); Chironomidae (including but not limited to Contarinia sorghicola Coquillett (sorghum midge); Mayetiola destructor Say (Hessian fly); Sitodiplosismosellana Géhin (wheat midge); Neolasiopteramurtfeldtiana Felt (sunflower seed midge); fruit flies (Tephritidae), Oscinella frit Linnaeus (frit flies); maggots (including but not limited to Delia platura Meigen (seedcorn maggot); D. coarctata Fallen (wheat bulb fly) and other ground flies, Meromyza americana Fitch (wheat stem maggot); Musca domestica Linnaeus (house flies); Fannia canicularis Linnaeus, F. femoralis Stein (lesser houseflies); Stomoxys calcitrans Linnaeus (stable flies); Fall housefly, horn fly, blowfly, Chrysomya spp.; Phormia spp.; and other muscoid fly pests, horse flies Tabanus spp. spp.); bot flies Gastrophilus spp.; Oestrus spp.; cattle grubs Hypoderma spp.; deer flies Chrysops spp.); Melophagus ovinus Linnaeus (sheep tick) and other Brachycera, mosquitoes Aedes spp.; Anopheles spp.; Culex spp.; black flies Prosimulium spp.; Simulium spp.; blood-sucking midges, sand flies, sciarids, and other Nematocera.

[0200] Included as objects of interest are adults and nymphs of the Hemiptera and Homoptera orders, such as, but not limited to: aphids from the family Adelgidae, blind bugs from the family Miridae, cicadas from the family Cicadidae, leafhoppers, Empoasca spp.; planthoppers from the family Cicadellidae, Cixiidae, Flatidae, Fulgoroidea, Issidae and Delphacidae, treehoppers from the family Membracidae, psyllids from the family Psyllidae, whiteflies from the family Aleyrodidae, aphids from the family Aphididae, phylloxera from the family Phylloxeridae, Mealybugs from the Pseudococcidae family, scale insects from the Asterolecanidae, Coccidae, Dactylopiidae, Diaspididae, Eriococcidae, Ortheziidae, Phoenicococcidae, and Margarodidae families, web bugs from the family Pseudococcidae, stink bugs from the family Pentatomidae, cinch bugs from the family Pentatomidae, bugs), Blissus spp.; and other seed bugs from the family Lygaeidae, cicadas from the family Cercopidae, pumpkin bugs from the family Coreidae, and fall chiggers and cotton bugs from the family Pyrrhocoridae.

[0201] Agriculturally important members from the order Homoptera further include, but are not limited to: Acyrthisiphonpisum Harris (pea aphid); Aphis craccivora Koch (cowpea aphid); A. fabae Scopoli (black bean aphid); A. gossypii Glover (cotton aphid, melon aphid); A. maidiradicis Forbes (corn root aphid); A. pomi De Geer (appleaphid); A. spiraea (A.spiraecola Patch (spirea aphid); Aulacorthum solani Kaltenbach (foxglove aphid); Chaetosiphon fragaefolii Cockerell (strawberry aphid); Diuraphis noxia Kurdjumov / Mordvilko (Russian wheat aphid); Dysaphis plantaginea Paaserini (rosy apple aphid); Eriosomalanigerum Hausmann (wooly apple aphid); Brevicoryne brassicae Linnaeus (cabbage aphid); Hyalopterus pruni Geoffroy (peach mealyplum aphid). aphid); Lipaphis erysimi Kaltenbach (turnip aphid); Metopolophium dirrhodum Walker (cereal aphid); Macrosiphum euphorbiae Thomas (potato aphid); Myzus persicae Sulzer (peach-potato aphid, green peach aphid); Nasonovia ribis nigri Mosley (lettuce aphid); Graptostethus spp. (root and gall aphids); Rhopalosiphum maidis Fitch (cornleaf aphid); R.padi Linnaeus (bird cherry-oat aphid); Schizaphis graminum Rondani (greenbug); Sipha flava Forbes (yellow sugarcane aphid); Sitobion avenae Fabricius (English grain aphid); Therioaphis maculata Buckton (spotted alfalfa aphid); Toxoptera aurantii Boyer de Fonscolombe (black citrus aphid) and T. citricida Kirkaldy (brown citrus aphid); Adelges spp. (adelgids); Phylloxera devastatrix Pergande (pecan phylloxera); phylloxera); Bemisia tabaci Gennadius (tobacco whitefly, sweetpotato whitefly); B. argentifolii Bellows & Perring (silverleaf whitefly); Dialeurodes citri Ashmead (citrus whitefly); Trialeurodes abutiloneus (bandedwinged whitefly) and T.vaporariorum Westwood (greenhouse whitefly); Empoasca fabae Harris (potato leafhopper); Laodelphax striatellus Fallen (smaller brown planthopper); Macrolestes quadrilineatus Forbes (aster leafhopper); Nephotettix cinticeps Uhler (green leafhopper); N. nigropictus. )(rice leafhopper); brown planthopper (Nilaparvata lugens brown planthopper; Peregrinus maidis Ashmead (corn planthopper); Sogatella furcifera Horvath (white-backed planthopper); Sogatodes orizicola Muir (rice elphacid); Typhlocyba pomaria McAtee (white apple leafhopper); Erythroneoura spp. (grape leafhoppers); Magicicada septendecim Linnaeus (periodicalcicada); Icerya purchasi Maskell (cottony cushion scale); Quadraspidiotus perniciosus Comstock (San Jose scale); Planococcus citri Risso (citrus mealybug); Pseudococcus spp. (other mealybug groups); Cacopsylla pyricola Foerster (pear psylla); Trioza diospyri Ashmead (persimmon psylla).

[0202] Agriculturally important species from the order Hemiptera include, but are not limited to: Acrosternum hilare Say (green stink bug); Anasa tristis De Geer (squash bug); Blissus leucopterus leucopterus Say (chinch bug); Corythuca gossypii Fabricius (cotton lace bug); Cyrtopeltis modesta Distant (tomato bug); Dysdercus suturellus (cotton lace bug); (cotton stainer); Euschistus servus Say (brown stink bug); E. variolarius Palisot de Beauvois (one-spotted stink bug); Graptostethus spp. (complex of seed bugs); Leptoglossus corculus Say (leaf-footed pine seed bug); Lygus lineolaris Palisot de Beauvois (tarnished plant bug); L. Hesperus Knight (Western tarnished plant bug); L. pratensis Linnaeus (common meadow bug); L. rugulipennis Poppius, European tarnished plant bug; Lygocoris pabulinus Linnaeus (common green capsid); Nezara viridula Linnaeus (southern green stink bug); Oebalus pugnax Fabricius (rice stink bug); Oncopeltus fasciatus Dallas (large milkweed bug); Pseudatomoscelis seriatus Reuter (cotton fleahopper).

[0203] In addition, embodiments may be effective against Hemiptera, such as Calocoris norvegicus Gmelin (strawberry bug); Orthops campestris Linnaeus; Plesiocoris rugicollis Fallen (apple capsid); Cyrtopeltis modestus Distant (tomato bug); Cyrtopeltis notatus Distant (suckfly); Spanagonicus albofasciatus Reuter (whitemarked fleahopper); Diaphnocoris chlorionis Say (honeylocust plantbug); Labopidicola allii Knight (onion plant bug); Pseudatomoscelis serrata (cotton plantbug); seriatus Reuter (cotton fleahopper); Adelphocoris rapidus Say (rapid plant bug); Poecilocapsus lineatus Fabricius (four-lined plant bug); Nysius ericae Schilling (false chinch bug); Nysius raphanus Howard (false chinch bug); Nezaraviridula Linnaeus (Southern green stink bug); Eurygaster spp.; Coreidae spp.; Pyrrhocoridae spp.; Tinidae spp.; Blostomatidae spp.); Reduviidae spp. species and Cimicidae spp.

[0204] Additionally, adults and larvae of the order Acari (Mites) are included, such as Aceriatosichella Keifer (wheat curl mite); Petrobia latens Müller (brown wheat mite); spider mites and red mites in the family Tetranychidae, Panonychus ulmi Koch (European red mite); Tetranychus urticae Koch (two spotted spider mite); T. mcdanieli McGregor (McDaniel mite); T. cinnabarinus Boisduval (carmine spider mite); T. turkestani Ugarov & Nikolski (strawberry spider mite). mite); Brevipalpus lewisiMcGregor (citrus flat mite) in the family Tenuipalpus; rust and bud gall mites in the family Eriophyidae, as well as other leaf-feeding mites and mites important to human and animal health, namely dust mites in the family Epidermoptidae, hair follicle mites in the family Demodicidae, grain mites in the family Glycyphagidae, and ticks in the family Ixodidae. Ixodes scapularis Say (deertick); I. holocyclus Neumann (Australian paralysis tick); Dermacentor variabilis Say (American dog tick); Amblyomma americanum Linnaeus (lone star tick), and itch and scabies mites in the families Itch, Pyreniformes, and Sarcoptes.

[0205] Of concern are insect pests of the order Thysanura, eg, Lepisma saccharina Linnaeus (silverfish); Thermobia domestica Packard (firebrat).

[0206] Additional arthropod pests covered include spiders of the order Araneae, such as Loxosceles reclusa Gertsch and Mulaik (brown recluse spider); and Latrodectus mactans Fabricius (black widow spider); and centipedes of the order Scutigeromorpha, such as Scutigera coleoptrata Linnaeus (house centipede).

[0207] Insect pests of concern include the superfamily of stink bugs and other related insects, including but not limited to species belonging to the following families: Pentatomidae (Green stink bug, Halyomorpha halys, Piezodorus guildini, Brown stink bug, Pseudo-green stink bug, Euschistus heros, Euschistus tristigmus, Pseudo-green stink bug, Dichelops melacanthus, and Bagrada hilaris (Bagrada Bug), Plataspidae (Megacopta cribraria - Bean plataspid), and Scaptocoris castanea - Root stink bug. bug), and Lepidoptera species include, but are not limited to, diamondback moths, such as the zea mays; soybean moths, such as the soybean looper, and bean moths, such as the pear moth.

[0208] Methods for measuring pesticidal activity are well known in the art. See, for example, Czapla and Lang, (1990) J. Econ. Entomol. 83:2480-2485; Andrews et al., (1988) Biochem. J. 252:199-206; Marrone et al., (1985) J. of Economic Entomology 78:290-293 and U.S. Patent No. 5,743,477. Typically, the protein is mixed and used in a feeding assay. See, for example, Marrone et al., (1985) J. of Economic Entomology 78:290-293. Such assays can include contacting a plant with one or more pests and determining the plant's ability to survive and / or cause the death of the pest.

[0209] Nematodes include parasitic nematodes such as root-knot nematodes, cyst nematodes, and decay nematodes, including Heterodera spp., Meloidogyne spp., and Globodera spp.; particularly members of the cyst nematodes, including, but not limited to: Heteroderaglycines (soybean cyst nematode); Heteroderaschachtii (beet cyst nematode); Heterodera avenae (cereal cyst nematode); and Globodera rostochiensis and Globodera pailida (potato cyst nematodes). Saprolegnias include Pratylenchus spp.

[0210] Seed treatment

[0211] In order to protect and improve yield production and proterties technology, seed treatment scheme can provide other crop planning flexibility and cost-effective control for insects, weeds and diseases.Seed material can be processed with the composition comprising the combination of chemical or biological herbicides, herbicide safeners, insecticides, fungicides, germination inhibitors and enhancers, nutrients, plant growth regulators and activators, bactericides, nematocides, avicides and / or molluscicides, typically carries out surface treatment.These compounds are typically prepared together with the auxiliary agent that normally used other carriers, surfactants or promotion is applied in the formulation field.Described coating can be applied by dipping propagation material with liquid formulations or by being coated with the wet or dry formulations of combination.The example of various types of compounds that can be used as seed treatment is provided in the following: The Pesticide Manual:A World Compendium [pesticide manual: world brief], CDST Tomlin writes, and is published by British Crop Production Council [British Crop Production Council].

[0212] Some seed treatments that can be used for crop seeds include, but are not limited to, one or more of the following: abscisic acid, acibenzolar-S-methyl, avermectin, cypermethrin, azaconazole, azospirillum, azadirachtin, azoxystrobin, Bacillus species (including one or more of Bacillus cereus, Bacillus firmus, Bacillus megaterium, Bacillus pumilis, Bacillus sphaericus, Bacillus subtilis, and / or Bacillus thuringiensis species), bradyrhizobium species (including bradyrhizobium betae, bradyrhizobium canariense, bradyrhizobium elkanii, bradyrhizobium spp. iriomotense), bradyrhizobium japonicum, bradyrhizobium liaonigense, bradyrhizobium pachyrhizi and / or bradyrhizobium yuanmingense), captan, carboxin, chitosan, clothianidin, copper, cyantraniliprole, difenoconazole, chlorazole, fipronil, fludioxonil, fluoxastrobin, fluquinconazole, chloranil, hypersensitive protein, imazalil, imidacloprid, ipconazole, isoflavvenoids, lipid chito-oligosaccharides, mancozeb, manganese, maneb, metalaxyl-M, metalaxyl, metconazole, myclobutanil, PCNB, fluopicolide, Penicillium, penthiopyrad, permethrin, picoxystrobin, prothioconazole, pyraclostrobin, chlorantraniliprole, S-isopropylamine, saponins, flutoxazone, TCMTB, tebuconazole, thiabendazole, thiamethoxam, thiocarb, thiram, tolclofos-methyl, triadimenol, Trichoderma, trifloxystrobin, triticonazole and / or zinc. PCNB seed coat refers to EPA registration number 00293500419 containing quinalphos and clozolin. TCMTB refers to 2-(thiocyanatomethylthio)benzothiazole.

[0213] Seed varieties and seeds harboring specific transgenic traits can be tested to determine which seed treatment regimens and application rates can complement the variety and transgenic trait to increase yield. For example, a variety with good yield potential but susceptibility to head smut could benefit from a seed treatment that provides protection against head smut, a variety with good yield potential but susceptibility to cyst nematodes could benefit from a seed treatment that provides protection against cyst nematodes, and so on. Similarly, varieties encompassing transgenic traits that confer insect resistance could benefit from a secondary mode of action conferred by a seed treatment, varieties encompassing transgenic traits that confer herbicide resistance could benefit from seed treatment with a safener that enhances the plant's resistance to the herbicide, and so on. Furthermore, when combined with a seed treatment, the improved root establishment and early seedling emergence resulting from the proper use of a seed treatment could lead to more efficient nitrogen utilization, better drought tolerance, and an overall increase in the yield potential of the variety or varieties harboring a particular trait.

[0214] Methods for killing insect pests and controlling insect populations

[0215] In some embodiments, a method for killing insect pests is provided, comprising contacting the insect pests with an insecticidal effective amount of a recombinant Cry toxin polypeptide of the present disclosure simultaneously or sequentially. In some embodiments, a method for killing insect pests is provided, comprising contacting the insect pests with an insecticidal effective amount of one or more of the recombinant pesticidal proteins of SEQ ID NOs: 57-112, 214-246, and 275-278, or variants or insecticidal active fragments thereof.

[0216] In some embodiments, a method for controlling an insect pest population is provided, comprising contacting the insect pest population with an insecticidal effective amount of one or more of the recombinant Cry toxin polypeptides of the present disclosure simultaneously or sequentially. In some embodiments, a method for controlling an insect pest population is provided, comprising contacting the insect pest population with an insecticidal effective amount of one or more of the recombinant Cry toxin polypeptides of SEQ ID NOs: 57-112, 214-246, and 275-278, or variants or insecticidal active fragments thereof. As used herein, "controlling a pest population" or "controlling pests" refers to any effect on a pest that results in limiting the damage caused to the pest. Controlling pests includes, but is not limited to, killing pests in a certain manner, inhibiting pest development, changing pest fertility or growth, causing pests to cause less damage to plants, reducing the number of offspring produced, producing pests with weaker adaptability, producing pests that are susceptible to predator attacks, or preventing pests from gnawing on plants.

[0217] In some embodiments, a method for controlling an insect pest population resistant to an insecticidal protein is provided, the method comprising contacting the insect pest population with an insecticidal effective amount of one or more of the recombinant Cry toxin polypeptides of the present disclosure simultaneously or sequentially. In some embodiments, a method for controlling an insect pest population resistant to an insecticidal protein is provided, the method comprising contacting the insect pest population with an insecticidal effective amount of one or more of the recombinant Cry toxin polypeptides of SEQ ID NOs: 57-112, 214-246, and 275-278, or variants or insecticidally active fragments thereof.

[0218] In some embodiments, a method for protecting a plant from an insect pest is provided, comprising expressing in a plant or a cell thereof at least one recombinant polynucleotide encoding a Cry toxin polypeptide of the present disclosure. In some embodiments, a method for protecting a plant from an insect pest is provided, comprising expressing in a plant or a cell thereof a recombinant polynucleotide encoding one or more Cry toxin polypeptides of SEQ ID NOs: 57-112, 214-246, and 275-278, or variants or insecticidal fragments thereof.

[0219] Insect Resistance Management (IRM) Strategies

[0220] The expression of Bacillus thuringiensis delta-endotoxins in transgenic corn plants has been shown to be an effective means of controlling agriculturally important insect pests (Perlak et al., 1990; 1993). However, in some cases, insects have evolved resistance to Bacillus thuringiensis delta-endotoxins expressed in transgenic plants. If this resistance were widespread, it would significantly limit the commercial value of germplasm containing genes encoding such Bacillus thuringiensis delta-endotoxins.

[0221] One approach to increasing the effectiveness of transgenic insecticides against target pests while simultaneously reducing the development of insecticide-resistant pests is to use a non-transgenic (i.e., non-insecticide protein) refuge (a portion of the non-insecticide crop / corn) alongside a transgenic crop that produces a single insecticide-active protein active against the target pest. The United States Environmental Protection Agency (epa.gov / oppbppdl / biopesticides / pips / bt_corn_refuge_2006.htm, which can be accessed using the www prefix) has published requirements for use with transgenic crops that produce a single Bt protein active against the target pest. Additionally, the National Corn Growers Association provides similar guidance on refuge requirements on its website (ncga.com / insect-resistance-management-fact-sheet-bt-corn, which can be accessed using the www prefix). Larger refuges may reduce overall yields due to losses caused by insects within the refuge area.

[0222] Another approach to increasing the effectiveness of transgenic insecticides against target pests and at the same time reducing the development of insecticide-resistant pests is to have a reservoir of insecticidal genes that are effective against groups of insect pests and exert their effects through different modes of action.

[0223] Another approach to controlling the development of resistance is to express two or more insecticide compositions in plants that are toxic to the same insect species, with each insecticide expressed at an effective level. This is based on the principle that the evolution of resistance to two different modes of action is far less likely than to develop resistance to only one. For example, Rouss outlined a dual-toxin strategy, also known as "pyramiding" or "stacking," for managing transgenic insecticide crops. (The Royal Society. Phil. Trans. R. Soc. Lond. B. [Philosophical Transactions of the Royal Society of London Series B], (1998) 353: 1777-1786). Stacking or pyramiding two different proteins, each effective against target pests and with little or no cross-resistance, can allow for the use of smaller shelters. The U.S. Environmental Protection Agency requires that the structural shelter of planted non-Bt corn (typically 5%) be significantly less than that of single-trait products (typically 20%). Various methods exist for providing IRM effects of shelter, including various geometric planting patterns in the field and in-bag seed mixtures, as further discussed by Roush.

[0224] In some embodiments, the Cry toxin polypeptides of the present disclosure can be used as an insect resistance management strategy in combination (i.e., pyramiding) with other pesticidal proteins or other transgenes (i.e., RNAi traits) (including but not limited to Bt toxins, Xenorhabdus species or Photorhabdus species insecticidal proteins, other insecticidal active proteins, etc.).

[0225] A method of controlling infestation by one or more lepidopteran and / or coleopteran insects in a transgenic plant that facilitates insect resistance management is provided, the method comprising expressing in the plant at least two different insecticidal proteins having different modes of action.

[0226] In some embodiments, methods of controlling Lepidopteran and / or Coleopteran insect infestations in transgenic plants and promoting insect resistance management comprise presenting at least one Cry toxin polypeptide insecticidal protein to Lepidopteran and / or Coleopteran insects.

[0227] In some embodiments, methods for controlling lepidopteran and / or coleopteran insect infestation in transgenic plants and promoting insect resistance management comprise presenting at least one Cry toxin polypeptide of SEQ ID NOs: 57-112, 214-246, and 275-278, or a variant or insecticidally active fragment thereof, to lepidopteran and / or coleopteran insects.

[0228] Also provided is a method for reducing the likelihood that Lepidopteran and / or Coleopteran insects will develop resistance to a transgenic plant expressing an insecticidal protein in the plant to control the insect species, the method comprising expressing in combination at least one Cry toxin polypeptide having an insecticidal effect on the insect species and a second insecticidal protein having a different mode of action against the insect species.

[0229] Ways to increase plant yields

[0230] Methods for increasing plant yield are provided. The methods include providing a plant or plant cell expressing a polynucleotide encoding a pesticidal polypeptide sequence disclosed herein, and planting the plant or its seeds in a field infested with a pest against which the polypeptide has pesticidal activity. In some embodiments, the polypeptide has pesticidal activity against a lepidopteran, coleopteran, dipteran, hemipteran, or nematode pest, and the field is infested with a lepidopteran, hemipteran, coleopteran, dipteran, or nematode pest.

[0231] As defined herein, " output " of plant refers to the quality and / or quantity of the biomass produced by plant. As used herein, " biomass " refers to any measured plant product. The increase of biomass output is any improvement on the output of measured plant product. Increasing plant yield has several commercial applications. For example, increasing plant leaf biomass can increase the output of the leafy vegetables consumed by humans or animals. In addition, increasing leaf biomass can be used to increase the output of medicine or industrial products of plant origin. The increase on the output can comprise any statistically significant increase, including but not limited to, compared with the plant that does not express the pesticidal sequence, increase at least 1%, at least 3%, at least 5%, at least 10%, at least 20% increase, at least 30%, at least 50%, at least 70%, at least 100% or larger increase on the output.

[0232] In specific methods, the improved pest resistance of plants expressing at least one Cry toxin polypeptide disclosed herein results in increased plant yield. Expression of one or more Cry toxin polypeptides results in a decrease in the ability of pests to infect or feed on plants, thereby increasing plant yield.

[0233] Processing methods

[0234] Further provided are methods for processing plants, plant parts or seeds to obtain food or feed products from plants, plant parts or seeds comprising at least one Cry toxin polynucleotide. The plants, plant parts or seeds provided herein can be processed to produce oils, protein products and / or by-products of derivatives obtained by processing commercially valuable plants, plant parts or seeds. Non-limiting examples include transgenic seeds comprising nucleic acid molecules encoding one or more Cry toxin polypeptides, which can be processed to produce soybean oil, soybean products and / or soybean by-products.

[0235] "Processing" refers to any physical and chemical method used to obtain any soy product and includes, but is not limited to, heat conditioning, flaking and grinding, extrusion, solvent extraction or aqueous soaking, and full or partial seed extraction.

[0236] The present invention also relates to the following embodiments:

[0237] 1. An insecticidal polypeptide comprising a heterologous alpha-loop region, wherein the insecticidal polypeptide is derived from a Cry toxin.

[0238] 2. The insecticidal polypeptide of embodiment 1, wherein the heterologous alpha loop region has at least one border consensus sequence comprising an amino acid sequence having at least 90% sequence identity to any one of SEQ ID NOs: 247, 248, 249, 250, or 258.

[0239] 3. The insecticidal polypeptide of embodiment 2, wherein the at least one border consensus sequence having at least 90% sequence identity to SEQ ID NO: 247 comprises:

[0240] i. histidine or arginine at position 1 of SEQ ID NO: 247;

[0241] ii. valine, methionine, or leucine at position 2 of SEQ ID NO: 247;

[0242] iii. Leucine at position 3 of SEQ ID NO: 247;

[0243] iv. arginine, glutamic acid, leucine, or serine at position 4 of SEQ ID NO: 247; or

[0244] v. Isoleucine at position 5 of SEQ ID NO: 247.

[0245] 4. The insecticidal polypeptide of embodiment 1, wherein the heterologous alpha-loop region is exposed to a solvent.

[0246] 5. The insecticidal polypeptide of embodiment 1, wherein the insecticidal polypeptide comprises a Bt-derived polypeptide of the Cry1 class.

[0247] 6. The insecticidal polypeptide of embodiment 1, wherein the insecticidal polypeptide comprises an amino acid sequence having at least 90% sequence identity to any one of the sequences shown in SEQ ID NOs: 57-112.

[0248] 7. An isolated polynucleotide encoding the insecticidal polypeptide of embodiment 1.

[0249] 8. The isolated polynucleotide of embodiment 7, wherein the isolated polynucleotide comprises a nucleic acid sequence having at least 90% sequence identity to any one of the sequences shown in SEQ ID NOs: 1-56.

[0250] 9. A DNA construct comprising the polynucleotide of embodiment 7.

[0251] 10. A host cell comprising the DNA construct of embodiment 9.

[0252] 11. The host cell of embodiment 10, wherein the host cell is a plant cell.

[0253] 12. The host cell of embodiment 10, wherein the host cell is a bacterial cell.

[0254] 13. A transgenic plant comprising the DNA construct of embodiment 9.

[0255] 14. A method for altering the activity of an insecticidal polypeptide, the method comprising:

[0256] a. shuffling the α-loop region of the first insecticidal polypeptide into the corresponding α-loop region of domain 1 of the second insecticidal polypeptide to produce a heterologous insecticidal polypeptide; and

[0257] b. screening the heterologous polypeptide for altered insecticidal activity;

[0258] Wherein the insecticidal polypeptide is derived from a Cry toxin.

[0259] 15. The method of embodiment 14, wherein the alpha ring region comprises at least one of alpha rings 3, 4, or 5.

[0260] 16. The method of embodiment 14, wherein the alpha loop region comprises a border sequence having at least 90% sequence identity to any one of SEQ ID NO: 247, 248, 249, 250 or 258.

[0261] 17. The method of embodiment 14, further comprising modifying the plant to encode a heterologous peptide having altered insecticidal activity.

[0262] 18. The method of embodiment 14, wherein the α-loop region is derived from a Cry toxin, and further wherein the Cry toxin has an amino acid sequence comprising a sequence having at least 95% sequence identity with any one of SEQ ID NOs: 159-180 or 214-246.

[0263] 19. An isolated polynucleotide comprising a polynucleotide encoding an insecticidal polypeptide, wherein the insecticidal polypeptide comprises a heterologous alpha loop region in domain 1, and wherein the insecticidal polypeptide is derived from a Cry toxin.

[0264] 20. The isolated polynucleotide of embodiment 19, further comprising: a heterologous promoter operably linked to the isolated polynucleotide.

[0265] 21. The isolated polynucleotide of embodiment 19, wherein the polynucleotide encoding the insecticidal polypeptide further comprises a heterologous polynucleotide encoding the heterologous alpha-loop region.

[0266] 22. An expression cassette comprising the isolated polynucleotide of embodiment 19.

[0267] 23. A DNA construct comprising the expression cassette of embodiment 22.

[0268] 24. A host cell comprising the DNA construct of embodiment 23.

[0269] 25. The host cell of embodiment 24, wherein the host cell is a bacterial cell.

[0270] 26. The host cell of embodiment 24, wherein the host cell is a plant cell.

[0271] 27. A method for altering the insecticidal activity of an insecticidal polypeptide, the method comprising:

[0272] i. shuffling domain 3 of an insecticidal protein derived from a Cry toxin, wherein the shuffling comprises a crossover at a consensus sequence in domain 3, wherein the crossover sequence has at least 90% sequence identity to any one of SEQ ID NOs: 251-257; and

[0273] ii. Screening the shuffled insecticidal polypeptides for altered insecticidal activity.

[0274] 28. The method of embodiment 27, wherein the shuffled insecticidal polypeptide comprises a heterologous fragment of domain 3.

[0275] 29. The method of embodiment 28, wherein the heterologous portion of domain 3 comprises a fragment derived from a Cry1If, Cry1Cb, Cry1Fa, Cry9Eb, Cry1Ae, Cry1Ja, Cry1Da, Cry1Bb, or Cry1Ca toxin.

[0276] 30. The method of embodiment 28, wherein the heterologous portion of domain 3 comprises a fragment having at least 95% sequence identity to any one of SEQ ID NOs: 159-180, 214-246, 259-265, or 268-270.

[0277] 31. The method of embodiment 27, further comprising, prior to the screening step, modifying the plant to encode a heterologous peptide having altered insecticidal activity.

[0278] 32. A recombinant insecticidal polypeptide having at least 95% sequence identity to the amino acid sequence of any one of SEQ ID NOs: 57-112 or 214-246, or a fragment thereof, wherein the recombinant insecticidal polypeptide has insecticidal activity.

[0279] 33. A composition comprising at least one recombinant insecticidal polypeptide according to embodiment 32.

[0280] 34. A recombinant polynucleotide encoding the insecticidal polypeptide of embodiment 32.

[0281] 35. The recombinant polynucleotide of embodiment 34, wherein the polynucleotide has codons optimized for expression in agriculturally important crops.

[0282] 36. The recombinant polynucleotide of embodiment 34, wherein the recombinant polynucleotide comprises a nucleic acid sequence having at least 95% sequence identity to any one of SEQ ID NOs: 1-56 or 181-213.

[0283] 37. The recombinant polynucleotide of embodiment 34, wherein the recombinant polynucleotide is operably linked to a heterologous promoter.

[0284] 38. A DNA construct comprising the recombinant polynucleotide of embodiment 34 operably linked to a heterologous regulatory element.

[0285] 39. A host cell transformed with the DNA construct of embodiment 38.

[0286] 40. The host cell of embodiment 39, wherein the host cell is a bacterial cell or a plant cell.

[0287] 41. The host cell of embodiment 40, wherein the plant cell is a monocot or a dicot cell.

[0288] 42. A transgenic plant comprising the polynucleotide of embodiment 34.

[0289] 43. A transgenic plant comprising the DNA construct of embodiment 38.

[0290] 44. A method of inhibiting the growth of or killing an insect pest or pest population, the method comprising contacting the insect pest or pest population with an insecticidal polypeptide comprising a heterologous alpha loop region in Domain 1, wherein the insecticidal polypeptide is derived from a Cry toxin.

[0291] 45. A method of inhibiting the growth of or killing an insect pest or pest population, the method comprising expressing in a plant the polynucleotide of embodiment 34.

[0292] 46. ​​The method of embodiment 44, wherein the insect pest or pest population is resistant to at least one Cry insecticidal protein.

[0293] 47. A DNA construct comprising a polynucleotide encoding a polypeptide having at least 95% sequence identity to the amino acid sequence of any one of SEQ ID NOs: 57-112, 214-246, and 275-278; and a heterologous regulatory element, wherein the heterologous regulatory element is operably linked to the polynucleotide.

[0294] 48. The DNA construct of embodiment 47, wherein the polynucleotide comprises a nucleic acid sequence having at least 95% sequence identity to any one of SEQ ID NOs: 1-56, 181-213, or 271-274.

[0295] 49. A transgenic plant comprising the DNA construct of embodiment 47.

[0296] The following examples are offered by way of illustration and not by way of limitation.

[0297] Examples

[0298] Example 1: Synthesis of various Cry toxin domain fragments

[0299] 42 full-domain fragments of Cry toxins (Dm1, Dm2 and Dm3) were optimized and synthesized for expression in E. coli (see Figure 1 ). All domain fragments were cloned into pUC19 subclones for expression. These fragments were used as starting materials for many batch reorganization libraries. All full-type Cry toxin protein information was obtained from the NCBI gene bank, Crickmore et al., "Bacillus thuringiensis toxin nomenclature" (2011), the website is lifesci.sussex.ac.uk / home / Neil_Crickmore / Bt / (which can be accessed on the world wide web using the "www" prefix), and btnomenclature.info / (which can be accessed on the world wide web using the "www" prefix). Table 1 lists the synthesized full-type toxin fragments.

[0300] Table 1. Synthetic fragments of full-type Bt toxins

[0301]

[0302] Example 2: Vector insert and backbone assembly

[0303] PCR products of the insert (domain 1, 2, or 3, or subdomain fragments) were amplified using Q5 High-Fidelity DNA Polymerase (NEB M0491L), while the plasmid backbone was amplified using Phusion High-Fidelity DNA Polymerase (ThermoFisher F530L or NEB M0530L), following the temperature and cycling instructions recommended in the respective DNA polymerase protocols.

[0304] All libraries were cloned into the pMAL vector pVER6805 for expression in a His-MBP-toxin configuration. After generating the insert (Dm1, 2, and 3) PCR fragments, a vector backbone (8 to 9 kb in length, excluding the insert) containing the His+MBP and other necessary vector elements was generated by inverse PCR.

[0305] Inserts and backbones were assembled into plasmids primarily using NEBuilder High-Fidelity DNA Assembly Master Mix (NEB E2621L) using 10 ul reactions (scaled down from the original 20 ul protocol) and following the recommended incubation temperatures and lengths.

[0306] NEBuilder is assembled reactant with deionized water with 1:2 dilution, and 1ul is used for the conversion of electrocompetent BL21 (DE3) cell (Lucigen company E.cloni EXPRESS 60300-2) of 1:8 dilution of 50ul.Alternatively, GeneArt Seamless Cloning and Assembly Kit (GeneArt Seamless Cloning and Assembly Kit, Invitrogen (Invitrogen) A13288) is sometimes used for the assembling of insert and main chain according to reaction instruction.In order to transform, the reactant of 10ul is added in Invitrogen (Invitrogen) OneShot chemical competence TOP10 cell (comprising test kit together) of 50ul.Culture is grown, and Miniprep test kit (Qiagen (Qiagen) 27104) is used to prepare plasmid DNA.Then, plasmid DNA is used for the chemical competence BL21-Gold (DE3) cell (Agilent (Agilent) 230132) of transforming 50ul.

[0307] BL21 cells are plated on LB agar plates selected with 100 μg / ml carbenicillin and grown overnight at 37°C. 150-160ul LB carbohydrate (100ug / ml) starter cultures are inoculated and grown overnight at 37°C with shaking. Magic Media cultures (Invitrogen K6803) are grown in deep-well plates, in which 1ml of Magic Media culture medium is inoculated with 20ul starter cultures. Magic Media plates are cultivated at 25°C for 8 hours, then cultivated at 16°C for 64 hours with shaking at 250rpm. Plates are rotated at 4000rpm for 15 minutes. Supernatant is discarded, steel balls are added to each well, and plates are stored overnight at -80°C.

[0308] The plate was vortexed until the cell pellet was resuspended and then shaken at 250 rpm for 1.5 to 2 hours at 37° C. After storage at −80° C. overnight, the plate was thawed and the steel balls removed using a large magnet followed by spinning at 4000 rpm for 20 minutes at 4° C.

[0309] To prepare samples for Western analysis, 7.5 μl of supernatant plus 7.5 μl of deionized water was combined with 5 μl of E-PAGE sample loading buffer (containing Invitrogen E-PAGE 96-well 6% gel EP09606) (with 4% β-mercaptoethanol added). The samples were heated at 70°C for 10 minutes and spun at 4000 rpm for 5 minutes at 4°C. 5 μl of sample plus 15 μl of deionized water and 5 μl of E-PAGE SeeBlue pre-stained standard (Invitrogen LC5700) plus 15 μl of deionized water were then loaded onto the 96-well E-PAGE gel. The gel was run on program EP for 20 minutes on an E-Base gel apparatus (Invitrogen EBM03 and EBD03).

[0310] According to the manufacturer's instructions, protein was transferred from the gel to a nitrocellulose membrane (Invitrogen IB23001) using the iBlot2 system (Invitrogen IB21001). The membrane was blocked for 1 hour with SuperBlock T20 (TBS) blocking buffer (ThermoFisher 37536) at room temperature and then incubated overnight at 4°C with a 1:2000 dilution of Sigma monoclonal anti-maltose binding protein-alkaline phosphatase antibody (A3963-5ML) produced in mice in SuperBlock T20. After washing (3 times) for 10 minutes with TBS-T (0.05% Tween-20), the blot was developed using Bio-Rad alkaline phosphatase conjugate substrate kit (170-6432) according to the manufacturer's protocol. Proteins exhibiting good expression profiles were then screened by insect assay.

[0311] To generate proteins for processing after expression screening, glycerol stocks were plated on LB carbohydrate (100 ug / ml) and incubated overnight at 30°C or 37°C. Colonies from these plates were used to inoculate 3 ml LB carbohydrate (100 ug / ml) starter cultures grown overnight at 37°C. 100 ml to 200 ml of Magic Media culture (Invitrogen K6803) were inoculated with 1 ml to 2 ml of the starter culture (i.e., 1% of the final volume) and shaken at 250 rpm for 8 hours at 25°C and then at 16°C for 64 hours. The cultures were rotated at 9000 rpm for 10 min at 4°C.

[0312] The reorganized insecticidal protein ("IPRS" polypeptide or protein) was expressed as a fusion with MBP (maltose binding protein) in a modified pMAL vector (Catalog No. E8000S from New England Biolabs). The pMAL vector was modified to attach a 6X His tag to the N-terminus of MBP after the methionine at position 1. The plasmid containing the insecticidal protein gene was cloned into E. coli BL21 (DE3). BL21 cells were cultured in a shaker, in 96-well deep plates or flasks, in MagicMedia TM The cells were grown in a shaker (Life Technologies) at 250 rpm at 37° C. for 8 hours, followed by 64 hours at 16° C. During the incubation at 16° C., the MBP-toxin fusion protein accumulated as a soluble protein in the BL21 cells.

[0313] To purify the fusion protein, E. coli cells were harvested by centrifugation and treated with a lysozyme solution consisting of 2 mg / ml lysozyme in 50 ml sodium phosphate buffer (containing 300 mM NaCl, 2 U / ml endonuclease (Epicentre) and 5 mM MaCl 2 , pH 8) at 37° C. with gentle shaking for 3 hours. The lysozyme-treated E. coli cells were then disrupted with 1% Triton X100 and a transparent lysate containing the toxin was prepared by centrifugation at 4000 rpm for 30 min (96-well plate) or at 9000 rpm (samples produced by flasks). The lysate was purified by affinity chromatography using a 50 μl elution buffer from Qiagen. TM The His-tagged MBP-toxin protein was purified from the clear lysate using NiNTA agarose gel per the manufacturer's standard procedure. For those clear lysate samples prepared in 96-well plates, a Pall Corporation TM (25 Harbor Park Drive Port Washington, NY 11050) 96 deep-well filter plates were used as affinity chromatography columns. The purified toxin protein eluted from NiNTA agarose was passed through Sephadex G25 to change the phosphate buffer to 25 mM HEPES-NaOH, pH 8, and used in insect bioassays to determine insecticides. MBP was digested overnight at 25° C. with 1 / 100 (w / w) Factor Xa (New England Biolabs) and removed from the toxin by Superdex 200 column chromatography, taking advantage of the size difference and weak affinity of MBP for Superdex.

[0314] Using LabChip TM Protein concentrations were determined by capillary electrophoresis using a GXII apparatus (Caliper LifeSciences). Protein analysis was repeated at least three times until the final concentration was within a predetermined tolerance (less than 10%) and was considered reliable.

[0315] The activity of IPRS polypeptide variants against the main corn pests, European corn borer (ECB, Ostrinia nubilalis), corn earworm (ECW, Helicoverpa zea) and fall armyworm (FAW, Spodoptera frugiperda) was determined by feeding assays as described in Cong, R et al., Proceedings of the 4th Pacific Rim Conferences on Biotechnology of Bacillus thuringiensis and its environmental impact, pp. 118-123, edited by RJ Akhurst, C.E. Beard and P. Hughes, 2002, Canberra, Australia. Briefly, the experiments were conducted on an artificial diet containing insecticidal proteins. Insecticidal protein was prepared as described in Example 1, and 10 μL of protein sample was mixed with 40 μL of molten (40° C.-50° C.) artificial insect diet based on Southland Premix (Southland Products, Lake Village, Arkansas) formulated for lepidopterans using low-melting agarose. The food-insecticidal protein mixture was placed in each well of a 96-well microtiter plate. One or more newborn insect larvae were placed in each well at 28° C. and reared for 4 days for CEW and FAW, and for 5 days for ECB.

[0316] Example 3: Cry1Jα loop 3-5 shuffling (targeting IPRS hits C21 and C51)

[0317] Full domain 1 (Dm1) shuffling generally resulted in very low soluble expression. In contrast, the data indicate that the region encompassing Dm1's alpha loops 3 to 5, which 1) have minimal interactions with the rest of the protein and 2) are solvent exposed, is shuffled (see Tables 2, 3, and 10, and Figure 5 and 6). Therefore, it is predicted that the reshuffling of the α loop 3-5 region has an effect on the solubility of the reshuffled polypeptide and may change the insecticidal activity. As a proof of concept library, two small libraries were prepared. In each library, the α loop 3-5 region of Cry1Jc and Cry1Ja was exchanged with the α loop 3-5 region of Cry1Ca and Cry1Ah. The common region between QIEQL (SEQ ID NO: 247, at the end of α loop 2B) and ANLHL (SEQ ID NO: 251, in the middle of α loop 5) of Dm1 was selected for reshuffling. These five amino acid segments (SEQ ID NO: 247 and 251) are highly conserved among several Cry1 toxins (see Figure 8 and 9 ). Common regions between α loops 3 and 4 (SEQ ID NO: 248) and α loops 4 and 5 (SEQ ID NO: 249) were also identified for potential chimeric α loop swaps. In addition to the α loop 3-5 swap, domain 3 of Cry1Jc and Cry1Ja was also swapped with domain 3 of Cry1Ac and Cry1Ca (see Figure 8 and 9 The total library size was 6, with a total of 12 constructs for both backbones (see Figure 2 All 12 constructs for the library were synthesized as described in Example 2. The α-loop 3-5 amino acid sequence regions of the various Cry toxins used in the shuffling are shown in SEQ ID NOs: 159-180 (encoded by the DNA sequences shown in SEQ ID NOs: 137-158, respectively).

[0318] In order to express these genes as MBP fusion proteins, they were cloned into pMal vectors. The toxin sequence was amplified from the pUC19 vector by PCR. The vector backbone was obtained by inverse PCR using the pMal vector. Then, the insert and vector backbone were connected using the homology-based cloning kits Geneart and NEBuilder. These twelve clones were transformed into BL21 E. coli cells and directly subjected to protein purification without checking expression.

[0319] The protein was purified, quantified, and submitted for insect assays against CEW and FAW. Initial testing was performed to assess activity using a yes / no assay. Based on the preliminary results, selected clones were submitted for dose-response assays of specific activity. Subsequently, one or more active clones were tested for activity against other lepidopteran pests (SBL, VBC, and ECB) to determine their spectrum of activity (see Table 2).

[0320] Table 2. Activity spectrum of active clones

[0321]

[0322] *NA means not active when tested; NM means not dead when tested; and ND means not determined.

[0323] Example 4: Shuffling of Dm1α loop 3-5 and Dm3 on the Cry1Ea backbone, targeting the following IPRS hits: IPRS-C13, IPRS-14, IPRS-15, IPRS-16, IPRS-17, IPRS-19 and IPRS-31

[0324] Building on the success of the α-loop 3-5 library of the 1Jc backbone, a library was designed to shuffle several hybrid domain 1 (Dm1) structures with Cry1Ea domain 2 (Dm2) and Cry1Ca domain 3 (Dm3) at three different intersections of hybrid domain 3 with varying lengths. The hybrid Dmls were similar to each other except in the α3-5 region. Along with the nine hybrid Dmls, three Cry1Ea-like Dmls were also used in the shuffling.

[0325] Eleven Dm1s (two Cry1Ea-like Dm1s and nine hybrid Dm1s) and three Cry1Ea Dm2-Cry1Ca Dm3 fragments (Cry1EaDm2 and Cry1Ca Dm3 fused at three different intersections) were synthesized. Three libraries (ECF2, 3, and 4) were constructed (see Figure 3 In the ECF2 library, 11 Dmls were shuffled with Cry1Ea Dm2 and Cry1Ca Dm3. Cry1Ea Dm2 and Cry1Ca Dm3 were fused at the intersection region 1 (SEQ ID NO: 251) in Dm3. In the ECF3 library, 11 Dmls were shuffled with Cry1Ea Dm2 and Cry1Ca Dm3. Cry1Ea Dm2 and Cry1Ca Dm3 were fused at the common intersection region 2 (SEQ ID NO: 252) in Dm3. In the ECF4 library, 11 Dmls were shuffled with Cry1Ea Dm2 and Cry1Ca Dm3. Cry1Ea Dm2 and Cry1Ca Dm3 were fused at the common intersection region 3 (SEQ ID NO: 253) in Dm3.

[0326] In order to express these genes as MBP fusion proteins, all 3 libraries were prepared in the pMal vector. From the pUC19 vector PCR amplification Dm1 and 3 Dm2-Dm3 fragments. The vector backbone was obtained by inverse PCR of the pMal vector backbone. Then, inserts (Dm1, Dm2-Dm2) and the vector backbone were assembled using Geneart and NEBuilder cloning kits based on homology.

[0327] All 33 clones (11 clones / library) are carried out sequence confirmation, and are transformed into BL21 Escherichia coli cells, and use western blot to check its expression.All 22 clones of expression are all grown in 200 ml culture, and with protein purification, quantitative and be submitted to the insect mensuration for FAW.The clone that will be selected based on initial test result is submitted to the dose-response determination, to obtain specific activity.Subsequently, tested the activity of the most active clone (IPRS-C16, SEQ ID NO:62) under test conditions for other lepidopteran pests (SBL, VBC and ECB), and some other clones, thereby determine their activity spectrum (referring to Table 3 and 4).

[0328] Table 3. Activity spectrum of shuffled clones

[0329]

[0330] *NA means not active when tested; and ND means not determined.

[0331] Example 5: Dm3 fragment shuffling on C16 and C21

[0332] Domain 3 (Dm3) is considered to relate to secondary receptor identification.Therefore, on IPRS-C16 (SEQ ID NO:62), IPRS-C18 (SEQ ID NO:66) and IPRS-C21 (SEQ ID NO:88), carry out Dm3 reorganization, thereby produce unique variant and may have different sites of action (SOA).Based on the comparison of several Cry toxins, 7 different intersection regions (normally conservative) between Dm2 and Dm3 will be used as the recombination site that Dm3 merges on IPRS-C16, IPRS-C18 and IPRS-C21 Dm1-Dm2 main chain.

[0333] 53 different synthetic Cry toxin domain-3s were selected as a source of diversity. Seven fragments of each domain (cross-common regions 1-7, SEQ ID NOs: 251-257; see Tables 5 and Figure 4 ) and were merged based on the intersections (each pool contained 53 PCR fragments). Two pools of Dm3 PCR fragments were prepared, each containing 7 individual Dm3 fragment pools. One pool was prepared for the IPRS-C21 backbone, and another pool was prepared for the IPRS-C16 and IPRS-C18 backbones. The corresponding pools forming each group were identical except for the intersection region homology ( Figure 4 ).

[0334] Seven (crossover 1-7, also referred to as F2-F8) vector backbones were prepared by inverse PCR using backbone-specific PCR primers on the backbone excluding the region to be exchanged. Since IPRS-C16 and IPRS-C18 have the same Dm3, universal primers were used for both backbones.

[0335] Each specific Dm3 pool was assembled with the corresponding inverse PCR vector backbone to obtain all variants in the pMal vector backbone expressed as MBP fusion proteins. After sequence confirmation, all variants were rearranged. Only those clones that expressed in the E. coli soluble fraction were further purified and tested for insect activity. Initially, IPRS-C16 and IPRS-C18 Dm3 variants were screened against FAW, and IPRS-C21 variant was screened against CEW. The active variants were further tested for their spectrum of activity against other lepidopteran pests (see Tables 4 and Figure 7 The Dm3 variants retained activity, but had reduced activity compared to their parents as tested against their respective target insects (IPRS-C16 and IPRS-C18: FAW, IPRS-C21: CEW).

[0336] Table 4. Spectrum of Dm3 exchange activity against other lepidopteran pests

[0337]

[0338] *NA means no activity when tested; NM means no mortality when tested; ND means not determined; and F number is the crossing point

[0339] Table 5. Cry toxin Dm3 fragment intersection points:

[0340]

[0341]

[0342] Example 6: Sequential α-loop 3-5 and Dm3 shuffling on the MP1068 backbone

[0343] MP1068 (SEQ ID NO: 214) is a proprietary Cry toxin. It has 63% homology with Cry1Ac. Its Dm1 is 84% ​​similar to Cry1Ac, Dm2 is unique, having 45% homology with Cry1Nb, and Dm3 has 79% homology with Cry1Bh. Because MP1068 Dm2 is very unique, variants based on MP1068 Dm2 as the backbone were created. Initially, the MP1068 toxin region was expressed as an MBP fusion protein; however, the attempt was unsuccessful because all expressed proteins were in the insoluble fraction. To overcome the soluble expression problem, the α-loop 3-5 fragment exposed to the solvent was reorganized (see Figure 5 and 6 ), thereby generating a variant of MP1068 with insect activity, followed by Dm3 shuffling of the backbone to improve activity.

[0344] The MP1068 in the pMal vector backbone is obtained by reverse PCR backbone specific primers. This vector backbone has all vector components along the MP1068 toxin, except that the α ring 3-5 region. 23 α ring 3-5 fragments (Table 5) are amplified from the synthetic Dm1 fragment PCR. All α ring 3-5 fragments of equal amounts are merged and gel purified. Geneart (Invitrogen) is used to assemble the α ring 3-5 PCR fragment pool and the MP1068 vector backbone based on homology assembly kit. The assembled reactant is transformed into BL21 cells and plated. Three 96-well plates are collected and their soluble expression is directly tested. All expressed clones are rearranged and sent to sequencing to remove redundant sequences.

[0345] Sequencing data revealed the presence of nine unique MP1068 variants (with different α loop 3-5 sequences swapped). All nine variants were tested for insect activity against CEW, FAW, and ECB in the dietary assay (Tables 6 and Figure 7 ).

[0346] Table 6. Insect activity of MP1068α-swapped variants

[0347]

[0348] *NA means not active when tested; NM means not dead when tested; and ND means not determined.

[0349] IPRS-C23 is selected as the main chain (referring to Example 5) for further Dm3 reorganization because it is more active than other 2 active clones tested. 6 Dm3 from Cry1Ca, Cry1Cb, Cry1Da, MP258 (referring to US20160194364 A1, SEQ ID NO:16, incorporated herein by reference), Cry1Bb and Cry1Ja are selected as the source of diversity. By PCR amplification, 5 fragments (intersection 1-4, also referred to as F2 to F5 intersection) of each Dm3 are obtained. Individual fragments (for example, F2 of all Dm3 in diversity) are merged into 5 Dm3 pools (F2 to F5 pools). The vector backbone excluding the region to be exchanged is obtained by inverse PCR. In order to promote the assembly based on homology, the end of the vector backbone and insert (Dm3 pool) has an identical sequence overlap of 15bp. Insert pool and vector backbone are assembled using NEB builder or Gene Art assembly kit gel purification. The assembly reaction was then transformed into BL21 cells and the colonies collected were screened by sequencing. Individual unique clones were rearranged and expression was checked using Bio-Rad 96-well E-Page gel and blotting. Clones expressing the hybrid toxin in the soluble fraction were grown in 150 ml of magic media culture and purified by standard Ni-NTA purification and tested for insect activity.

[0350] All possible 30 clones were purified and tested for activity against CEW, FAW and ECB and 10 were found to be active variants tested, 6 of these 10 active variants showed improved activity against all three insects tested (Table 7).

[0351] Table 7. C23 Dm3 shuffling activity

[0352]

[0353] *NA means no activity when tested; NM means no mortality when tested; ND means not determined; and F number is the crossing point

[0354] Example 7: Sequential Dm1 and Dm3 shuffling on the GS062 backbone (C45, 46, 47, 48 and C49)

[0355] GS062 (SEQ ID NO: 224) is a proprietary toxin that shares 62% homology with Cry1Da. Domain analysis revealed that it is a hybrid toxin, with Domain 1 being Cry1Ac-type (77%), Dm2 being Cry1Ca-type (80%), and Dm3 being Cry1Hb-type (79%). When tested, GS062 was active only against ECB, but inactive against CEW and FAW. Native GS062 was family-shuffled to improve activity against ECB with Dm1 on the GS062 backbone, and then to Dm3 to increase specificity for either CEW or FAW.

[0356] From its respective parent Cry toxin PCR amplification, the complete Dm1 from several proprietary Cry1 toxins was generated. All PCR amplified fragments were merged and gel purified to remove any traces of the parent clones. Then, PCR with the natural amino acid diversity representing the various Dm1 fragments was used to allow the merged Dm1 fragments to be recombined. Four 50 μL assembly reactions containing 0.5-1.0 μM pooled library oligonucleotides and Dm1 fragments were assembled in a Herculase II (Stratagene) reaction. By adding 0.5 μM flanking primers with 30 bp homology to the pMal vector backbone containing GS062 Dm2 and Dm3, subsequent PCR reactions were performed to amplify the approximately 1 Kb gene that was fully extended.

[0357] The vector backbone was obtained by inverse PCR of GS062 toxin in pMal vector. The inverse PCR primers were designed in such a way as to exclude GS062 Dm1 from the PCR fragment, so that the inverse PCR vector backbone fragment would include all pMal vector components as well as MBP, GS062 Dm2 and Dm3.

[0358] The rescued Dm1 mixture was assembled using the Invitrogen Geneart DNA Fragment Assembly Kit. The assembly reaction was transformed into Invitrogen Top10 chemically competent cells. After sequence analysis, all colonies were pooled and a mixed plasmid preparation was prepared. The mixed plasmid was transformed into Lucigen electrocompetent BL21 cells for protein expression.

[0359] Approximately 3000 E. coli (BL21) colonies were collected and screened for full-length MBP-toxin protein expression using Western blotting. Approximately 400 clones expressing the hybrid toxin in the soluble fraction in E. coli were collected and rearranged. Protein was purified from these clones and submitted for determination of ECB activity in a yes / no assay. 40 active clones from the 400 screened clones were then rearranged and sequenced based on ECB activity. During sequencing, redundant clones (clones with identical sequences) were removed, and only 16 unique clones were rearranged, purified, and tested for their specific activity against ECB and SBL in a dose-response manner.

[0360] Because lacking enough homology between the Dm1 that is selected for reorganization, many clones have complete Dm1 or wherein random mutation is exchanged to the Dm1 on GS062 main chain (Dm2-Dm3).These 16 Dm1 that hit are from MP477 (SEQ ID NO:223), GS128 (SEQ ID NO:244) and GS002 (SEQ ID NO:235).The ECB and SBL activity of these 16 clones were tested in a dose-response manner.After testing, these 16 clones all did not produce any measurable specific activity number (IC or LC50) to ECB, but 1 clone with GS002 Dm1 demonstrated good SBL activity (Table 8).

[0361] Table 8. Dm1 activity of GS062 backbone exchange

[0362]

[0363] *NA means not active when tested; NM means not dead when tested; and ND means not determined.

[0364] IPRS-C49 was tested and showed no activity against CEW and FAW, but was highly active against SBL, moderately active against VBC, and slightly active against ECB (see Table 8).

[0365] IPRS-C49 (SEQ ID NO: 112) was selected as the backbone for further Dm3 shuffling (see Example 3) because it was more active than the other three active clones. Six Dm3s from CrylCa, CrylCb, CrylDa, CrylAb, CrylAc, and CrylBe were selected as sources of diversity.

[0366] All possible 30 clones were purified and tested for activity against CEW and FAW. Four variants tested were active against CEW but inactive against FAW. Two of the four active variants were selected for further lepidopteran activity studies, which showed improved activity against ECB, SBL, and VBC (Table 9).

[0367] Table 9. Activity of C49 Dm3 shuffled variants.

[0368]

[0369] *NA means no activity when tested; NM means no mortality when tested; ND means not determined; and F number is the crossing point

[0370] A similar reorganization was performed using GS047 (SEQ ID NO: 228). All 30 possible clones were purified and tested for activity against CEW and FAW. Four variants were active against FAW. All four tested showed FAW activity (SEQ ID NOs: 275-278, encoded by SEQ ID NOs: 271-274, respectively).

[0371] Example 8: Dm1 α-ring exchange on C16 and C21 (α-ring 3, 4, 5, 3-4, 4-5 and 3-5 shuffling)

[0372] Based on the success of the α-loop 3-5 segment shuffling strategy (used in different batch shuffling strategies), individual and combined α-helical shuffling was tested to show which α-helix or α-helices could improve activity or soluble expression. The α-loop 3-5 segments shuffled in the previous library included α-loop 3, 4, and only a portion of α-loop 5. In this library, shuffled α-loop 3, α-loop 4, and complete α-loop 5, either individually or in combination, are present on two batch shuffled variants, C16 and C21. The α-loop 3-5 segments shuffled in this library are slightly longer than the α-loop 3-5 segments shuffled in all previous libraries (see Figure 8 and 9 ).

[0373] Alpha loops 3, 4, 5, 3-4, 4-5, and 3-5 were PCR amplified from 45 synthetic Dm1 fragments (see Figure 11). Different α ring fragments of Cry1Ca were obtained from C21, which contained the Cry1Ca α ring 3-5 fragment. Six different individual and combined α ring fragment pools were prepared for each backbone (α ring 3 pool, 4 pool, 5 pool, 3-4 pool, 4-5 pool, and 3-5 pool). The α fragments of Cry1Ea and Cry1Ca were not included in the pools corresponding to C16 and C21, respectively, to avoid the production of parental backbones. All pools were digested with Dpn-1 and gel purified to avoid parental contamination. Table 10 shows which different domain 1 α helices were PCR amplified. Because C21 contains the Cry1Ca α ring 3-5 fragment, different α fragments of Cry1Ca were obtained.

[0374] By using backbone-specific primers, inverse PCR generated C16 and C21 vector backbones corresponding to the alpha loop 3, 4, 5, 3-4, 4-5, and 3-5 regions, which do not contain the region to be shuffled.

[0375] 12 assembly reactions (6 pools / main chain) were carried out. The carrier backbone of gel purification was assembled with respective α-helical fragment pools to obtain all variants to be expressed as MBP fusion proteins in the pMal carrier. After sequence confirmation, all unique variants were rearranged, and only those clones expressed in the soluble fraction were further purified, and their insect activity was tested. The variant based on C16 was tested for FAW, and the C21 variant was tested for CEW, because C16 and C21 were active to FAW and CEW respectively. 14 active variants were isolated (8 from the C16 main chain and 6 from the C21 main chain). Table 10 shows the test activity of variants.

[0376] Table 10. Insecticidal activity of C16 and C21 alpha loop 3, 4, 5, 3-4, 4-5 and 3-5 variants

[0377]

Claims

1. An insecticidal polypeptide comprising the amino acid sequence of SEQ ID NO:

62.

2. An isolated polynucleotide encoding the insecticidal polypeptide of claim 1.

3. The isolated polynucleotide of claim 2, wherein the isolated polynucleotide comprises the nucleic acid sequence of SEQ ID NO:

6.

4. A DNA construct comprising the polynucleotide of claim 2.

5. A host cell comprising the DNA construct of claim 4, wherein the host cell is a bacterial cell, a yeast cell, an insect cell or an amphibian cell.

6. A method for producing a transgenic plant, the method comprising introducing the DNA construct of claim 4 into a plant cell.

7. A recombinant insecticidal polypeptide having an amino acid sequence of SEQ ID NO: 62, wherein the recombinant insecticidal polypeptide has insecticidal activity.

8. A composition comprising at least one recombinant insecticidal polypeptide according to claim 7.

9. A recombinant polynucleotide encoding the insecticidal polypeptide of claim 7.

10. The recombinant polynucleotide of claim 9, wherein the polynucleotide has codons optimized for expression in an agriculturally important crop. The recombinant polynucleotide according to claim 9 , wherein the recombinant polynucleotide comprises a nucleic acid sequence having SEQ ID NO:

6.

12. The recombinant polynucleotide of claim 9, wherein the recombinant polynucleotide is operably linked to a heterologous promoter.

13. A DNA construct comprising the recombinant polynucleotide of claim 9 operably linked to a heterologous regulatory element.

14. A host cell transformed with the DNA construct of claim 13, wherein the host cell is a bacterial cell, a yeast cell, an insect cell or an amphibian cell.

15. A method for producing a transgenic plant, the method comprising introducing the polynucleotide of claim 9 into a plant cell.

16. A method for producing a transgenic plant, the method comprising introducing the DNA construct of claim 13 into a plant cell.

17. A method of inhibiting the growth of or killing an insect pest or pest population, the method comprising contacting the insect pest or pest population with the insecticidal polypeptide of claim 1.

18. A method of inhibiting the growth of or killing an insect pest or pest population, the method comprising expressing the polynucleotide of claim 2 in a plant.

19. The method of claim 17, wherein the insect pest or pest population is resistant to at least one Cry insecticidal protein.

20. A DNA construct consisting of a polynucleotide and a heterologous regulatory element, wherein the polynucleotide encodes a polypeptide having the amino acid sequence of SEQ ID NO: 62, wherein the heterologous regulatory element is operably linked to the polynucleotide.

21. The DNA construct of claim 20, wherein the polynucleotide comprises a nucleic acid sequence having SEQ ID NO:

6.

22. A method for producing a transgenic plant, the method comprising introducing the DNA construct of claim 20 into a plant cell.